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Oogenesis is the process by which an oocyte (egg) develops to a point where it is 
capable of fertilisation. This process is complex, requiring many fundamental cellular 
and molecular interactions. The study of oogenesis is greatly facilitated in the fruitfly 
Drosophila melanogaster due to this organism's accessible morphology and the 
advanced understanding of its genetics and molecular biology. 
A reverse genetics approach has been adopted in this laboratory to investigate genes 
involved in oogenesis. This approach uses a P-element enhancer trap reporter system 
to provide clues to the temporal and spatial expression of genes. Molecular techniques 
are then used to clone genes situated near the enhancer trap in the genome with in situ 
hybridisation used to match cloned genes to the original reporter expression pattern. 
Occasionally an expression is observed from the in situ hybridisation that bears no 
relation to the reporter gene but is very interesting nonetheless. The work in this thesis 
stems from such an observation. 
We isolated a eDNA with an in situ hybridisation expression pattern that showed gene 
expression very early in oogenesis with rapid localisation of the transcript to the 
developing oocyte. Egg chambers at mid-stages of oogenesis exhibited localisation of 
the transcript to the anterior region of the developing oocyte while late stages of 
oogenesis showed strong expression in the nurse cells and loss of localisation in the 
oocyte. A number of localised transcripts are known to have crucial roles in axis 
determination in the developing oocyte and embryo. 
Work presented in this thesis shows that this gene encodes a class V unconventional 
myosin. Examples of this class have been described in mouse and yeast and there is 
evidence that they are involved in vesicle trafficking. Additional cDNAs were isolated 
and sequenced although no full length cDNAs were found. A PCR and genomic DNA 
cloning strategy was used to obtain most of the remaining coding sequence. 
Hybridisation to polytene chromosomes from the salivary glands of third instar larvae 
located the gene to the 43BC region on the right arm of the second chromosome. 
Results mapping the class V myosin to one of three genes in this region will be 
presented. 
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A region from the carboxyl terminus of the gene was expressed in Escherichia coli 
with the recombinant protein used to raise antibodies in rabbits. Preliminary results 
show that these antibodies detect protein from ovary tissue. 
A cDNA encoding a putative ion-dependent inorganic phosphate co-transporter was 
isolated and sequenced in full. A PCR approach designed to amplify from the class V 
myosin ATP binding site identified sequence from a previously uncharacterised gene 
showing similarity to an- ATPase required for meiotic- spindle= formation in 
Caenorhabditis elegans. 
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ATP Adenosine-5' -triphosphate 
bp base pair 
°C degrees Centigrade 
Ci Curies 
cDNA Complementary deoxyribonucleic acid 
cfu colony forming units 
cm centimetre 
DAB 3', 3'-Diaminobenzidine tetrahydrochioride 
dATP Deoxyadnenosine-5 ' -triphosphate 
dCTP Deoxycytosine-5' -triphosphate 
dGTP Deoxyguanosine-5 ' -triphosphate 
dTTP Deoxythymidine-5' -triphosphate 
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ddGTP 2' (3'-di) Deoxyguanosine-5' -triphosphate 
ddTTP 2' (3'-di) Deoxythymidine-5 ' -triphosphate 
dNTP deoxynucleotide-5 ' -triphosphate 
DNA Deoxyribonucleic acid 
DNase Deoxyribonuclease 
DTT Dithiothreitol 
EDTA Ethylenedianiine-tetra-acetic acid 
g gram 
g gravitational force 
HEPES N-2-hydroxyethylpiperazine-N' -2-ethanesulphonic acid 
HRP Horse radish peroxidase 
IPTG Isopropyl-3-D-thio-galactopyranoside 
kDa kiloDaltons 
kb kilobase pairs 
Kienow Large fragment of DNA Polymerase I 
1 litre 
M moles per litre 
MOPS Morpholinopropanesulphonic acid 
mRNA messenger RNA 
nt nucleotide 
A 
OD Optical density 
OLB Oligo labelling buffer 
pfu plaque forming units 
PCR Polymerase chain reaction 
pH -Log 10 [hydrogen ion concentration] 
RT-PCR Reverse transcription polymerase chain reaction 
RACE Rapid amplification of cDNA ends 
RNA Ribonucleic acid 
rpm revolutions per minute 
SDS Sodium dodecyl sulphate 
Tris Tris(hydroxymethyl)-amino-methane 
Tris-HCJ Tris solution, pH adjusted with HC1 acid 
X-Gal 5-bromo-4-chloro-3-indolyl-3-galactopyranoside 
TCA Trichloroacetic acid 
uv ultra-violet 
V Volts 
v/v volume per volume 
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Intensive studies over many years have produced a detailed explanation of how an 
embryo develops from a single egg, one of the most fascinating occurrences in all 
of biology. The egg itself is a very complex cell containing a haploid genome, 
position information essential for the establishment of body pattern and, in non-
mammals, nutrients which must support growth until the egg hatches. Oogenesis 
is the process by which an egg or oocyte is formed and thus the study of oogenesis 
is an integral part of understanding how life develops from a single cell. 
The application of modern molecular techniques has revolutionised the study of 
many biological systems. These techniques are readily applicable to the field of 
developmental biology and the study of oogenesis. The fruit fly, Drosophila 
melanogaster, provides an ideal organism for the study of the developmental 
pathways in oogenesis because of the wealth of genetic information and the 
technical facilities which exist for this organism. 
1.2 The Morphology of Oogenesis 
The morphology of oogenesis is described in detail in Bownes and Dale (1982). 
An adult female Drosophila contains a pair of ovaries (figure 1. 1A), each attached 
to a lateral oviduct which fuse into the common oviduct, which in turn leads to the 
uterus. Sperm is stored in the seminal receptacle and spermathecae, and is used to 
fertiise mature eggs in the uterus. A network of muscles fibres called the 
peritoneal sheath cover each ovary and assist with the progression of developing 
eggs down the ovarioles. Each ovary consists of 15-20 ovarioles which are joined 
at their ends by terminal filaments. 
At the tip of each ovariole are 1-4 germ-line derived stem cells (figure 1.1 B). A 
stem cell divides to give rise to a daughter stem cell and cystoblast. The cystoblast 
undergoes four further mitotic divisions, each with incomplete cytokinesis to 
produce a cluster of 16 interconnected cells or a cystocytes. One cystocyte, usually 
a posterior-most cell with four intercellular connections (called ring canals) will 
become the oocyte. The remaining 15 cells become nurse cells. 
The cystocyte complex becomes surrounded by somatically derived prefofficular 
cells which later give rise to various follicle cell types. This collective group of 
cystocytes and follicle cells is termed an egg chamber. Egg chambers mature, 
enlarge and progress down the ovariole towards the oviduct. Thus, each ovariole 
contains a series of egg chambers at different stages of development. 
There are 14 morphologically distinct stages of oogenesis as originally described 
by King (1970), see also figure I.I. Stage 1 consists of the 16 cell cyst 
surrounded by a monolayer of approximately 80 follicle cells, and is located at the 
anterior most region of the ovariole known as the germarium. During stages 2 to 5 
the follicle cells proliferate to approximately 1200 cells. One of the cystocytes 
becomes distinguishable as the oocyte and undergoes meiosis. The nurse cells 
become polyploid with up to 2096 genomic copies and they begin to synthesise the 
requirements of the oocyte. The nurse cells exhibit a graded ploidy with those 
closest to the oocyte having a greater number of genomic copies. The follicle cells 
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Figure 1.1: The structure of the adult female reproductive system of Drosophila 
melanogaster. A) Ovaries with 2 ovarioles separated from the ovary. Ov: ovary, 
LO: lateral oviduct, G: germarium, PS: peritoneal sheath, V: vitellarium, F: follicle, 
ME: mature egg, CO: common oviduct, SR: seminal receptacle, S: spermatheca, 
AG: accessory gland, U: uterus (from Bownes and Dale, 1982). B) Ovariole (from 
Spradling 1993a). 
During stages 6 to 8 the follicle cells become evenly distributed around the egg 
chamber with those around the oocyte becoming columnar in shape. Stages 9 to 11 
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During stages 6 to 8 the follicle cells become evenly distributed around the egg 
chamber with those around the oocyte becoming columnar in shape. Stages 9 to 11 
see complex follicle cell migration and differentiation into several subtypes. A 
cluster of 6-10 cells, called border cells, migrate through the nurse cells to the 
anterior surface of the oocyte and are required for formation of the micropyle, the 
appendage which allows sperm to enter the oocyte for fertilisation. By stage 11 
three distinct subtypes of follicle cell can be seen; anterior pole cells, posterior pole 
cells and cOkimnar main body cells. About 80 squamousfoffic1e cells - remain 
surrounding the nurse cells. 
Deposition of yolk protein begins from stage 8 and continues to stage 10. Yolk 
proteins are synthesised in the fat body and secreted into the haemolymph for 
transport to the oocyte. Yolk proteins are also secreted by the follicle cells. The 
oocyte takes up the yolk proteins by endocytosis with a dramatic increase in the 
size of the oocyte being observed. The inner protective layer of the egg, called the 
vitelline membrane is secreted by follicle cells surrounding the oocyte during stages 
9 and 10. Deposition of yolk protein ceases once the viteffine membrane is 
complete. The egg shell, or chorion, is secreted by columnar follicle cells between 
stages 11 and 14. The follicle cells then begin to degenerate. 
The nurse cells synthesise lipid droplets, a variety of organelles and RNA species, 
both ribosomal and messenger, which are required for early embryonic protein 
synthesis and pattern formation. Prior to stage 10, RNA synthesis is intense with 
the nurse cells increasing in volume. At stage lOB there is a rapid and massive 
movement of nearly all of the nurse cell cytoplasm into the oocyte. The nurse cells 
begin to degenerate after this stage. 
Experiments measuring the incorporation of 3H uridine show that the oocyte is 
transcriptionally inactive except for a brief period at stages 9 and 10. At stage 13 
the nuclear envelope breaks down and the chromosomes move to the metaphase 
plate of meiosis and arrest. 
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1.3 The Molecular Basis of Oogenesis 
1.3.1 Genetic Screens 
Oogenesis is a highly complex process involving cell determination, intercellular 
and intracellular transport, cell to cell communication, and temporal and spatial 
genetic regulation (reviewed by Spradling [1993a] and Lasko [1994]). 
A number of genetic screens have been carried out primarily in the 1970's and 
1980's to identify mutations that affect female fertility (for review, see Lasko, 
1994). A screen by Bakken (1973) identified 19 female sterile loci on the second 
chromosome and 17 loci on the third chromosome. These loci could be 
distinguished as belonging to one of three groups: maternal-effect lethals (group I), 
sterile, but producing a normal looking egg (group II), and defective in oogenesis 
(group III). This study was important in that it clearly demonstrated the 
requirement for maternal factors in embryonic development. 
One question that has puzzled researchers is: how many genes are involved 
exclusively in oogenesis? Perrimon et al (1986) have investigated this question 
through the identification of female sterile mutants on the X-chromosome. 
Extrapolation of the results led them to suggest that only 75 genes in Drosophila are 
required exclusively for oogenesis. SchUpbach and Wieschaus (1989, 1991) have 
extensively analysed the second chromosome for female sterile and maternal effect 
mutations. Based on these results, these authors calculate that approximately 300 
genes are required specifically for oogenesis. Analysis of zygotic lethals using 
mitotic recombination techniques have identified nearly 800 loci that are required 
maternally for oogenesis or early embryogenesis (see Lasko, 1994). In addition, 
many 'housekeeping' genes required throughout development will also function 
during oogenesis. 
1.3.2 The Enhancer Trap 
Drosophila has yielded many of its genes to researchers through traditional genetic 
approaches. This method involves identifying mutations which disrupt the process 
being investigated. The gene is mapped using genetic recombination, with greater 
accuracy obtained through deficiency mapping and by the study of chromosomal 
rearrangements that affect the gene's function. Cloning is facilitated by 
chromosomal walking from a known region until a transcript is obtained. This 
process can be time and labour intensive and requires that the gene of interest has a 
selectable phenotype or is easily identifiable. Certain genes are difficult to detect 
using the classical method; those with a degree of redundancy; those with subtle 
functions, being expressed in a limited number of cells; those which function 
several times during development but which only exhibit one mutant phenotype - 
often prior to oogenesis (Freeman, 1991). 
An alternative method was recently introduced which uses P-element mediated 
enhancer detection (O'Kane and Gehring, 1987). In this system a modified 
transposable P-element is randomly inserted into the genome. The modified P-
element carries the Escherichia coli lacZ gene fused in frame to the second exon of 
the P-element transposase gene. Low levels of lacZ expression can occur from the 
constitutive but weak P-element promoter. However, when the promoter comes 
under the influence of nearby enhancer elements tissue specific expression of lacZ 
can occur. Thus, lacZ acts as a tissue specific reporter gene. 
An enhancer trap line is generated by crossing a fly containing the modified 
P-element with a fly that carries a disabled P-element, one which produces active 
transposase but which is unable to transpose itself. Stable lines are generated by 
using a marker incorporated in the modified P-element, usually an eye colour gene. 
A number of assumptions were made about this system when it was introduced; 
that the promoter would function in various tissues and from a variety of enhancer 
elements and that there would no spurious enhancer elements giving "false" 
patterns. Also unknown was what number of specific expression patterns would be 
seen (Freeman, 1991). 
Several studies have validated the enhancer trap approach. Fasano and Kerridge 
(1988) in a study on oogenesis obtained at least 184 lines with single insertions. 
Of these, 32% showed minor background f3-galactosidase staining indicating no 
enhancer activity while 68% showed novel patterns. 13% were germ-line specific, 
33% follicle cell specific while 20% were expressed in both the germ-line and the 
follicle cells and 2% showed staining specific to the gennarium. Bier et al (1989) 
examined over 3700 lines by staining the embryos and obtained 64% with tissue 
specific 13-galactosidase staining of which 49% were specific to either the nervous 
system or the gut. These results showed that the P-element mediated enhancer trap 
system was capable of producing specific staining patterns in the majority of cases. 
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Wilson et al (1989) used a modified P-element that also contained part of a bacterial 
plasmid cloning vector which facilitated the cloning of genomic DNA 3' to the 
P-element. In their study, 26 transposants (lines carrying a P-element) were 
examined with 4 showing an in situ hybridisation pattern from DNA cloned using 
the P-element-bacterial plasmid system. The in situ hybridisation patterns matched 
the -galactosidase staining patterns. An extensive study of oogenesis by 
Grossniklaus et al (1989) involved the examination of over 600 lines. 
Approximately 47% of these lines showed -galactosidase staining in one or more 
ovarian cell with most being temporally and spatially regulated. Germ-line 
expression showed staining mostly in the nurse cells but one line showed specific 
staining in the oocyte nucleus. The oocyte seemed more transcriptionally active 
than had been reported previously. Nurse cell expression was divided into two 
classes. The first class included genes active at an early stage of oogenesis, prior 
to stage 6 and accounted for 15% of nurse cell expression, while the second class 
included genes expressed from stage 6 on, but especially at stages 9 and 10, that is, 
just prior to the nurse cells dumping their cytoplasm into the oocyte. Several lines 
showed varying levels of expression among the nurse cells indicating that the nurse 
cells are not all transcriptionally equivalent. Subsets of the follicle cells showed 
specific staining patterns indicating that these cells are functionally different to their 
neighbours. Gradient patterns of expression were also observed in the follicle 
cells. 
The P-element mediated enhancer trap system has proved extremely useful in the 
identification of a wide variety of genes and will provide the basis for considerable 
progress in our understanding of developmental systems. The P-element also 
provides a tool for further analysis of a gene by the generation of mutations either 
by insertion into the gene or by imprecise excision. 
More recent developments in P-element have utilised the yeast Gal-4 transcriptional 
activator in one P-element and a Gal-4-Upstream-Activating-Sequence (UAS) 
reporter gene construct in a separate P-element (Freeman, 1991). Activation of the 
Gal-4 activator by nearby gene enhancers results in reporter gene expression from 
the second P-element to allow identification of tissue and temporal patterns of 
expression. However, this system is far more potent as the reporter gene can be 
replaced with other sequences, for example, a toxin to allow targeted cell killing, an 
antisense construct to nullify gene expression, or ectopic expression of the gene of 
interest. A bank of Gal-4 lines allows gene expression in a variety of specific cells 
and at differing times. 
1.3.3 To Make Ovaries, First Define Your Sex - Sex Determination 
As oogenesis is a female specific process, the sex of the adult must be correctly 
established to enable female gametogenesis to occur. Sex determination is a 
complex process in itself and only a brief discussion of tbemoleu1ar genetics will - 
be given here as a lead into the molecular genetics of oogenesis. 
1.3.3.1 Sex Determination in the Soma 
Bridges (1916) observed that flies with an X:0 genotype could develop as males 
and although these flies were sterile, concluded that a Y chromosome was 
redundant in sex determination. Bridges was able to establish by 1921 that the 
ratio of X chromosomes to autosomes (X:A ratio) determined the sex of the fly (see 
Cline, 1993). Sex determination is currently best defined as an X:A ratio ~ 1 will 
give rise to a female fly while an X:A ratio :! ~ 0.5 produces a male fly. Flies with 
an intermediate ratio develop as intersexes with the most striking examples 
showing large patches of mosaic tissue derived from individual cells which have 
adopted either a male or a female state. Thus, the primary event for somatic sex 
determination in the fly is a system for determining the ratio of X chromosomes to 
the number of autosomes in a cell. 
Sex-lethal (Sxl) is a gene central to sex determination and was identified as long 
ago as 1932 by Muller (see Cline, 1993). Muller realised that Sex-lethal was 
required for dosage compensation, that is, the level of transcription of the male X 
chromosome is, on average, twice that of a female X chromosome to compensate 
for the reduced dose of X linked genes in the male. However, at that time, the role 
Sex-lethal played in development was not realised. 
Genes involved in the primary events of sex determination generally show sex-
specific lethality because of dosage compensation effects whereas phenotypes 
showing altered sexual characteristics are usually the result of mutations in genes 
downstream of the primary signal. Those genes with a female determining role are 
X-linked and termed numerator elements while those that are male determining are 
autosomal and are termed denominators. These terms reflect the observation that 
increased doses of such genes in one sex alter the X:A ratio towards the opposing 
sex. 
1.3.3.2 Numerator and Denominator Elements 
The first numerator identified was sisterless-a (sis-a), a gene which showed a 
female specific lethal phenotype. A recessive loss-of-function allele of sisterless-a 
was shown to be overcome by a gain-of-function Sex-lethal - allele -implying that 
sisterless-a was a zygotically acting positive regulator of Sex-lethal. The sisterless-
a gene was cloned by Erickson and Cline (1993) and encoded a small 189 amino 
acid protein which had similarity to basic helix-loop-helix transcription factors. 
Analysis of the expression pattern showed that initial expression occurred in the 
embryo from nuclear cycle 8 and persists up to stages 12-13. 
Genetic analysis identified a second numerator in the neurogenic achaete-scute 
complex (Cline, 1988). A duplication in this region was lethal to male flies also 
carrying a duplication of Sex-lethal. The numerator locus in the achaete-scute 
region was called sisterless-b (sis-b) and was mapped to the sc-a component. Of 
the 6 transcripts produced by the sc-a unit, the 14 transcript was shown to be 
mostly responsible for sisterless-b activity with a protein product that shows 
similarity to members of the myc family. A pattern of expression similar to 
sisterless-a was seen for sisterless-b. A genetic screen to identify further numerator 
elements has yielded the weakly acting sisterless-c locus (Cline, 1993). 
The runt gene is a neurogenic locus which has also been identified as having a role 
in sex determination. This role was identified as an interaction between a 
sisterless-b deficiency and a null runt allele in a trans-heterozygous fly resulting in 
severely reduced female viability (Duffy and Gergen, 1991). This phenotype is 
suppressed by a dominant feminising Sex-lethal allele. Increased doses in triploid 
intersexes show a feminising effect and decreased doses masculinise the flies 
indicating that runt acts as a numerator element. The runt gene may code for a 
tyrosine kinase and its expression in the embryo is initially in a broad central 
domain suggesting that other elements may act as numerators at the ends of the 
embryo (Kania et al, 1990). 
The deadpan (dpn) locus is the only known denominator element and is located on 
chromosome 2 (Bier et al, 1989). Studies showed that this locus had a stronger 
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effect on male viability than female and this effect was even more pronounced 
when combined with additional copies of sisterless-b (Younger-Shepherd et al, 
1992). Mutations in deadpan can be rescued by a female-lethal Sex-lethal allele 
demonstrating that deadpan is a regulator of Sex-lethal. Expression is seen in the 
embryo at similar stages to that for sisterless-a and sisterless-b but subsequent 
expression becomes confined to neuroblasts showing deadpan as also having 
neurogenic functions. 
1.3.3.3 Maternal Effect Genes 
It was realised early in the study of Drosophila sex determination that maternal 
effect genes were involved in this process. The daughterless mutation showed 
lethality to female offspring with this effect being traced to a function in oogenesis 
by use of temperature sensitive mutations (Cline, 1976). These studies also 
demonstrated that daughterless had a zygotic role. The gene product is a protein 
with similarity to the Bicoid and Paired transcription factors (Cronmiller et al, 
1988) and interacts with products of the achaete-scute complex. DNA binding 
activity has been demonstrated when the daughterless protein and achaete-scute T3 
are used in combination but not when these factors are applied individually (Murre 
et al, 1989). The Sex-lethal' allele rescues daughterless mutants showing that 
there is an interaction between these genes (Cline, 1983). Null alleles show a 
zygotic requirement for daughterless in both sexes for somatic development while a 
role in the germ-line for egg chamber morphogenesis is also postulated (Cummings 
and Cronmiller, 1994). 
The hermaphrodite (her) gene exhibits similar effects to those of daughterless on 
female progeny at elevated temperatures (Pultz et al, 1994). This gene shows 
distinct maternal and zygotic mutant phenotypes; the herl(2)" allele has a maternal 
phenotype only while zygotic alleles are not rescued by constitutive expression of 
Sex-lethal or transformer. The gene encodes a putative zinc finger protein implying 
a role as a transcription factor (Ryner and Swain, 1995). 
Two neurogenic loci with involvement in sex determination are groucho and 
extramacrochaetae. The Groucho protein was implicated by identification in a yeast 
two-hybrid system as interacting with a number of basic helix-loop-helix proteins 
including Deadpan (Paroush et al, 1994). The extrainacrochaetae gene encodes a 
protein with a helix-loop-helix domain but without the DNA-binding basic domain 
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suggesting that this protein binds to others to form heterodimers that are then 
unable to activate gene expression (Younger-Shephard et a!, 1992). 
Two alleles of the fl(2)d locus produce differing sex-specific effects; the fl(2)d' 
allele is lethal to females and semi-lethal to males when homozygous whereas 
fl(2)d2  is lethal to both sexes when homozygous. The locus has been mapped to 
region 50A-F on chromosome 2 by deficiency mapping (Granadino et al, 1992) but 
the gene product is unknown. A role for female specific splicing of Sex-lethal is 
shown by the ability of SexlethalMl  to rescue fl(2)d mutants and the detection of 
male forms of Sex-lethal transcripts in XX fl(2)d flies. 
The sans-flue gene has roles in Sex-lethal expression in both the germ-line and the 
soma. Constitutively expressing alleles of Sex-lethal suppress the sans-fille 
mutation (in the soma) while germ-line clones of sans-fille lack sex-specific 
transcripts of Sex-lethal. The gene has been cloned and encodes a protein with 
similarity to the mammalian U 1 A snRNP protein suggesting a requirement for the 
maintenance of Sex-lethal expression rather than its initiation (Flickinger and Salz, 
1994). 
The virilizer gene was identified in a screen for female sterile loci on the second 
chromosome (Schupbach and Wieschaus, 1989). This gene is required for dosage 
compensation and sex determination in females and has an unknown vital function 
in both sexes (Hilfiker et al, 1995). In genetic mosaics, XX cells with mutant 
virilizer differentiate with male attributes indicating that virilizer is a positive 
regulator of female specific Sex-lethal splicing. 
1.3.3.4 Regulation of Sex-lethal 
In response to the factors that have assessed the chromosome number, transcription 
of the Sex-lethal gene begins from the early promoter, P E7  in female embryos. This 
promoter results in the production of female specific Sex-lethal protein. At the 
blastoderm stage the maintenance or late promoter, PM1 becomes active in both 
sexes but the presence of Sex-lethal protein in the female results in the splicing out 
of the third exon. This exon contains a stop codon and results in truncated non-
functional protein in the male (reviewed in Cline [1993[ and MacDougall et a! 
[1995]). The female form of Sex-lethal autoregulates its own splicing and also 
initiates a cascade that results in sex specific proteins from the doublesex gene. In 
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the female the transformer gene is spliced by Sex-lethal protein to produce active 
transformer protein, itself a splicing factor. The products of the transformer and 
transformer-2 genes then control the splicing of the doublesex gene. Active 
doublesex protein is produced in both males and females but the male version is 
larger. 
1.3.3.5 Sex determination in the Germ-line 
The sex determination of the germ-line differs from that of the soma. This 
observation resulted from transplantation of pole cells from one sex into the other 
(Marsh and Wieschaus, 1978). Transplantation of pole cells showed that XX cells 
would give rise to eggs in a female whereas non functioning sperm were formed in 
males. A reciprocal transplantation of XY germ cells showed spermatogenic 
development in both males and females (Van Deusen, [1976], Steinmann-Zwicky 
et al [1989]). These results show that the female germ-line requires an inductive 
signal in addition to a cell autonomous signal. 
Investigations into the role of the genetic cascade required for somatic sex 
determination, the genes transformer, transformer-2, doublesex and intersex show 
that these genes are not required in the germ-line for sex determination (Schupbach 
[1982], Marsh and Wieschaus [1978]). However, transformer-2 is required for 
the formation of fully functional sperm later in spermatogenesis (Belote and Baker, 
1983). Correct functioning of this cascade in the soma is also required for the 
inductive signal that a female germ-line must receive for correct development 
(Nothiger et al, 1989). 
Sex-lethal is also essential for germ-line sex determination although this role 
appears to differ to that in the soma, based on mutants which affect one process but 
not the other (Salz et al, 1987)). Genes required for somatic induction of Sex-
lethal; sisterless-a, sisterless-b and daughterless are not required for its activation in 
the germ-line (see Steinmann-Zwicky, 1992) Investigations into the expression of 
Sex-lethal in wild type ovaries has shown the protein to accumulate in the 
cytoplasm of stem cells cystoblasts and 2-cell cysts. The protein is not detectable 
in later stage cysts but reappears in the nuclei in the centre of the germarium (Bopp 
et al [1993], Oliver et al [1993]). The Sex-lethal protein is not detected in 
mutations of ovo, ovarian tumor, fused or sans-flue placing all of these genes 
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upstream of Sex-lethal. Analysis of Sex-lethal transcripts shows the presence of 
the default male form in mutant alleles of sans-fille. 
Mutations in genes required for germ-line sex determination in the female 
demonstrate undifferentiated or spermatogenic phenotypes. To date, six such 
genes have been identified with this phenotype, ovo, ovarian tumor, fused, and 
sans-flue (also known as liz orfs(1)A1621) as mentioned above, as well as fl(2)d 
and bag-of-marbles. 
The ovarian tumor gene has cloned and analysed at the molecular level. Mutations 
in ovarian tumor can be placed into three classes; quiescent - where no germ-line 
forms, oncogenic - where large numbers of undifferentiated germ cells are found, 
and differentiated - where oogenesis begins but becomes blocked at an early stage 
(Sass et al, 1995). These different states suggest multiple roles for ovarian tumor 
in the germ-line. Alternative splicing produces two isoforms; a 98kDa protein and 
a 104kDa protein (Steinhauer and Kalfayan, 1992). The 104kDa form can rescue 
all classes of mutant whereas the 98kDa form only rescues the least severe, 
differentiated class. Constitutive expression of Sex-lethal rescues the oncogenic 
class, not the quiescent or differentiated classes (Sass et al, 1995), although 
Rodesch et al (1995) claim that constitutive Sex-lethal rescues ovarian tumor 
mutants that lack the 104kDa protein, that is, all classes. The amino acid sequence 
does not predict a function but shows similarity to that deduced from the bag-of-
marbles gene. 
The ovo gene is genetically complex with both dominant and recessive mutations 
showing an essential requirement in the germ-line (Oliver et al [1987], Oliver et al 
[19901). However, the shaven-baby and lozenge-like alleles show defects in the 
cuticle and in eye development respectively (Ménel-Ninio et al, 1991). The gene 
encodes a putative transcription factor of 13 lkDa containing four zinc fingers. Use 
of an ovo-lacZ reporter transgene in pseudofemales has demonstrated that ovo 
expression in the female germ-line is dependent on a female karotype in the germ-
line (Oliver et al, 1994). 
The sans-fille gene is likely to be involved in the maintenance of Sex-lethal splicing 
in the soma and this would also appear to be its role in the germ-line. Th e fused 
gene encodes a putative serine/threonine kinase and is a possible candidate in soma 
to germ-line communication (Oliver et al, 1993). Although alleles of the bag-of- 
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marbles gene have tumourous ovary phenotypes, it would appear to be involved in 
control of cystoblast and cystocyte division rather than germ-line sex 
determination, as will be described later. 
1.3.3.6 Summary of Sex Determination 
Sex determination in the soma is reasonably well understood. The primary control 
is Sex-lethal with activation of this gene being controlled at the level of 
transcription. The developing embryo is able to assess its chromosome content and 
respond by activating Sex-lethal accordingly with only females producing an active 
protein. The Sex-lethal signal is transduced at the level of splicing to control the 
female-specific splicing of the doublesex product. 
Sex determination in the germ-line is less well understood but it is clear that two 
pathways are involved. First, the karotype of the germ-line must be XX for correct 
female development and second, a signal is required from the surrounding somatic 
tissue. The genes Sex-lethal, ovo and ovarian tumor have major roles in female 
germ-line development but many other genes have yet to be identified. Sex 
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Figure 1.2 Summary of sex determination in the female (adapted from 
MacDougall et al, 1995). See text for details. 
1.3.4 Determining the Oocyte 
The earliest stages of oogenesis occur in the germarium. The germarium can be 
considered in 4 distinct cytological regions; region 1, region 2a, region 2b, and 
region 3 (Mahowald and Kambysellis [1980], Cooley and Therkauf [1994]). In 
region 1 the germ-line stem cells are dividing to produce cystoblasts. These 
cystoblasts undergo 4 incomplete divisions to produce an interconnected syncytium 
or cystocyte. The final division to produce the 16 cell cyst marks the beginning of 
germarial region 2a. Two cells within the 16 cell cyst contain 4 intercellular 
connections, the ring canals and either can become the oocyte. By region 2b the 
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oocyte is morphologically differentiated from the nurse cells. The pro-oocyte 
occupies the centre of the 16 cell cyst in region 2b but by region 3 it has taken up 
position at the posterior pole. Region 3 of the germarium is also called a stage 1 
egg chamber. A stage 2 egg chamber is formed when follicle cells surround the 16 
cell cyst and it buds from the germarium. 





Figure 1.3 A schematic representation of the germarium adapted from Christerson 
and McKearin (1994). See text for complete description. 
The fusome is a structure that is observed in region 1 and 2a of the germarium (Lin 
et a!, 1994). It is composed of residual mitotic spindle components arising from 
incomplete mitosis during cystocyte formation. The fusome is seen as a distinct 
region of cystocyte cytoplasm extending through the ring canals into all cells in the 
cystocyte and contains vesicles but lacks ribosomes or mitochondria. Once the ring 
canals have matured the fusome disappears. The fusome is proposed to be 
involved in a number of roles in oocyte development; 1) physical blockage of 
cytokinesis, 2) controlling the pattern of cystocyte interconnections by orienting the 
mitotic spindles, 3) to synchronise cystocyte divisions, and 4) may determine the 
oocyte by creating polarity through unequal divisions. 
The early stages of gametogenesis appear similar between males and females 
indicating some shared processes between the sexes. The bag-of-marbles gene 
was identified in a P-element screen that resulted in both male and female sterility 
with the ovaries exhibiting abnormal germaria and testes cells that failed to progress 
from the primary spermatocyte stage (McKearin and Spradling, 1990). The 
transcriptional unit was identified from a chromosomal walk and confirmed by its 
ability to rescue the mutant phenotype in transformed flies. The deduced protein 
sequence of 442 amino acids contains PEST sequences, potential targets for 
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proteolytic degradation (Rogers et al, 1986) and weak similarity to the ovarian 
tumor protein. The transcript is seen shortly after stem cell division and then in 
stage lOb egg chambers as well as the early embryo. The early stem cell 
expression suggests a role in control of cystoblast division and a function in the 
precise control of cell divisions explains its presence in the syncytial embryo. 
The encore gene was identified as a female sterile locus by P-element mutagenesis 
(Hawkins et al, 1996). The recessive encore allele shows three classes of 
mutation when homozygous; the most common possessing twice the normal 
number of germ cells, seen as 31 nurse cells and 1 oocyte, while a less frequent 
class shows bipolar egg chambers with additional germ cells and incorrect 
positioning of the oocyte. The least frequent class of mutation shows fewer than 
normal germ cells and no oocyte. Since the last two classes of mutation are often 
seen as adjacent egg chambers containing a total of 32 germ cells, it seems 
reasonable to predict that the egg chamber that contains less than 16 germ cells is 
caused by incorrect follicle cell migration during the pinching off of the egg 
chamber. 
The encore mutant phenotype arises from an extra round of mitotic cell division in 
the cystocyte as demonstrated by 2 cells within the 32 germ cell egg chamber 
carrying five ring canals instead of the normal four (Hawkins et al, 1996). 
The encore gene appears to interact with the bag-of-marbles (barn) gene with the 
expression pattern of bag-of-marbles being more expanded in an encore mutant 
than in the wild type. A bag-of-marbles-encore double mutant exhibited the 
tumorous ovary phenotype of barn indicating that barn is a dominant suppresser of 
encore. These results suggest that barn protein influences the cystoblast mitotic cell 
divisions and that encore is required to regulate barn. Mutations in encore also 
affect the oocyte nucleus with it becoming more like the nuclei of the nurse cells 
and showing polyploidy, especially in egg chambers with a normal complement of 
nurse cells. This observation suggests that encore is also required for oocyte 
maintenance. 
Another gene required for germ cell development is stonewall (Clark and 
McKearin, 1996). This gene was identified from a P-element mutagenesis screen 
and encodes a nuclear protein with a DNA binding domain that shows similarity to 
the Myb and Adf- 1 transcription factors. The stonewall 5 allele, which produces 
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transcripts but not protein, only affects female ovaries. In this mutant, stem cells 
divide correctly to produce cystoblasts and cystocytes but the oocyte fails to 
differentiate implicating a function in oocyte maintenance for the stonewall gene. 
The Bicaudal-D gene, when mutant, produces a number of phenotypes ranging 
from sterility to the double abdomen embryos which give the gene its name. Sterile 
mutants produce egg chambers containing 16 nurse cells with no oocyte being 
specified. Bicaudal embryos are formed because of incorrect localisation of 
posterior patterning determinants stemming from the Bicaudal-D gene. 
The Bicaudal-D gene has been characterised at the molecular level and encodes a 
protein with extensive coiled-coil a-helices similar to those in the tail regions of 
type II myosins (Wharton and Struhl, [1989], Suter et al [1989]): The mRNA 
from this gene accumulates in the pro-oocyte in germarial region 2a, a process 
which is dependent on the correct function of the gene itself as mutants producing a 
16 nurse cell cyst fail to localise the mRNA (Suter and Steward, 1991). Later 
results have shown that the localisation of the Bicaudal-D protein to the pro-oocyte 
is dependent on its phosphorylation (Suter and Steward, 1991). Mutations in 
Bicaudal-D that lead to failure in phosphorylation of the protein show loss of 
protein localisation to the oocyte and failure of oocyte differentiation. 
Ran et a! (1994) generated null mutations in the Bicaudal-D locus and determined 
that Bicaudal-D is essential for oocyte determination, but not for formation of ring 
canals. These authors also determined that Bicaudal-D has a zygotic role and 
observed the presence of protein in other tissues suggesting a wider role for this 
gene in the fly. 
In severe Bicaudal-D mutants the protein distribution is altered with no oocyte 
development taking place implying that cytoskeletal formation has a role in 
determining the oocyte. Further evidence supporting this hypothesis comes from 
Theurkauf et al (1993) who show that the microtubule organising centre (MTOC) 
forms in the presumptive oocyte shortly after completion of the 16 cell cyst. This 
MTOC polarises the egg chamber and it is interesting to note that mutations in 
Bicaudal-D disrupt its formation. 
The orb gene is expressed very early in oogenesis with the transcript localised to 
the presumptive oocyte during region 2 development of the germarium and then at 
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both the posterior and anterior of the oocyte at later stages of oogenesis (Lantz et al, 
1992). This localisation is dependent on the correct functioning of Bicaudal-D but 
is independent of oskar localisation. The orb gene encodes a 99kDa protein with 
two RRM RNA binding domains that differ suggesting different specificity for 
RNA. Females exhibit a 4.7kb transcript limited to the germ-line while males 
express 3.2kb and 2.0kb transcripts in late 3rd instar gonads and in the testes. 
Mutations in orb cause defects in abdominal development and can ventralise the 
embryo showing that orb's role later in oogenesis is in the - lóéalisátio.ñ of 
determinants such as os/car and gurken (Christerson and McKearin, 1994). There 
is also an essential function for orb early in oogenesis as another set of mutations 
cause oogenesis to arrest in the germarium (Lantz et al, 1994). 
Cytoplasmic bridges are a common feature among developing gametes. In 
spermatogenesis the role of these bridges may be to synchronise sperm 
development and to equalise the distribution of gene products (Spradling, 1993b). 
The role of the cytoplasmic bridges, or ring canals, in the interactions of the 
Drosophila nurse cells and oocyte has been well established (Robinson et al, 
1994). Several genes involved in the establishment of the ring canals have been 
identified and characterised. Xue and Cooley (1993) have described the cloning of 
the keich gene. In homozygous mutant lines, normal cytoplasmic transport from 
the nurse cells to the oocyte is disrupted, however, uptake of yolk protein is 
normal. The ring canals are present and appear normal as shown by actin staining. 
Interestingly, the kelch gene appears to be polycistronic, containing an in-frame 
stop codon. Immunoblots detected 2 proteins, a strong 80kDa band, the product of 
the first ORF, and a weak 180kDa band which suggests partial suppression of the 
stop codon. Antibodies to keich protein localise it to the ring canals leading these 
authors to propose that the keich protein is involved in the regulation of 
cytoplasmic flow. 
The Drosophila gene encoding the homologue of the mammalian cytoskeletal 
adducin protein has been reported by two groups (Ding et al [1993a] and, Yue and 
Spradling [1993]). There are two forms of human adducin, a and 0 , however, 
Drosophila appears to have only one which shares homology with both human 
forms. Ding et a! (1993a) showed that the adducin-like mRNA was localised at the 
anterior of the oocyte and that this localisation was dependent on the swallow gene. 
In humans, adducin promotes the association of spectrin and F-actin, both 
cytoskeletal components. Therefore, it is reasonable to assume that adducjn-1ike 
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(or hu-li tao shao [hts] as named by Yue and Spradling, 1993), will be involved in 
the formation and maintenance of the egg chamber cytoskeleton in Drosophila. 
The hu-li tao shao protein is a component of the fusome as demonstrated by 
antibody staining (Lin et a!, 1994). The protein is seen in the follicle cells around 
the membrane, whereas in the germ-line internal structures are stained. This 
staining begins with a perinuclear spherical structure in the stem cells and 
progresses to an elongated and branched structure in 2-8 cell cysts. The 
maturnalian Addücin protein shows association with cx-spectrin -and-  consistent with 
this observation, antibodies detect a-spectrin in these fusomal structures. The 
fusome is also seen in the germarium of Bicaudal-D and egalitarian mutants 
showing that these genes do not control its formation. 
During stage lOb of oogenesis the nurse cells dump most of their cytoplasm into 
the oocyte. In chickadee mutants this process is disrupted because the ring canals 
become blocked with the nurse cell nuclei (Cooley et al, 1992). The chickadee gene 
has been shown to encode a homologue of profilin, a protein involved in the 
assembly of actin filaments. It has been suggested by these authors that the 
subcortical actin filaments contract to propel the nurse cell cytoplasm into the 
oocyte while a second, independent, cytoskeletal set of actin filaments anchor the 
nurse cell nuclei. The chickadee encoded profilin acts exclusively with this second 
set of actin filaments as cytoplasmic streaming still occurs in chickadee mutants. 
The quail gene also produces a similar phenotype to chickadee with the molecular 
cloning of the gene showing that it encodes a protein with similarity to vertebrate 
Villin, a protein that can cap, nucleate, sever and bundle actin filaments (Mahajan-
Miklos and Cooley, 1994). The predicted protein of 887 amino acids contains six 
repeats characteristic of actin binding proteins. Interestingly, the quail product is 
more divergent from vertebrate Vilhin than a similar Drosophila actin binding 
protein, Gelsolin, is from the vertebrate version of Gelsolin. This finding suggests 
that there are subfamilies of Villin, a finding supported by antibodies to vertebrate 
Villin recognising a protein in the larval midgut. This protein does not correspond 
to the quail product as in situ hybridisation with quail does not detect a transcript in 
the midgut tissue. 
A third actin binding protein comes from the singed gene, originally named for its 
mutant bristle phenotype, but a gene which also shows female sterility (Cant et al, 
1994). This female sterility manifests itself as a blockage of the ring canals by the 
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nurse cell nuclei during stage 10 of oogenesis. The singed gene product shows 
similarity (35% identity and 67% similarity) to ectinodermal Fascin, a protein 
found in actin bundles. The singed protein is detected by antibodies in cell 
extensions of follicle cells that are undergoing migration, for example, the border 
cells and the centripetal follicle cells migrating around the oocyte anterior. Female 
sterile mutant phenotypes and mosaic studies also show a requirement for the 
singed gene in the germ-line. 
1.3.5 Regulation of the Chorion, Vitelline Membrane, and Yolk 
Protein Genes 
During the later stages of oogenesis the oocyte increases rapidly in size due to 
uptake of yolk proteins and transfer of cytoplasm from the nurse cells. After this 
size increase, the vitelline membrane and chorion (eggshell) are synthesised. The 
expression of the yolk proteins, chorion and vitelline membrane genes is both 
temporally and spatially regulated. These genes are, therefore, good candidates for 
the study of molecular mechanisms controlling this regulation. 
The yolk protein genes are regulated by two hormones, juvenile hormone and 20-
hydroxyecdysone. Both hormones can act on the fat body to stimulate yolk protein 
synthesis but only juvenile hormone acts on the follicle cells. This action may be 
indirect as yolk protein expression in the follicle cells appears to be dependent on 
stimulation of yolk protein uptake from the fat body (reviewed by Bownes, 1994). 
Two genes identified to date which are involved in this regulation are apterous and 
cricklet. The apterous gene is a putative transcription factor but appears to have an 
indirect role in juvenile hormone signalling as it is not expressed in the brain tissue 
where juvenile hormone is synthesised, the corpus allatum. However, mutations 
in apterous cause, among other defects, female sterility with oogenesis blocked at 
stage 7-8 (Cohen et al, 1992). The cricklet gene has been proposed to code for a 
juvenile hormone carrier protein as the female sterile phenotype cannot be rescued 
with a juvenile hormone analogue (Shirras and Bownes, 1989). 
The 3 single copy yolk protein genes are located on the X-chromosome (Barnett et 
al, 1980). The ypl and yp2 genes are separated by a region of 1.2kb and show 
divergent expression with the 5' ends facing each other. The yp3 gene is located 
more than 1000kb away. (reviewed in Slee and Bownes, 1990). 
22 
Molecular studies using reporter gene constructs have begun to identify and localise 
the mechanisms involved in the expression of the ypl and yp2 genes. A fat body 
enhancer of both genes has been mapped to a 125bp element that starts at a position 
196bp from the cap site of the ypl gene. An enhancer element that controls 
expression of both genes in the follicle cells has been mapped to a 181 bp element 
that is 159bp from the yp2 cap site. An additional enhancer that affects expression 
of ypi has been located in the first exon of yp2 . In addition, a novel DNA binding 
protein with high specificity for a 31bp element that maps 148bp downstream from 
the ypl transcriptional initiation site has been discovered. 
In addition to hormonal regulation, the yolk protein genes are also influenced by 
nutritional conditions. Regulatory elements for 20-hydroxyecdysone have been 
mapped for yp3 in upstream sequence, within coding and intron sequence and in 
sequence 3' to the gene (Bownes et al, 1996). Nutritional regulatory regions have 
been mapped within the intergenic region of ypl and yp2 (Sondergaard et al, 
1995). These genes are also regulated by the sex determination pathway, with both 
male and female specified versions of the doublesex gene product being shown to 
bind in the intergenic region. As the male form of doublesex protein is larger than 
the female form it is possible that the additional male-specific domain represses 
binding by other enhancers or transcription factors. 
Analysis of the yp3 gene is less advanced but the fat body and ovarian regulatory 
elements are contained within a 747bp region 5' to the coding sequence. Two 
independent elements of 328bp and 419bp within this region have been shown to 
govern ovarian and fat body expression respectively (Ronaldson and Bownes, 
1995). 
The chorion is a multilayered structure composed of about 20 different proteins 
synthesised in the follicle cells during stages 11-14 of oogenesis. The six major 
proteins, now referred to as Cpl5, Cp16, Cpl8, Cp19, Cp36 and Cp38, are 
clustered at position 7F of the X-chromosome (Cp36 and Cp38) and position 66D 
of the 3rd chromosome (Spradling et a!, 1980). High demand for chorion proteins 
results in selected amplification of the genes in the follicle cells (Delidakis and 
Kafatos, 1987). Regulatory elements of the Cp36 gene from the X-chromosome 
were investigated using a P-element reporter gene construct. The results showed 
distinct cis-acting elements regulating anterior and posterior expression of the 
reporter gene (Tolias and Kafatos, 1990). 
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Not only are the chorion proteins tightly regulated during oogenesis, they are also 
regulated with respect to each other with those on the X chromosome expressed 
before those on the 3rd chromosome. Expression begins in the follicle cells at the 
anterior-dorsal region and appears to be partially under the control of the dorsal-
ventral axis specification pathway (Tolias et al, 1993). 
The minor chorion proteins are believed to be required for formation of the 
specialised eggshell structures; the micropyle, aeropyle, opuculum and dorsal 
appendages (Parks and Spradling, 1987). 
The vitelline membrane is the innermost part of the eggshell and is synthesised 
during stages 9 and 10 of oogenesis (Fargnoli and Waring, 1982). The vitelline 
membrane is composed of the products of at least six genes, all on chromosome 2, 
four at 26A and one each at 32E and 34C. Analysis of cis-acting sequences of one 
26A gene has identified a 170bp element responsible for follicle cell expression 
while another element was shown to reduce expression in the border cells (Jingman 
and Petri, 1993). 
1.3.6 Gurken, a Signal that has Two Roles 
A role for gurken, a gene coding for a TGF-a-like signalling molecule and its 
receptor torpedo, a gene coding for an epidermal growth factor receptor (EGF), in 
defining the dorsal-ventral axis had been established (reviewed in St Johnston and 
NUsslein-Volhard, 1992) before it was realised that these genes also functioned in 
formation of the anterior-posterior axis. The original theory for anterior-posterior 
axis formation in the oocyte involved direct signalling from the posterior follicle 
cells mediated by the Notch and Delta system (Ruohala-Baker et al, 1991). 
Investigations of spindle-C mutants showed that anterior type follicle cells could 
appear at both poles of the egg chamber when the pro-oocyte failed to migrate to 
the posterior pole (González-Reyes and St Johnston, 1994). This finding 
suggested that the pro-oocyte was involved in defining the posterior pole of the egg 
chamber. Use of an enhancer trap line, L53b, and the slow-border-cells (sibo) 
gene as markers for anterior type follicle cells showed that gurken mutants had 
anterior type follicle cells at the posterior pole indicating a role for gurken in 
defining the anterior-posterior axis (González-Reyes et al, 1995). Additional 
evidence comes from flies carrying hypomorphic torpedo mutations in conjunction 
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with one copy of the rolled gene, a MAP-kinase which functions downstream of 
torpedo. The hypomorphic torpedo alleles allow the flies to survive to adulthood 
but females show obvious defects in the anterior-posterior polarity of developing 
egg chambers (González-Reyes et al, 1995). The anterior follicle cell markers, 
L53b and slow-border-cells, were used to investigate whether other genes affecting 
polarity had a role in establishing the anterior-posterior axis. The genes 
investigated were: orb, cappuccino and spire which affect polarity of both axes; 
fs(1)K10, Which causes a doEsãlised phenotype and cornichón, a ventralising - 
mutant. Only cornichon showed an effect producing a similar phenotype to that 
seen by gurken and torpedo mutants (González-Reyes et al, 1995). 
The cornichon gene has been isolated and analysed at the molecular level by Roth et 
a! (1995) who also described the requirement for gurken and torpedo in 
determining the anterior-posterior axis. The cornichon protein is small at 144 
amino acids and is highly conserved between D melanogaster and D virilis even 
though these species are thought to have diverged some 60 million years ago. The 
comic/ion protein sequence shows a large hydrophobic domain which may be 
membrane spanning suggesting a role in the regulation of the gurken membrane 
spanning signalling protein (Roth et al, 1995). 
Studies on the formation of the anterior-posterior axis (González-Reyes and St 
Johnston, 1994, González-Reyes et a!, 1995 and Roth et a!, 1995) show that the 
pro-oocyte nucleus fails to migrate from the posterior pole to an anterior-dorsal 
position, where signalling for dorsal-ventral axis formation occurs, in gurken, 
torpedo and cornichon mutant lines. A Kinesin--galactosidase fusion protein 
(Clark et a!, 1994) was used to identify the ends of the microtubule array showing 
that rearrangement of the microtubule cytoskeleton accompanies the pro-oocyte 
nucleus migration from the posterior pole to an anterior-dorsal position. 
Thus, a model for establishing the anterior-posterior axis followed by the dorsal-
ventral axis mediated by the same signalling and receptor molecules can be 
envisaged. Initially, the pro-oocyte migrates to the posterior pole of the egg 
chamber and the microtubules are arranged with their minus-ends at the posterior of 
the pro-oocyte which localises the pro-oocyte nucleus there. Signalling to the 
posterior follicle cells via the gurken, torpedo and comic/ion system causes these 
follicle cells to adopt a differentiated posterior state. These posterior follicle cells 
then signal back to the pro-oocyte by the Notch and Delta system to begin 
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rearranging the microtubule cytoskeleton transferring the pro-oocyte nucleus to the 
anterior-dorsal position where once again gurken, cornichon and torpedo proteins 
signal to a group of follicle cells to undertake a dorsal fate. 
The signal-receptor mediated pathway involving gurken and torpedo in determining 
dorsal-ventral polarity was established prior to the role of these molecules in 
anterior-posterior axis formation. Germ-line activity of cappuccino, spire, 
cornichon,fs(1)K10 and squid is required to control the gtirkënsignal received by 
a subset of follicle cells at the anterio-dorsal region of the oocyte via the torpedo 
protein. The spitz gene product also shows similarity to TGF-a molecules and 
Ruohola-Baker et al (1993) originally proposed that the product of the spitz gene 
was the molecule which signalled to the torpedo product. It is possible that this 
molecule is used for an independent signalling pathway. 
The product of the rhomboid gene, a putative transmembrane protein, is involved 
in this regulation either by improving follicle cell-oocyte contact or by direct 
involvement in the signalling pathway (Ruohola-Baker et al, 1993). A further gene 
that has been shown to be involved in this pathway is the neurogenic locus brainiac 
which is also required in the germ-line in determining the signal to the torpedo 
product (Goode et a!, 1992). The fs(1)K10 RNA is localised specifically to the 
oocyte nucleus possibly by cappuccino and spire activity (Cheung et al, 1992). 
Mutations infs(1)K1O show a dorsalised phenotype with the role of the fs(1)K10 
product proposed as being to negatively regulate the signal being supplied from the 
oocyte, whereas torpedo (loss-of-function), cornichon and gurken mutations are 
ventralising - no dorsalising signal is formed. The squid gene also produces a 
dorsalised phenotype when mutant (Kelley, 1993). The product of this gene is a 
putative RNA binding protein that may act by either post-transcriptionally 
modifying the mRNA encoding the signal or by sequestering the mRNA (Kelley, 
1993). On the basis of this information it appears that follicle cells which do not 
receive the torpedo mediated signal adopt a ventralised state by default. 
Several factors that operate downstream of the initial dorsal-ventral signalling have 
been identified including the D-raf serine-threonine kinase and the CF2 
transcription factor. A role for D-raf in transmitting the Toll mediated signal has 
been established by Brand and Perrimon (1994). A Gal-4 enhancer trap system 
was used to target gain-of-function D-raf to the follicle cells with activation 
resulting in a dorsalised phenotype. 
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The CF2 transcription factor is cleared from the anterior-dorsal follicle cells most 
probably as a result of gurken-torpedo mediated signalling leading to its 
phosphorylation (Hsu et al, 1996). Thus, the CF2 transcription factor is able to act 
in the ventral follicle cells although it is not known at this stage whether it functions 
as a direct activator of genes or as a repressor. 
follicle cells 















Figure 1.4 Summary of the early events for establishing the dorsal-ventral 
axis by the gurken (grk) and torpedo (top) signalling pathway. fs(1)K10 
(Kb), squid (sqd), orb, cappuccino (capu) and spire (spin are required to 
localise the gurken mRNA to the dorsal-anterior side of the oocyte nucleus. 
Production of Gurken signal requires the function of cornichon (cm) and 
brainiac (brn) genes. The Gurken signal activates Torpedo in the follicle cells 
which, in turn, activates a Ras signalling pathway. The CF2 transcription 
factor is only active in the ventral follicle cells as a result of this signalling 
pathway. Adapted from Morisato and Anderson (1995). 
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1.3.7 Embryonic Body Patterning and the Maternal Genes that 
Control It 
One area that has received considerable attention in recent years is the formation of 
the embryonic body pattern which has been shown in Drosophila to be controlled 
by maternally derived gene products. Many of the genes involved in this process 
have been identified and the mechanisms of their action has been elucidated. This 
process has been comprehensively reviewed by St Johnston and NUsslein-Volhard 
(1992). 
Once fertilised, an egg develops through an embryonic stage to emerge as a larvae 
after about 24 hours. After fertilisation the zygotic nucleus undergoes a series of 
rapid divisions. After nine divisions the nuclei migrate to the surface of the egg to 
form a syncytial blastoderm. The pole plasm is a specialised and distinct region of 
cytoplasm at the posterior pole containing the polar granules. At the syncytial 
blastoderm stage there are 3-4 nuclei in the pole plasm which form pole cells and 
ultimately the germ-line. The remaining nuclei are surrounded by membranes after 
undergoing a further four divisions at the surface giving rise to the formation of the 
blastoderm. 
1.3.7.1 Anterior 
Manipulations of the egg cytoplasm showed that it contained maternally derived 
determinants. Removal of some material from the anterior pole showed defects in 
the development of the head and thoracic segments. Similarly, removal of 
cytoplasm from the posterior pole showed defects in abdominal development but 
interestingly, not in the unsegmented most posterior region (Frohnhöfer et al, 
1986). 
A number of female sterile mutant lines were identified which showed defects in 
developing embryos affecting the embryonic body pattern. These mutations have 
allowed the identification of the genes involved in the control of body pattern 
formation. 
The anterior determinant is encoded by the bicoid gene. RNA from the bicoid gene 
is localised at the anterior pole of the egg (Berleth et a!, 1988). Once the egg is 
fertilised, the RNA is translated and the gene product diffuses towards the posterior 
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pole forming a gradient. The bicoid gene product contains a homeodomain 
defining it as a direct regulator of transcription. It has been shown to control the 
expression of zygotic genes in the anterior region of the embryo. One of these 
zygotic targets is the hunchback (hb) gene (Tautz et al, 1987). In the absence of 
bicoid, no hunchback expression is seen. The bicoid gene product has been shown 
to bind to high and low affinity sites in the promoter for the hunchback gene 
(Driever and NUsslein-Volhard, 1989). Evidence suggests that the bicoid product 
acts as a morphogen; high concentrations of protein can activate high and low 
affinity sites whereas low concentrations of protein will only activate the high 
affinity sites. Furthermore, the anterior pattern extends towards the posterior when 
the dosage of bicoid is increased. The zygotic target genes are activated in a 
specific region of the embryo through a combination of these bicoid protein binding 
sites so that they only respond to a certain concentration of bicoid protein. The 
hunchback gene product is also a transcriptional regulator and has been shown to 
repress the expression of the gap gene Kruppel in the anterior region of the 
embryo. However, the hunchback gene is only required for determining part of the 
anterior region which suggests that there are other targets for the bicoid gene 
product which act more anteriorly than hunchback. Candidate genes are 
orthodenticle, empty spiracles, buttonhead, and giant, with each being required in 
early embryonic development. As yet none have been shown to be directly 
regulated by the bicoid product (St Johnston and NUsslein-Volhard, 1992). 
1.3.7.2 The Posterior 
The pole plasm contains polar granules, electron dense structures consisting of 
protein and RNA at the very posterior of the oocyte. During embryogenesis the 
pole plasm directs a small subset of cells, the pole cells, to form the germ-line in 
the developing fly (Mahowald, 1968). The pole plasm contains two signals; the 
pole cell determinant and the posterior determinant responsible for abdominal 
development. A set of genes called the posterior group have been identified 
through extensive screens as being required for the formation of pole plasm 
(reviewed in St Johnston and Nüsslein-Volhard, 1992). Mutations in many of the 
posterior group of genes cause defects in both abdominal development and pole 
plasm formation. These genes are cappuccino, spire, staufen, oskar, valois, vasa, 
tudor and mago nashi. Two genes which show abdominal defects but no effect on 
the pole plasm when mutant are pumilio and nanos. The germ-cell-less gene is 
probably required only for pole cell formation (Jongens et al, 1992). 
Continued investigations into the molecular nature of the posterior group of genes 
has allowed a picture to emerge of the roles of several members and the molecular 
interactions which occur. 
The primary posterior determinant is the product of the nanos gene (Wang and 
Lehmann, 1991) as shown by injection of in vitro synthesised nanos mRNA into 
the abdominal region of mutant embryos. Further experiments have shown that the 
nanos mRNA rescues abdominal defects produced by all of the posterior group of 
genes. 
The nanos gene product appears to act in a similar fashion to the bicoid product in 
that a diffusing protein gradient is formed emanating from the posterior pole (Smith 
et al, 1992). The expression of the gap genes knirps and giant are dependent on 
nanos, but unlike bicoid and hunchback, this is an indirect relationship. 
Recent experiments have determined that the caudal gene functions within the 
embryo to form a posterior to anterior gradient which is the opposite of that formed 
by bicoid protein and that caudal activity is required for the activation of the gap 
genes knirps and giant (Rivera-Pomar et al, 1995). Interestingly, the activation of 
caudal mRNA requires bicoid protein with cross-linking experiments determining 
that bicoid protein binds to the caudal 3'UTR (Dubnau and Struhl, 1996). Further 
evidence comes from the work of Rivera-Pomar et al (1996) who show that in 
bicoid mutants a caudal protein gradient fails to form and that bicoid protein can be 
immunoprecipitated from cross-linked caudal mRNA in a 83kDa-7 1kDA complex 
along with a 120kDa protein. This result suggests that at least three proteins, one 
of which is Bicoid, are required for correct caudal function. 
Creation of germ-line clones lacking both nanos and maternal hunchback has 
shown the role of nanos protein is to repress the expression of maternally derived 
hunchback transcripts whose product would otherwise act as a transcriptional 
repressor of both knirps and giant. The hunchback gene is transcribed during 
oogenesis with the mRNA being found evenly distributed throughout the oocyte. 
In wild type embryos the maternally derived hunchback product is degraded in the 
posterior half, while nanos mutants show an even distribution of both hunchback 
mRNA and protein throughout the embryo (Hulskamp et al, [1989], Irish et al 
[1989]). 
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A sequence motif in the 3'UTR of the hunchback mRNA has been shown to 
mediate inactivation by the nanos gene product (Wharton and Struhi, 1991). 
Removal of these motifs, termed nanos response elements (NREs) from a 
hunchback transgene resulted in expression of the hunchback protein throughout 
the embryo. 
Gavis and Lehmann (1994) have extended the studies on nanos translational 
control by showing that the oskar gene is limiting. Increasing the dose of os/car 
from 2 to 4 copies results in more nanos protein being translated at the posterior 
pole although nanos mRNA levels remained the same. Replacement of the nanos 
3'UTR with that from the a-tubulin gene created a dominant female sterile mutation 
with embryos showing defects consistent with ectopic expression of the posterior 
determinant. A bicoid 3'UTR attached to the nanos coding sequence produces 
bicaudal mutant embryos by localising the nanos mRNA to the anterior of the 
oocyte. Inclusion of the nanos 3'UTR to make a nanos-bicoid3'UTR transgene 
results in the anterior localisation of nanos mRNA but not its translation showing 
that the nanos 3'UTR controls the translation of its mRNA. This result is 
interesting as the bicoid 3'UTR appears dominant over the natural nanos 3'UTR in 
terms of mRNA localisation. 
A further role for nanos function has been established in the proper formation of 
the germ cells in the developing embryo (Kobayashi et al, 1996). Pole cells which 
lack nanos activity fail to migrate to the gonad. Gene expression in these mutant 
pole cells is observed much earlier than in the wild type where gene expression is 
not seen until the pole cells reach the gonad. 
1.3.7.3 The oskar Gene is the Posterior Determinant 
Transplantation and injection experiments showed that os/car was the determinant 
for abdominal and pole cell formation (Sander and Lehmann, 1988). Two groups 
reported the isolation of the os/car gene (Ephrussi et al [1991] and Kim-Ha et al 
[1991]) with several alleles identified as being defective in RNA localisation while 
others were defective in posterior function. The os/car mRNA is seen localised to 
the oocyte in germarial regions 2b-3 (it is frequently used as an oocyte marker in 
experiments on oocyte determination) and is localised throughout the oocyte from 
stages 1-6, but by stage 9 is localised to the posterior of the oocyte. The genes 
cappuccino, spire and staufen were all determined to be required for posterior 
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localisation and it was shown that nanos function was dependent on oskar. In 
addition, the nonsense mutants showed that maintenance of the oskar mRNA at the 
posterior was dependent on oskar protein (Ephrussi et al [1991] and Kim-Ha et al 
[1991]). 
The role of oskar as pole cell and abdominal determinant was confirmed by 
mislocalising it to the anterior by coupling the bicoid 3'UTR to the os/car coding 
sequence and - introducing this construct as  transgene. MislöcàlisátioriresüWs in 
bicaudal double abdomen embryos which also have formed pole cells at the anterior 
(Ephrussi and Lehmann, 1992). Increasing the doses of os/car to four copies 
showed increased levels of nanos RNA and staufen protein and a conconimitant 
increase of pole cells to 40-60 compared with 10-15 when one copy of os/car is 
present (Ephrussi and Lehmann, 1992). The oskar-bicoid3'UTR transgene was 
also useful in determining which of the posterior group of genes are essential for 
abdominal development and which are involved in posterior localisation. The genes 
cappuccino, spire, staufen and valois were dispensible for abdominal development 
while nanos, vasa and tudor were essential. 
Further work has recently emerged on the control of os/car expression with 
transgenes used to show that signals which control os/car localisation and 
translational repression reside in the 3'UTR (Rongo et al, 1995). The os/car 
protein is not detected until stage 8 egg chambers at the posterior pole even though 
the mRNA can be detected much earlier showing that translational repression takes 
place. Mutants that fail to localise the os/car mRNA to the posterior; cappuccino, 
spire, mago nashi and staufen, show no os/car protein, whereas protein is detected 
in tudor, vasa, and valois although at reduced levels in the latter two mutants. 
Crosslinking with uv light was used to detect proteins from ovary extracts which 
bound to oskar mRNA (Kim-Ha et al, 1995). An 80kDa protein named Bruno was 
identified and shown to bind specifically to 3 sites within the oskar 3'UTR. These 
sites were called Bruno response elements (BREs). A transgene of os/car lacking 
the BREs was introduced into an oskar- line and shown to rescue the abdominal 
defects but to also produce anterior defects. This result showed that Bruno 
mediated translational repression of os/car in the ovary. Introduction of the 
oskarBRE transgene into cappuccino, spire, mago nashi and orb mutants showed 
the same effect as with oskar; rescue of abdominal defects but creation of anterior 
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defects. However, in a staufen mutant this transgene continued to show posterior 
defects showing staufen is necessary for oskar translation (Kim-Ha et al, 1995). 
Webster et a! (1994) placed the Drosophila virilis oskar gene, virosk as a transgene 
into D melanogaster to examine the effect of the cis-acting localisation signals. The 
virosk gene was localised correctly to the posterior although a novel intermediate 
was observed; the 'dot', a small spherical shaped signal that proceeded through the 
oocyte. Although the virosk gene rescued bddy patterning defects in óskar 1) 
melanogaster ovaries, it was impaired in the maintenance of the mRNA signal at the 
posterior and in pole cell formation. In a wild type background the virosk gene 
showed a dominant negative lethality, probably due to failure to maintain 
localisation at the posterior and thus producing ectopic anterior signalling (Webster 
et al, 1994). 
Analysis of the oskar transcript sequence has revealed two potential translational 
initiation sites referred to as Ml and M130 by Markussen et a! (1995). These 
initiation sites can give rise to 69kDA or 54kDa proteins which are referred to as 
LongOskar and ShortOskar respectively. Both forms were detected by Western 
blots using ovary extracts with an additional band seen at 57kDa which is likely to 
correspond to a post-translationally modified form of the 54kda oskar protein. 
Mutation of both translational initiation sites showed that the ShortOskar was 
sufficient to rescue the oskar mutant phenotype. The LongOskar was tightly 
localised to the posterior pole but did not rescue pole plasm mutations. It would be 
interesting to speculate that the LongOskar represents an early translational product 
required to initiate tight localisation of oskar mRNA to the posterior pole while the 
ShortOskar is produced later and is the more dominant version. 
The vasa protein is localised to the perinuclear region of the nurse cells during early 
oogenesis, then at the pole plasm at the oocyte posterior later in oogenesis. 
Localisation to the posterior is dependent on cappuccino, spire, oskar and stauftn 
but the perinuclear position is not dependent on these genes, although it is 
abolished in vasa mutants. These observations suggest two independent roles for 
vasa (Liang et al, 1994). The vasa gene encodes a DEAD box protein with RNA 
helicase activity. Missense mutants which affect the RNA helicase activity localise 
to the posterior but cause defects in later processes showing that the RNA 
interaction is essential. Mutations in many other parts of the gene cause loss of 
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localisation both at the posterior pole and in the perinuclear region in the nurse cells 
(Liang et al, 1994). 
The pipsqueak gene is required for abdominal segmentation and pole cell 
formation. These defects would appear to be due to a lack of properly localised 
vasa protein in pipsqueak mutants (Siegel et al, 1993). The pipsqueak gene 
encodes a protein containing a BTB box at the amino-terminus, a feature often 
associated with zinc fingers, although pipsqueak protein does not appear to possess 
zinc fingers (Horowitz et al, 1996). The protein contains 34 histidine-lysine 
tandem repeats raising the possibility that these repeats co-ordinate a metal ion and 
facilitate protein-protein interactions. There are also four conserved domains at the 
carboxyl terminus with no known homologies which have been named the 
pipsqueak motif. Antibodies show a nuclear location for the pipsqueak protein 
and, curiously, two spots on the oocyte nucleus during stages 6-10 suggesting the 
regulation of a specific loci. 
Pole cells can be formed at any site within the embryo if the products of oskar, 
vasa and tudor are present. The tudor gene encodes a very large protein of 2516 
amino acids which appears to be novel (Golumbeski et al, 1991). Antibodies to 
recombinant tudor protein recognise three different proteins; a 285kDa species in 
ovarian extracts, a 135kDa species in 0-2 hour embryos and a 205kDa species in 0-
4 hour embryos. The tudor mRNA is localised to the oocyte in the germarium, 
similar to that of oskar. After stage 8 high levels of transcript are seen in the nurse 
cells. The protein distribution shows nurse cell perinuclear localisation and is also 
present in the oocyte prior to vitellogenesis. Localisation in the oocyte is dynamic 
with a transient anterior position from stages 4-6 followed by concentration to the 
posterior pole from stages 9-10 (Bardsley et al, 1993). 
The mago nashi gene was cloned using Restriction Fragment Length 
Polymorphisms (RFLPs) in combination with a chromosomal walk (Newmark and 
Boswell, 1994). It encodes a small 147 amino acid protein with no known 
similarities. In mago nashi mutants the polar granules are absent or severely 
affected. 
The germ-cell-less gene is required specifically for pole cell formation and encodes 
a novel 569 amino acid protein (Jongens et al, 1992). Expression of an antisense 
transgene caused a reduction or loss of pole cells. The germ-cell-less mRNA is 
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localised to the pole plasm and shows dependence on all the posterior group genes 
required for nanos localisation. A transgene resulting in increased expression of 
germ-cell-less produces additional pole cells while localisation to the anterior 
causes ectopic pole cell precursor formation (Jongens et al, 1994). The protein is 
located on nuclear pores suggesting that it may have a role in limiting access to or 
from the nucleus. 
1.3.7.4 The Terminal System 
The terminal system determines the development of the unsegmented ends of the 
embryo, the acron at the anterior and the telson at the posterior. Evidence shows 
that the terminal system is controlled by a different mechanism to that of the 
anterior-posterior axis (reviewed by St Johnston and Nüsslein-Volhard, 1992). 
Transplantation of cytoplasm can be used to rescue several terminal system 
mutations as was the case for the anterior-posterior system but there are notable 
differences. The site of injection of the rescuing cytoplasm is immaterial as is the 
position in the donor oocyte from which it was derived. These results indicate that 
the terminal system does not produce a localised cytoplasmic determinant as has 
been shown for the anterior-posterior axis. In addition, at least one gene in the 
female soma is required for determining terminal structures (Stevens et a!, 1990). 
The torso gene has been identified as functioning in determining the terminal 
system. The gene product of torso has a putative membrane spanning domain, a 
cytoplasmic domain showing homology to tyrosine kinases while the N-terminal 
region contains a signal peptide, thus, the torso product can be classified as a 
member of the receptor tyrosine kinase family (Sprenger et a!, 1989). The torso 
gene is transcribed during oogenesis but is not translated until after fertilisation 
whereupon it localises throughout the zygotic membrane. 
Other genes in the terminal system have been ordered by the use of torso gain-of-
function mutants which probably produce constitutively active torso receptor. 
Thus, mutant genes upstream of the gain-of-function torso should have no effect 
while those downstream will show an effect. Genes upstream of torso have been 
shown to be torso-like, trunk, fs(1) pole hole and Js(1) Nasrat. A downstream 
gene identified by this method was 1(1) pole hole which has been shown to encode 
the Drosophila homologue (D-raf) to the mammalian proto-oncogene c-raf, a 
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serine-threonine kinase involved in signal transduction pathways (Ambrosio et al, 
1989). 
The zygotic targets of this pathway are the genes huckebein and tailless but the 
transcription factor that controls these genes has yet to be identified (Weigel et al. 
1990). The current model for the terminal system proposes that there is an 
interaction between the somatic follicle cells and the oocyte. Of the upstream 
genes, torso-like has been shown to be required-in-the soma while the other genes 
have been shown to be germ-line dependent. At this stage it is not known how the 
ligand for the torso product is formed. Two possibilities exist; torso-like produces 
an inactive ligand acted on by the upstream germ-line gene products to produce an 
active ligand after fertilisation, or perhaps the ligand is the product of one of the 
germ-line genes and it is activated by the torso-like product. The torso-like cDNA 
has been cloned recently (Savant-Bhonsale and Montell, 1993). It encodes a 353 
amino acid protein with an N-terminal signal sequence indicating that the protein is 
secreted. Ectopic expression of torso-like produced embryonic phenotypes similar 
to those seen with gain-of-function torso mutants, but ectopic terminal structures 
were not seen. These authors propose that the torso-like product may interact with 
the trunk product to produce the ligand and that trunk product may be limiting 
explaining the lack of ectopic terminal structures when torso-like was mis-
expressed. Further support for the ligand being the product of the trunk gene 
comes from its comparison with spätzle protein (Cassanova et a!, 1995). The trunk 
protein contains a domain similar to the proteolytic sites in component 3 of the 
complement pathway and also contains a cysteine residues in a similar arrangement 
to the spatzle protein. These "cysteine knots" are regions susceptible to proteolysis 
and are found in a number of signalling molecules. 
Perrimon (1993) has reviewed recent developments in understanding this pathway. 
Activation of D-raf involves p2lras,  a guanine nucleotide binding protein and the 
product of the Ras] gene, and Son-of-sevenless (Sos) whose product is the 
guanine nucleotide releasing/exchange factor. Mutations in Ras] or Sos can 
suppress torso gain-of-function alleles (Doyle and Bishop, 1993). A target for D-
raf activity has been found in the form of the Dsorl mutation where a gain-of-
function allele bypasses the need for torso and D-raf activity. The wild type Dsorl 
product appears to be the Drosophila homologue of the tyrosine/threonine kinase 
Mek. The Mek kinase's target may be a serine/threonine kinase of the MAP class, 
a mammalian MAP kinase has been shown to translocate to the nucleus and activate 
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transcription factors such as Jun and Elk-i. One further gene which has been 
recently identified and appears to be involved in this system is corkscrew which 
codes for a putative protein tyrosine phosphatase (Perkins et a!, 1992). A 
mammalian protein tyrosine phosphatase homologue has been shown to bind to 
activated receptor tyrosine kinases and to become phosphorylated on tyrosine 
residues. 
One curious aspect of the terminal signal transduction pathway is how do the same 
set of activated zygotic gap genes, tailless and huckebein, produce differing 
structures at the termini, the acron and telson. Cytoplasm transplantations indicate 
that these gap genes interact with components of the anterior-posterior axis 
(Sugiyama and Okada, 1990). Wild type cytoplasm from the anterior pole was 
able to produce anterior structures in a torso- mutant while wild type posterior 
cytoplasm restored posterior structures in the torso- mutant. This ability was lost 
in bicoid and nanos mutants, where terminal structures from the opposite pole were 
formed indicating a requirement for the correct anterior-posterior determinant for 
proper terminal structure formation. 
A number of signal transduction pathways have now been identified which use a 
receptor tyrosine kinase and a kinase cascade to transduce their signal - another 
being the sevenless system which is involved in differentiation of the R7 
photoreceptor cell in the Drosophila eye. These pathways show a high degree of 
conservation throughout evolution (Perrimon, 1993). 
1.3.7.5 The Dorsal-Ventral System 
The dorsal-ventral pattern is established by three sequential signalling pathways as 
defined by the phenotypes of mutations observed to affect this pathway (reviewed 
in Morisato and Anderson, 1995). The three stages are; 1) maternal effect that 
disrupt the polarity of the embryo and show defects in the eggshell, 2) those that 
produce a normal eggshell but show embryonic defects and 3) zygotic mutations 
that disrupt the dorsal-ventral pattern at more specific parts of the embryo. 
The role of gurken in establishing the first stage of dorsal-ventral signalling has 
been discussed earlier (see section 1.3.6). The second stage of signalling involves 
the dorsal group of genes which will be discussed below. The third stage of 
dorsal-ventral patterning occurs in the embryo as a result of the primary patterning 
set down by the first two stages. As this stage occurs in the embryo, it will only be 
mentioned very briefly. 
The second stage of dorsal-ventral patterning has features similar to the terminal 
system in that a membrane spanning receptor protein is central to a signal 
transduction pathway. The transmembrane receptor protein is believed to be the 
product of the Toll gene due to it possessing domains homologous with other 
receptor proteins such as the human platelet glycoprotein lb and the interleukin- 1 
receptor (Hashimoto et al [1988], Schneider et al { 1991]). The Toll gene product 
is present throughout the embryonic membrane by the syncytial blastoderm stage 
(Hashimoto et al, 1991). Phenotypes of Toll range from dorsalised embryos 
resulting from loss-of-function mutants to ventralised embryos resulting from gain-
of-function mutants which are probably constitutively active (Schneider et al, 
1991). As with the terminal system, the gain of function mutants have enabled 
other genes in the dorsal-ventral group to be positioned upstream or downstream of 
Toll. Genes which function upstream of Toll are gastrulation defective, pipe, 
nudel, windbeutel, snake, easter and spatzle, while those that function downstream 
include tube, pelle and dorsal. The cactus gene is also part of the dorsal-ventral 
group and its function will be discussed later. 
The product of the dorsal gene is believed to be the transcription factor that controls 
dorsal-ventral polarity in the embryo. Several lines of evidence support this 
conclusion; the rescuing effect of transplanted cytoplasm, the interaction with the 
cactus gene product, and only a -i-/dorsal heterozygote shows a dominant effect, 
producing a partially ventralised embryo indicating that higher levels of dorsal 
product are required for proper determination of ventral regions (see St Johnston 
and NUsslein-Volhard, 1992). The Toll signal is transmitted from the ventral side 
of the embryo and regulates the nuclear localisation of the dorsal product. dorsal 
RNA and protein are synthesised during oogenesis and evenly distributed 
throughout the oocyte cytoplasm. The distribution of the dorsal protein changes at 
about the ninth nuclear division in the zygote (Steward, 1989). In ventral positions 
dorsal protein associates with the nuclei, in lateral positions it is evenly distributed 
between the nuclei and cytoplasm, while in dorsal positions it is found only in the 
cytoplasm. During mitosis the protein levels become uniformly distributed as the 
nuclear membranes breakdown. Localisation of the dorsal product occurs by 
selective nuclear targeting. 
The dorsal gene product shows homology to subunit of the mammalian nuclear 
transcription factor NF-KB which is also regulated via a nuclear localisation signal 
(Ghosh et al, 1990). NF-KB is inactive in the cytoplasm as p65 and p50 subunits 
bound to the lxB protein, but upon receiving a signal the licB protein is released 
and the p65 subunit translocates to the nucleus (Nolan et al, 1991). The cactus 
gene product shows homology to 1 icB, with loss-of-function cactus mutations 
exhibiting a ventralised phenotype consistent with the hypothesis of nuclear 
targeting of dorsal protein (Roth et al, 1991). However, other factors must also be 
involved as the cactus mutants are not the strongest ventralised phenotypes that can 
be found. Govind et al (1993) postulate that the Toll mediated ventral signal 
modifies both dorsal and cactus products, perhaps by phosphorylation, to produce 
maximal nuclear localisation of dorsal product in ventral regions. Thus, the 
spatially regulated ventral signal may be required to act directly on dorsal protein 
for nuclear localisation. Later results from Belvin et al (1995) show that the cactus 
protein is rapidly degraded in response to the Toll mediated signal. The cactus 
protein contains PEST sequences, regions which are susceptible to proteolytic 
attack (Rogers et al, 1986). Injection of in vitro synthesised mRNA to produce 
cactus protein lacking the PEST sequences resulted in retention of more cactus 
protein than in the wild type. However, the PEST sequences are not required for 
signal-dependent degradation leading Belvin et al (1995) to propose that cactus is 
more stable when attached to dorsal protein and that it undergoes both signal 
dependent and signal independent rapid degradation in the embryo. 
Both tube and pelle have been cloned and sequenced (Letsou et al 1199 1 ],  Shelton 
and Wasserman [1993]). The tube gene encodes a novel protein of 50kd for which 
no direct function has been found while pelle encodes a 501 amino acid protein 
which shows a protein kinase domain similar to raf and mos, mammalian kinases 
with serine/threonine specificity. The pelle product may phosphorylate the dorsal 
and/or cactus products as suggested by Govind et al (1993). 
The role of the easter gene has been further defined by Chasen et al (1992), who 
show that the easter product, a serine protease, is in the form of an inactive 
zymogen which is evenly distributed in the periviteffine space. Therefore, easter 
product is regulated post-translationally to produce active protease restricted to 
ventral regions. Of the 7 genes upstream of Toll, only spatzle was bypassed by a 
dominant active mutant of easter in double mutants suggesting that the spatzle 
product may produce the ligand for the Toll receptor when acted upon by the easter 
serine protease. Morisato and Anderson (1993) have shown that a proteolytically 
processed form of spätzle product is lacking in dorsal group mutants upstream of 
spätzle, but present in those downstream of spatzle. 
Further evidence that spätzle provides the ligand for the Toll receptor comes from 
purification of a 24kDa form of the protein which is only recognised by antibodies 
to the carboxyl terminal region (Schneider et al, 1994). This purified protein was 
able to produce polarising activity on injection into embryos. A deletion mutant in 
the spätzle gene which leaves only 106 amino acids from the carboxyl terminal 
region was also shown to activate Toll but a deletion leaving 168 amino acids was 
not (Morisato and Anderson, 1994). This observation suggests that intrinsic 
properties of the spätzle protein prevent it activating the Toll receptor and that these 
parts of the protein must be removed by proteolytic cleavage. 
Epistatic experiments show that the snake gene is immediately upstream of easter 
and that gastrulation defective is upstream of snake (Chasan et al [1992], Roth 
[1994]). The snake protein appears to be secreted as an inactive zymogen. Mosaic 
studies have demonstrated that the genes pipe, nudel and windbeutel are required in 
the soma (Stein et al, 1991). The nudel gene has been cloned and sequenced with 
the deduced protein sequence showing similarity to extracellular matrix proteins but 
also containing a serine protease region (Hong and Hashimoto, 1995). This result 
suggests that the nuclei protein resides on the surface of the follicle cells and is 
somehow activated by the pipe and windbeutel gene products. The nudel protein 
then initiates a proteolytic cascade which leads to the spatially restricted activation 
of the spätzle protein. 
The zygotic targets for the dorsal protein are the genes zerknüllt (zen), 
decapentaplegic (dpp) and tolloid (reviewed by Morisato and Anderson, 1995) 
which act in dorsal regions, and twist and snail which act ventrally. In the wild 
type, the exclusion of dorsal protein from the nucleus allows expression of 
zerknüllt, decapentaplegic and tolloid, while in the ventral regions localisation of 
dorsal protein is required for the expression of twist and snail. In lateral regions 
the even distribution of dorsal protein between the cytoplasm and nucleus prevents 
expression of any of the above genes. Thus, the dorsal protein must act in a 
similar way to bicoid protein in that a threshold concentration has the ability to 
activate a gene. Binding sites for dorsal protein have been found upstream of the 
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zerknullt and twist genes which suggests that the dorsal protein acts as both 
transcriptional repressor and activator 
1.3.8 Localisation of Transcripts 
Oogenesis requires the targeted localisation of many proteins. While it is possible 
for proteins to diffuse to the place they are required, there is increasing evidence for 
targeting cytoplasmic proteins by the localisation of their mRNAs (reviewed by St 
Johnston, 1995). 
As discussed earlier, the bicoid mRNA is localised to the anterior margin of the 
oocyte implying the existence of a mechanism which causes this localisation. 
Several mutant genes have been identified that result in the mis-localisation of 
bicoid mRNA. These are exuperantia (exu), swallow (swa) and staufen. The 
staufen gene product has also been shown to be involved in the localisation of the 
posterior determinant. 
Several steps have been observed in the localisation of bicoid mRNA. First, it 
localises to the apical region of the nurse cells, then it is transported to the cortex of 
the oocyte at the anterior pole where it is anchored (St Johnston et al, 1989). 
Mutations in exuperantia disrupt the nurse cell localisation phase while swallow 
mutants cause bicoid mRNA to dissociate from the cortex. The swallow mRNA 
shows a localisation pattern similar to bicoid mRNA during stages 5 to 6 of 
oogenesis, but it is not clear whether or not swallow is involved in bicoid 
localisation at that time (Hedge and Stephenson, 1993). The swallow gene product 
encodes a putative RNA binding protein and a helical domain that may be involved 
in protein-protein interaction (Hedge and Stephenson, 1993) Analysis of the 3' 
UTR of bicoid mRNA has shown a 53nt element (BLE1) that determines the early 
steps of RNA localisation, while deletions in other regions of the 3' UTR impair 
later steps of localisation (Macdonald et a!, 1993). Therefore, it is probably that 
localisation of bicoid mRNA involves the step-wise use of a number of elements. 
The green fluorescent protein (GFP) from the jellyfish Acquorea victoria is 
proving to be a useful tool for the study of many biological systems. The GFP 
gene has been coupled to the exuperantia gene and used as a transgene to study the 
localisation patterns of exuperatia protein (Wang and Hazelrigg, 1994). This study 
showed that the exuperantia protein was part of a ribonucleoprotein complex which 
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contains bicoid mRNA and is targeted to the oocyte anterior probably via 
microtubule attachment. These authors note that exuperantia protein can bind RNA 
non-specifically in vitro and do not believe that it binds bicoid RNA directly. 
Transport to the posterior pole is more complex as the molecules must translocate 
across the oocyte. The earliest members of the posterior group of genes to show 
localisation are staufen protein and oskar mRNA (St Johnston et al, 1991). 
However, the interaction of these two molecules is complex as Os/air lôcalisatiori is 
abolished in a staufen mutant but posterior stabilisation of staufen protein requires 
oskar, probably as protein as in-frame stop codon mutations that affect the oskar 
protein but not the mRNA exhibit this effect. A similar experiment to that with the 
3' UTR of bicoid RNA was performed with the 3' UTR of os/car mRNA showing 
that localisation involves several elements acting in a step-wise combinatorial 
fashion (Kim-Ha et a!, 1993). 
One further posterior group mRNA that shows an interesting pattern of localisation 
is that of the Hsp83 gene (Ding et al, 1993b). The mRNA from this gene is 
localised to the posterior pole by a combination of RNA degradation and protection 
- RNA not at the posterior pole is selectively degraded while that at the posterior 
pole is protected. This gene product is also found at the anterior pole of the zygote 
where expression is dependent on bicoid and the other genes that operate in the 
anterior regions (Ding et al, 1993b). 
Interestingly, not all mRNA localisation is essential as shown with the fs(1 )K1 0 
gene by Serano and Cohen (1995). The fs(1)K10 mRNA is normally found 
localised to the anterior cortex of the oocyte during early stages of oogenesis and is 
required for establishing the dorsal-ventral polarity in the egg chamber (see section 
1.3.6). Mutations in cappuccino and spire that affect the fs(1)K10 mRNA 
localisation continue to show normal synthesis and localisation of fs(1)K10 
protein. Transgenes were constructed to produce either a uniformly distributed 
transcript throughout the oocyte or posterior localisation of transcript. In both 
cases functional and localisedfs(1)K10 protein was produced. 
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1.4 Aims of this Thesis 
It can be seen from the preceding discussion on the molecular genetics of oogenesis 
that some areas are particularly well understood, for example, the genes used in 
oogenesis to initiate the establishment of the embryonic axes. However, there is 
much more that is poorly understood, for example: what processes determine the 
oocyte, what are the interactions that occur between the germ-line cells and the 
follicle cells, what are the interactions between the subtypes of follicle cells, and 
how does the sex determination pathway influence oogenesis? Thus, there are 
many aspects of oogenesis which are open to further investigation. 
As the oocyte develops it enlarges considerably as a result deposition of many 
products synthesised in the nurse cells and in the soma. These products from the 
nurse cells include proteins and mRNAs essential for oogenesis and later 
embryonic development. A complex targeting and transport system is required for 
the proper localisation of these molecules. Genetic screens for mutations have 
allowed many genes involved in these processes to be identified, cloned, and 
investigated in detail, for example, gurken, oskar, and vasa. However, not all 
genes involved in oogenesis are amenable to this approach, hence the introduction 
of the P-element enhancer trapping system. This system allows screening for 
genes involved in oogenesis on the basis of reporter gene expression. Of particular 
interest are patterns that show temporal and/or spatially restricted expression 
indicating that this gene may have a specific and critical function in oogenesis. 
This laboratory has been using a P-element based reverse genetics approach to 
investigate genes involved in oogenesis. Genes with patterns that suggest an 
important role are investigated further. Occasionally, an expression pattern is 
observed by in situ hybridisation that shows no relationship to the original P-
element reporter system, but is considered interesting nonetheless. This Thesis 
presents a study of a previously uncharacterised gene encoding a class V myosin 
which was identified from such an observation. In addition, a second gene 
encoding a putative ion-dependent inorganic phosphate co-transporter with 
functions in oogenesis was isolated and fully sequenced. 
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Chapter 2 
Cloning of an Unconventional Myosin 
2.1 Results Obtained Prior to the Commencement of This 
Work 
A project was initiated to clone genes involved in oogenesis using a reverse genetics 
approach. Several hundred lines containing P-element reporter insertions P[lacZ;rosy] 
were analysed by dissection of the ovary and stained in a solution of X-Gal for 3-
galactosidase activity (M Bownes, personal communication, results not shown). 
Several lines with staining patterns in the ovaries were selected for further study. 
These lines included two which showed staining in a subset of follicle cells at the 
anterior and posterior of the egg chamber, one early in oogenesis and the second at a 
later stage. Another line demonstrated staining only in the germarium with molecular 
analysis showing that this expression pattern corresponded to the histone Hi gene 
(Walker and Bownes, personal communication). 
A further line named H14 shows an ovary specific -galactosidase staining pattern in 
the follicle cells from about stage 7. In later stages, the staining becomes localised to 
follicle cells at the anterior and posterior of the egg chamber. The border cells, a group 
of follicle cells which migrate through the nurse cells to lie at the anterior of the oocyte, 
also show staining. By stage 11-12 the staining is localised to follicle cells at the poles 
of the oocyte (M Bownes, personal communication). 
In order to locate the gene producing this expression pattern, cloning experiments were 
initiated (R Slee, personal communication). As these enhancer trap lines contained an 
early version of the P-element reporter transposon, this cloning required construction 
of a bacteriophage genomic library with recombinant genomic DNA flanking the P-
element isolated using a lacZ probe. This isolated genomic DNA was used as a probe 
to obtain cDNAs from a whole body adult library in the bacteriophage NM1 149 vector. 
Three cDNAs were obtained with insert sizes of approximately 1kb, 1.5kb and 1.7kb, 
and named NMC 1, NMC4 and NMC7 respectively. All three cDNAs were used to 
perform in situ hybridisation on whole mount ovarieswith those of NMC1 and NMC4 
showing a high degree of staining in the nurse cells. However, the NMC7 cDNA 
revealed a staining pattern quite different to the original f-galactosidase pattern but 
highly interesting nonetheless. A temporally and spatially specific pattern showing 
localisation of a transcript early in the germarium in the presumptive oocyte was 
observed, see figure 2.1. During stages 3-7 of oogenesis the transcript remains 
localised in the oocyte. By stage 9 significant amounts of transcript can be seen in the 
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nurse cells while in the oocyte the transcript is seen as a band running dorso-ventrally 
at the anterior. Localised transcripts have been shown to be important for establishing 
the polarity of the oocyte, for example, bicoid, oskar, gurken and orb (see Chapter 1). 
Thus, this gene, in having a localised transcript, warranted further investigation. 
A Northern blot using NMC7 cDNA as probe suggested a transcript in the ovaries of 
approximately 3.5-4kb. (R Slee, personal communication). 
The inserted DNA from NMC7 recombinant phage was subcloned as two fragments, 
both of approximately 800bp, owing to an EcoRI site within the phage insert as shown 
in figure 2.2. The two recombinant plasmids, pNMC7a and pNMC7b, were 
subsequently sequenced and a deduced partial open reading frame of 984bp and an 
untranslated 3' region of 661bp (3'UTR) were observed. 
open reading frame  
.4- 1.65kb -* 
Figure 2.2 Schematic representation of the recombinant bacteriophage NMC7 and 
the two subcloned plasmids, pNMC7a and pNMC7b, derived from it. The open 
arrow represents the predicted open reading frame. Restriction endonucleases; E: 
EcoRI, H: HindIll 
The deduced amino acid sequence was compared to the GenEMIBL database using the 
GCG TFASTA program (Devereux et al, 1984). Significant homology was observed 
to an L-glutamate decarboxylase, the cDNA for which was reported by Huang et al 





Figure 2.1 in situ hybridisation to egg chambers showing that the transcript is localised to the oocyte from very early stages of oogenesis 
becoming an anterior band at mid stages (6-8). Later stages (9-10) show high levels of transcription with signal apparent in the nurse cells 
and loss of the anterior banding pattern. The transcript is also detectable in early embryos (not shown). This result was kindly provided by A 
McCormack. 
NMC7a 	 . IQAKKMHRTRIRSRSCIARQPHYAAN 26 
Mgad YTNDDLKVHSLLSSTINGIKKVLKKHNDDFENTSF'w. .. . LSNTCRFLHC 446 
NNC 7 LMKI TGDVDEYVKFNTEKQNQQQLKNLNLFEYRRVI LDLIVNKYQAADHA 76 
Mgad LKQYSGD.EGFMTQNIAKQNEHCLKNFDLTEYRQVLSDLSIQIYQQLIKM 495 
NMC7 DPGLLDPKIVPAILNNDEIQ. . RGRQAHGMRSRATSIGASSSPEHGGGpA 124 
Mgad PEGLLQPMIVSANLENESIQGLSGvRPTGyRKp.sss .............. 531 
NMC7 WKQLIGQLEHFYKQFQHPGLDNCYAEQIFHQLLYFICA . GLNCLMLRGDI 173 
Ngad . . . MVDGENSFHTVLCDQGLDPEI ILQVFKQLFYMINAVTLNNLLLRKDA 578 
NMC7 CMWETGMIIRYNIGCIEDWVRSKKN. SNDVLTALAPLNQVSQLLQSRKSE 222 
................... ....... 
Mgad CSWSTGMQLRYNISQLEEWLRGKNLHQSGAVQTMEPLIQAAQLLQLKKKT 628 
NC7 QIJD.QTICDLCTSLSTAQVLKVMKSYK. LDDYESEITNVFLEKLTEKLNA 270 
Mgad HEDAEAICSLCTSLSTQQflJKILNLYTPLNEFEERVTVSFIRTIQAQLQE 678 
NNC7 RQMQKSNSDEFTIDQKFIQPFKVVFRYSDIKLEDIELpSHLNLDEFLT}(I 320 
I. 
Mgad RN.. . . DPQQLLLDSKHVFPVLFPYNPSALTMDSIHIPACLNL. EFLNEV 723 
Figure 2.3 Comparison of mouse GAD protein (Mgad) with deduced protein 
sequence from Drosophila cDNA NMC7 using GCG GAP routine. Amino acid 
idendity is 36% and similarity 58%. 
2.2 Work From This Project 
All standard materials and methods used in this work are given in Chapter 7 and 
referred to where relevant. Specific materials and/or methods are described in detail 
within the appropriate results Chapter. 
2.2.1 Isolation of Further cDNAs 
The transcript size had been estimated as 3.5 - 4 kb from a Northern blot (R Slee, 
personal communication). Therefore, an early goal of the project was to isolate further 
cDNAs representing more of the transcript. 
An ovarian cDNA library which had originated from the laboratory of Jan (Jongens et 
al, 1992) was kindly provided by D Zhao (personal communication). This library was 
screened using the insert from pNMC7a, an 847bp EcoRI fragment that represented 
282 amino acids from the open reading frame. 
2.2.2 2ZAP Library Screen. 
Approximately 5 x io recombinant bacteriophage were plated on a 25cm x 25cm 
Nalgene plate using standard phage plating techniques (Sambrook et al, 1989) and E 
coli XL 1-Blue plating cells (Stratagene). Duplicate lifts to Hybond-N membranes 
were taken and processed as described in the materials and methods. The membranes 
were prehybridised at 65°C and probed with the pNMC7a insert which had been 
labelled with cx-32P dCTP as described in 7.5.5.2. 
The primary screen yielded 25 positive recombinants in duplicate of which 10 were 
initially selected for further work. Subsequent screening resulted in 5 of these initial 
10 recombinants remaining positive and being plasmid rescued. (7.2.3). An EcoRI 
digestion indicated that four of these 5 plasmids contained an insert of 2.2kb while the 
fifth was smaller at 1.4kb. These plasmids have been named ZAP-A, -D, -F, -G 
(2.2kb insert) and ZAP-E (1.4kb insert). 
A restriction map of the recombinant plasmids containing the 2.2kb cDNA suggested 
that they were identical. Initial DNA sequence information derived from the ends of 
the inserts using universal primers showed that both the 1.4kb and 2.2kb cDNAs were 
related to NMC7. This relationship is shown in figure 2.4 which shows that both 
?ZAP derived cDNAs matched NMC7 from the EcoRlI site within NMC7 and 
continued towards the 5' end of the gene, that is, neither 2LZAP derived cDNA 
contained the last 120bp of protein coding sequence nor the 3'UTR. Thus, combining 
the results from the NMC7 cDNA and the new XZAP cDNAs approximately 3.2kb of 
cDNA from this gene was represented. 
E 
NMC7 E  
ZAP-A – 
ZAP-E 	 —Ix 	 =_ 
Figure 2.4 A schematic diagram showing the relationship between the original 
cDNA isolated, NMC7, and the new cDNAs, ZAP-A and ZAP-E, isolated from the 
ZAP library. Restriction endonuclease; E: EcoRI. 
2.2.2.1 Sequencing Strategy 
In order to determine the DNA sequence of the 2LZAP derived cDNAs a subcloning 
strategy was developed. The cDNA from plasmid pNMC7b was also sequenced to 
ensure that both strands at the 3' end were covered. In addition to this subcloning 
strategy, several synthetic oligonucleotide primers were obtained to fill gaps not 
covered by the recombinant plasmids. 
The recombinant plasmids generated are listed in Table 2.1. Simple deletions were 
constructed by utilising a restriction endonuclease site in the vector's multiple cloning 
site and a similar site within the insert. Thus, by cutting the plasmid, heat denaturing 
the restriction endonuclease and re-circularising the remaining vector-insert DNA by 
ligation in a SOjfl volume, a deletion construct was easily generated. For situations 
where the restriction endonuclease was not heat denaturable or additional restriction 
fragments were to be recovered, the DNA fragments were purified from agarose gels 
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(7.5.4.4). Recombinant subcloned plasmids were constructed by cleavage of the 
plasmid followed by purification of the required fragment from an agarose gel by 
Qiaex. This fragment was ligated into a pBluescript vector which had been cleaved 
with the appropriate restriction endonuclease and treated with ClAP to reduce 
occurrences of vector re-ligation events (7.5.2). Figure 2.5 shows a schematic 
representation of the subcloned recombinant plasmids. Sequencing was carried out 
using the Sequenase 2.0 system (7.7.1), then later using dye-labelled universal 
forward (custom made) and reverse primers and dye-terminators on an Applied 
Biosystems automated sequencer (7.7.2.1). 
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Figure 2.5 Schematic diagram showing restriction map of ZAP-A (pBMF1O) as 
uppermost filled bar. The cDNA ZAP-E (pBMF20) is also represented by a filled 
bar while all recombinant plasmids subcloned from pBMF1O and pBMF20 for 
sequencing are represented as shaded lines with the numbers coreesponding to the 
pBMF series as shown in Table 2.1. Restriction endonuclease sites are: B: Bglll, C: 
Cal, E: EcoRI, EV: EcoRV, H: Hindill, N: NsiI, P: PstI, S: Sad, X: XhoI. The 
Hindill site is marked with an asterisk (*) to indicate that there are two adjacent 
HindIll sites at this position. T7 and 13 represent the respective positions of the Ti 
and T3 primers with respect to the cDNA inserts. 







E 	 Xh 	Xh 
	 B100<- 926Y* 	28004- 	
HI 
200bp 
Figure 2.6 A) Schematic diagram of pNMC7b subcloning - see also Table 2.1. T3 
and T7 represent the position of T3 and T7 sequencing primers relative to the cDNA 
insert. B) Primers used for sequencing with all 3.2kb of eDNA represented by the 
bar. "1806' and "2800" are the approximate distances, in bp, these primers are from 
the first nucleotide of the cDNA. The remaining primers were designed by R Slee 
for sequencing pNMC7a and pNMC7b. Restriction endonucleases; C: ClaI, E: 
EcoRI, H: Hindlil, S:SacI, Xh: XhoI. 
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Table 2.1 Plasmids Used to Determine the cDNA Sequence. Nucleotide (nt) 
positions are relative to pBMF 10 
Plasmid Description Vector Primer(s) 
Name 
pBMF 10 XZAP 2.2kb cDNA pBS SK- T7, T3 
ZAP-A, -D, -F, -G 
pBMF 11 PstI deletion of pBMIF10, pBS SK- T3 
nt 1-799 
pBMF 12 Hindifi deletion of pBMF1O, pBS SK- - 17 
nt 1166-2324 
pBMF 13 Sacl deletion of pBMF1O, pBS SK- T3 
nt 1-271 
pBMIF 14 XhoI deletion of pBMF1O, pBS SK- 17 
nt 826-2324 
pBMF 15 XhoI subclone of pBMF1O, pBS SK- T3, 17 
nt 1-541 
pBMF 16 XhoI subclone of pBMF1O, pBS SK- T3, T7 
nt 541-826 
pBMF 17 EcoRV-Hindffl fragment subcloned pBS SK+ T3, T7 
from pBMF10, nt 457-1159 
pBMF 18 EcoRV-Hindffl fragment subcloned pBS SK+ T3 
from pBMF1O, nt 1-457 
pBMF 19 EcoRV deletion of pBMF1O, pBS SK- 17 
nt 457-2324 
pBMF 20 XZAP 1.4kb cDNA pBS SK- T3, T7 
ZAP-E 
pBMF 21 PstI deletion of pBMF20, pBS SK- 13 
nt 2132-2324 
pBMF 22 HindIll-PstI subclone of pBMF20, pBS SK- 13 
nt 1166-2132 
pBMF 23 BglII-BamHI deletion of pBMF20, pBS SK- 13 
nt 1328-2324 
pBMF 24 NsiI-SacI deletion of pBMF20, pBS SK- T3 
nt 1497-2324 
pBMF 25 Sacl deletion of pBMF20, 
nt1138-2324 pBS SK- T3 
pBMF 26 Sacl fragment subcloned from pBS SK- 13, 17 
pBMF1O, nt 346-718 
pBMF 27 Sac! fragment subcloned from pBS SK- 13, T7 
pBMIF10, contains cloning artefacts 
pBMF 28 BglII-BamHI deletion of pBMF19, pBS SK- T3 
nt 1-1328 
pBMF 29 Cial deletion of pNMC7b pBS SK- 17 
pBMF 30 	Sac! deletion of pNMC7b 	 pBS SK- 	T3 
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2.2.2.2 Sequence Analysis Shows an Incomplete Open Reading Frame and Similarity 
to the Class V Unconventional Myosins 
A database search with the predicted protein sequence from NMC7 revealed significant 
similarity to a mouse cDNA reported as coding for a L-glutamate decarboxylase (GAD) 
by Huang et a! (1990) as described in section 2.1 above. This sequence will be 
referred to as the Huang sequence Glutamate decarboxylases- catalyse the conversion 
of glutamate to GABA (y-aminobutyric acid), the primary inhibitory neurotransmitter. 
However, the Huang sequence shows no significant similarity to other glutamate 
decarboxylases described to date (see section 2.3) casting doubt on this sequence being 
an authentic glutamate decarboxylase. The 723 amino acid Huang sequence was used 
to search the database and revealed similarity to the carboxyl end of a family of 
proteins known as the dilute class unconventional myosins, or Class V unconventional 
myosins. 
Structurally, the Class V myosins comprise a myosin head domain, a series of 
calmodulin binding repeats termed the IQ motifs, and a tail domain which consists of 
regions predicted to form coiled-coil a-helices and globular domains. At the time of 
the comparison, three examples of this class were reported; mouse dilute (Mercer et al, 
1990), chicken p190 (Espreafico et a! [1992], Sanders et al [1993]) and budding yeast 
MY02 (Johnston et a!, 1991). A schematic representation of the 3 unconventional 
myosins and the mouse "GAD" protein is shown in figure 2.7 
Initially, because of a frame shift at the 5' end of the 2.2kb cDNA, it was thought that 
the 3.2kb cDNA coded for a 674 amino acid protein lacking a myosin head domain, 
but with similarity to the tail domain of the Class V unconventional myosins. Further 
support for this theory came from the estimated size of 3.5-4kb for the transcript (R 
Slee, personal communication) and the existence of the Huang sequence with a 
predicted protein of 723 amino acids. However, further analysis of the sequence 
resolved the frame shift and showed that the predicted open reading frame could extend 
to the first nucleotide of the cDNA. On the basis of this result, it was decided to 
perform further Northern blots to verify the size of the transcript. 
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myosin head domain 	 globular tail domain 
Figure 2.7 Block diagram representing class V unconventional myosins from 
mouse (Mercer et al, 1991), chicken (Espreafico et al [1992], Sanders et al [1992]) 
and yeast (Johnston et a!, 1991) along with the mouse "GAD" (Huang et al, 1990) 
and the Drosophila protein sequence predicted from cDNA sequencing (see 
Appendix I). Boxes with vertical lines represent the 'IQ' motifs while shaded 
regions represent domains predicted to form coiled-coil a-helices. Adapted from 
Espreafico et al (1992). Percentages indicate the amino acid identity between each 
region in the myosin V sequences. 
2.2.3 Northern Blot Shows A Large Transcript. 
RNA was prepared using the Qiagen RNeasy system (7.10) from adult male and 
female Oregon R flies, from ovary tissue and the female carcass from the ovary 
dissection. This RNA was then run on an agarose/formaldehyde gel (7.11.2) and 
transferred to Hydond N. RNA markers from GibcofBRL were included on the gel to 
allow sizing. A probe was prepared using the OLB (7.5.5.2) system from the 2.2kb 
cDNA. The membrane was prehybridised at 42°C for 4 hours and hybridised 
overnight with probe also at 42°C. Standard washes were carried out (7.11.4) and the 
membrane exposed to X-ray film. The membrane was then reprobed with labelled 
bacteriophage X DNA which would detect the markers. The results shown in figure 
2.8 shows a single transcript most evident in the ovary lane that was estimated to be 
6kb in size. This result showed that the gene in question was producing a transcript 
considerably larger than the combined cDNAs obtained to date represented and that in 
all probability the gene coded for a full length unconventional myosin. 
One question which remained unanswered at this point was whether the 5' EcoRI site 
in the current 2.2kb cDNA was part of the gene or part of the library cloning 
technique, that is, an EcoRI linker. It was apparent from the way in which both 
cDNAs from the ovarian )LZAP library were truncated at the 3' EcoRI site (this site 
divides NMC7 into two approximately equal fragments) that there was a possibility 
that the library had been poorly constructed and that EcoRI sites internal to the eDNA 
molecules had not been adequately protected during library construction. 
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2.2.4 5'RACE Attempt 
An attempt was made to obtain the missing 5' cDNA sequence by use of a PCR based 
technique called 5' RACE (Rapid Amplification of cDNA Ends). This method employs 
a gene specific primer to reverse transcribe the 5' sequence from the transcript. An 
anchor is then placed at the 5' end to allow PCR amplification. This anchor can be a 
specific primer ligated to the reverse transcribed single-stranded DNA molecule by 14 
RNA ligase or a polynucleotide tail added by the enzyme terminal deoxynucleotide 
transferase (TdT). Figure 2.9 is a schematic representation of the RACE system. This 
technique is frequently used to obtain the last few hundred base pairs from a cDNA 
whereas in this case it was hoped to amplify up to 3kb of cDNA. 
Unknown sequence 	Known sequence 
Gene specific primers 	 t3 13 
based on known sequence 	Race2 Racel 
WV 
pppG '' 	 1 	 I 	 ¼) '...J JAAAAAAA 
 
Racel Reverse transcribe I 	 I 	












AA 41 	 - 
ETm 
Race2 
PCR amplify using Race2 and complementary primer 
Figure 2.9 The RACE Procedure 
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The method did not produce the desired 5' end of the cDNA (results not shown) but 
was the source of 2 gene specific primers, Race 1 and Race2, which were used 
extensively at later stages of the cloning. A 5'RACE procedure was used later to 
obtain the last few hundred base pairs of the cDNA sequence, see section 2.2.13. 1. 
Figure 2.10 is a schematic representation of the position of primers Race! and Race2 
and additional primers used for sequencing of the cDNA that had been synthesised at 
this point in the project. 
1806 	3'UTR-5 925Y2796 2950 
E 	 Xh Xh 	 * r*** H 
4* * * 	* * 	 * * 
Race2 Racel 601 	1311 	B100 	926Y 	 2800 3'UTR-3 
200bp 
Figure 2.10 Schematic diagram of the cDNA showing positions of oligonucleotide 
primers. Primers Race I and Race2 were designed for the 5'RACE procedure. 
Primers 3'UTR-5, 3'UTR-3, 2796 and 2950 were designed for PCR and sequencing 
of the 3'UTR (A McCormack, personal communication) but were also used for 
general sequencing. Restriction endonucleases; E: EcoRI, H: Hindill, Xh: XhoI. 
2.2.5 Further Library Screens 
A general strategy was adopted to screen all libraries in possession in the laboratory for 
the myosin cDNA. This screening included the genomic DNA library in the ?FIX 
bacteriophage vector. The ?FIX genomic library was screened in conjunction with a 
3rd instar larval cDNA library by A McCormack (personal communication) using the 
2.2kb eDNA as probe. No cDNAs were obtained from the larval cDNA library while 
a single recombinant phage was recovered from the XFIX genomic library. This 
recombinant phage is referred to as FIX- IA. 
DNA was prepared from FIX- lA using the method described in 7.6.2.5 and restricted 
with the following restriction endonucleases or combinations of endonucleases; 
BamHI, BarnHL/EcoRI, Ba,nHIJNotI BamHL/XbaI, EcoRI, EcoRlJNotI, EcoRJJXbaI, 
Not! and XbaI. The restriction endonucleases Not! and XbaI have been engineered 
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into the ?FIX vector and allow the inserted genomic DNA to be isolated. The 
restriction digests were separated on an 14cm x 14cm agarose gel and blotted to 
Hybond-N as described in the materials and methods (7.11.1). The result is shown in 
figure 2.11. 
Ml 23 4M 5678 9M Ml 2 3 4 M 5 6 7 8 9 M 
12 
ff 
M Markers 	 5 EcoRl 
1 BamHI 6 EcoRl + Noit 
2 BamHI + EcoRl 	 7 EcoRl + Xbal 
3 BamHI + Nofl 8 Notl 
4 BamHI + XbaI 	 9 XbaI 
Figure 2.11 Restriction digests of FIX-IA with a schematic representation of the gel 
shown on the right. Reproduction quality and aging has resulted in loss of visibilty 
of lower molecular weight bands on the photograph. Marker sizes are in kb. 
It was found that an accurate restriction map could not be generated from the bands 
visible on the gel. Hybridisation with the 2.2kb cDNA fragment showed that the gene 
was located at the end of the cloned genomic DNA ligated to the 20kb left arm of the 
bacteriophage vector. An EcoRI digest showed hybridisation to a small - 1kb band in 
addition to the left arm plus insert band. These results are shown in figure 2.12. 
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4 BamHI+XbaI 4 - 
5 EcoRl 3- 
6 EcoRl + Notl 
2- 
7 EcoRl + XbaI 1.6 - 
8 NotI 
1 tit 9 XbaI 
B 1 
1 kb 
Figure 2.12 A) Hybridisation of restriction digests of FIX-IA with the 2.2kb 
myosin V cDNA fragment. Marker sizes are in kb. B) A schematic map of the 
genomic DNA determined from this hybridisation is shown. The heavy line 
represents inserted genomic DNA which extends to the right, the light line represents 
vector sequence, the dashed line represents the myosin V gene. Restriction 
endonucleases; E: EcoRI, X: XbaI. The XbaI site marked with an asterisk (*) is part 
of the vector cloning site and is not an XbaI site within the genome. 
2.2.6 Reverse Northern 
The principle of a Reverse Northern is to use RNA as a template for producing a probe 
and then probing DNA to discover which DNA fragments contain exons from the 
transcript of interest. Use of the Race 1 primer allowed a probe that would represent 
the missing 5' sequence to be generated from total ovary RNA. The probe was 
prepared as follows: 
200ng Racel primer was annealed to -I Ogg total ovary RNA prepared with an 
RNeasy kit (7.10) in a volume of 20tI by heating to 70°C for 5 minutes, then allowing 
to cool slowly. The RNA was reverse transcribed by the addition of 8tl Superscript II 
5x buffer (BRL), 3jil 0.1M DT!', 500.tM each of dATP, dGTP, dTTP, 5tl (50.tCi) 
of CC-32P dCTP and water to a total of 39p1. The reaction mix was equilibrated to 42°C 
in a water bath for 2 minutes before lpJ of Surescript II (BRL) reverse transcriptase 
was added, then allowed to proceed for 30 minutes at 42°C followed by 5 minutes at 
55°C. The unincorporated nucleotides were removed by use of a Pharmacia Nick 
column as described for general radiolabelling of DNA (7.5.5.2). The RNA-DNA 
hybrid molecule was denatured in a heating block at 110°C then added to the 
prehybridised membrane. Hybridisation was carried out at 65°C overnight. 
The autoradiograph result is shown in figure 2.13 and shows hybridisation to the 
following bands; -8kb Ba,nHI, -7kb EcoRI, -6kb XbaI and -4kb Barn HI/XbaI. 
These bands were clearly different from those seen when hybridisation with the 2.2kb 
cDNA was used (see above) and suggested that isolation of any one of these large 
fragments would provide a probe to use for screening cDNA libraries, and in 
particular, the ovarian AZAP, for larger or 5' cDNAs. 
M 12 34M56 789M 
I 	I 	I 	I 	I 	I 	I 	I I 	I 	II 
.-7 M Markers 
• 	1 BamHI 
I 
; 	2 BamHl + EcoRl 
4 	
' 3 BamHI+Nod 
3 4 BamHl+XbaI 
5 EcoRI 
2 	
6 EcoRl + Not! 
1.6 - 
7 EcoRl + Xbal 
8 Notl 
9 XbaI 
O.5 — è 	4 
Figure 2.13 Reverse Northern. The restriction digests shown in figure 2.11 were 
transferred to a Hybond-N membrane and probed with first strand cDNA prepared 
by reverse transcription from RNA as described in the text. Markers in the outside 
lanes were labelled with radionucleotide (see 7.4.5.1) with sizes shown being in kb. 
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Attempts were made to recover all XbaI fragments from FIX-i A but this proved only 
partially successful. However, a small amount of the Not! DNA fragments were 
recovered which were then labelled and used to probe both the ovarian ?ZAP library 
and the 0-4 hour embryonic NB40 plasmid library (see below). 
2.2.7 An Unrelated Gene, cDNA-34, is Identified 
The ovarian library yielded one recombinant plasmid from 14 positives from the 
primary screen. Initial DNA sequencing using T7 and T3 primers did not produce any 
sequence identity with the current myosin eDNA. A comparison with the mouse dilute 
peptide sequence by the GCG TFASTA routine using mouse dilute as the query 
peptide and the new cDNA sequence as target produced no similarities. Thus, it was 
concluded that a cDNA from an unrelated gene had been isolated. How this result 
came about from the Reverse Northern is still not fully understood, but some theories 
will be discussed in Chapter 6. The new cDNA, referred to as cDNA-34, has been 
completely sequenced and analysed and the results are reported in Chapter 5. 
2.2.8 Screening of the NB40 Embryonic Library 
2.2.8.1 Conventional Screening 
On the recommendation of D St Johnston (personal communication), the early (0 - 4 
hour) embryonic plasmid library was obtained from N Brown (Brown and Kafatos, 
1988). This library was recommended because, although embryonic, it had proved 
useful for obtaining full length transcripts of genes involved in oogenesis (eg gurken, 
D St Johnston, personal communication). It was also known that the transcript from 
the myosin V gene was present in the early embryo from Northern analysis (A 
McCormack, personal communication) The NB40 embryonic libraries have been 
constructed using the plasmid pNB40, a pUC derived plasmid which allows 
directional cloning of cDNAs resulting in an SP6 promoter at the 5' end of the cDNA 
and a T7 promoter at the 3' end. 
Information supplied with the library suggested that non saturating amounts of DNA, 
about Sng, should be used to transform highly competent cells. The library should be 
plated on 6 - 10 standard 90mm petri dishes at a density of 15 000 cfu per plate to give 
sufficient representation of transcripts. Colony lifts should be taken after 3-4 hours 
growth, before the colonies are visible. 
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Transformation of E co/i XL 1-Blue cells with 5ng of the library using the standard 
cold CaC1 2 method (7.3.1) produced too few transformants (approximately 15 000 
cfu/ml) to reliably screen. Therefore, electroporation was used to transform the XL 1-
Blue cells to a higher efficiency (7.3.2). A control transformation using 1-2ng of 
pBluescript KS+ produced a transformation efficiency of 109 cfuJ.tg of DNA. while 
transformation with 4ng of the library gave a lower efficiency of 4 x 10 ' cfuI.tg 
resulting in 160 000 cfu available for plating. The library was plated on 10 LB-agar + 
ampicillin plates at a density of approximately 10 000 cfu per plate, slightly lower than 
that recommended in the supplied protocol. The plates were incubated for 4 hours at 
37°C with standard colony lifts taken on Hybond-N 82mm diameter membranes. The 
probe used was the NotI fragment representing the entire insert from the XFIX- I A 
cloned genomic DNA. This probe was being used to concurrently screen the ovarian 
22AP and NB40 early embryonic libraries for further cDNAs from the putative 
myosin gene. 
The initial signal obtained was weak and it was found to be impossible to identify the 
positive colonies on the primary plates because the density of colonies was too great. 
In order to improve the chance of obtaining a positive colony, a small area including 
the positive colony was scraped with a matchstick and transferred to 200pJ LB-broth in 
a microfuge tube Dilutions were plated out to give plates that were quite dense, but 
with colonies still clearly separated and these were again screened. No clear positives 
were obtained 
It was decided to rescreen the library by plating at a lower density in order to give 
clearly defined colonies which could be more readily isolated directly from the primary 
screen. The library was replated by again transforming E coli XL1 Blue cells by 
electroporation. The efficiency obtained was 1.5 x 107 cfu/jig for the library providing 
approximately 60 000 cfu which were plated on 20 LB-agar + ampidihin 90mm plates. 
Standard colony lifts were taken as before and hybridisation was with the 2.2kb 
cDNA. No positives were obtained. At this point it was decided to investigate the 
NB40 library using PCR as described below. 
2.2.8.2 PCR on the NB40 Embryonic Library 
The pNB40 vector contains an SP6 promoter site at the 5' end of the cDNA insert. 
Therefore, an SP6 primer in combination with a myosin specific primer was an 
attractive option for obtaining further cDNA information using a PCR approach. 
Firstly, it was prudent to determine if the NB40 library contained any cDNAs from the 
RX 
myosin gene. The use of primers designed for sequencing of the existing cDNA 
showed that the library did contain cDNAs from the myosin V gene. These results are 
presented in figure 2.14. 
3 
E 	XhXh 	 E 	 H 
1.6 
2 	1 I 1806* 	I 
1 	 4* 2800 
- 200bp  
0.5 
1 k PCR product 
Figure 2.14 PCR with primers 1806 and 2800 showing that myosin V cDNAs are 
present in the NB40 library. Restriction endonucleases; E: EcoRI, H: Hindu!, Xh: 
XhoI. Marker sizes are in kb. 
PCR amplification with the myosin specific Race 1 or Race2 primers in combination 
with the SP6 primer yielded inconclusive results. Amplification from the library 
produced bands of about 1.6kb. However, a control reaction using library template 
and the SP6 primer also produced a similarly sized band as shown in figure 2.14. The 
SP6 primer sequence had been copied from that published by Promega Inc to give an 
18 nucleotide molecule. The predicted annealing temperature for this SP6 primer was 
calculated as 48°C using the method of Lathe (1985), that is, 20C(A + T) + 40C(G + 
Q. Thus, the PCR was constrained by this relatively low T the SP6 primer. 
A new SP6 primer designated SP6/40 was designed with 4 additional bases 
complementary to the pNB40 vector and 5' to the consensus SP6 sequence to produce 
a primer with a predicted T. of 64°C using the formula described above. A PCR was 
carried out using this new primer in combination with Race 1, Race2 and the 
sequencing primer 601. The distance between the Race primers and primer 601 is 
approximately 400bp as shown schematically in figure 2.15. The results show that the 
SP6/40- Race! or Race2 combinations produced bands of 1.6kb and 1.8kb while the 
SP6/40 - 601 combination produced bands of 2kb and 2.2kb, that is, 400bp larger 
(figure 2.15). This result was clear evidence that there were at least 2 cDNA species in 
this library that extended the current cDNAs by about 1.3kb and 1.5kb (allowing for 
the position of the Race primers in the existing sequence and the distance the SP6 
promoter is from the start of the cDNA). 
1 	234567 
1 Markers 
2 Original Library SP6 + Racel 
3 Original Library SP6 + Race2 
4 Original Library SP6 + 601 
5 Amplified Library SP6 +Racel 
6 Amplified Library SF6 +Race2 
7 Amplified Library SP6 + 601 
E 	 Xh Xh 
:::::::::::::::::::I________________ 
* 	 4* * * 
SP6 Race2 Racel 601 	1311 
Figure 2.15 PCR result from the NB40 library. Lanes 2, 3 and 4 show 2 bands 
likely to be from the myosin V gene. The original library was the aliquot received 
from N Brown. The amplified library was the result of transforming E coli, 
culturing, then performing a plasmid preparation. However, the transformation was 
not efficient and the amplified library is less than fully representative. 
2.2.8.3 Cloning and Sequencing of the PCR Products 
Two strategies were used to obtain sequence information from these PCR products: 
direct sequencing and cloning into pBluescript. Direct sequencing of the PCR product 
was only successful on one occasion using the Race2 primer but the sequence matched 
that of the existing cDNA and proved that the EcoRI site at the 5' end of the 2.2kb 
cDNA from the A.ZAP library was part of the transcript. 
The pBluescript SK- vector was prepared for cloning of the PCR products by initially 
cutting with the enzyme EcoRV to produce blunt ends followed by treatment with calf 
intestinal alkaline phosphatase to reduce vector re-ligation events. The phosphatase 
was removed by standard phenol/chloroform extraction followed by ethanol 
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precipitation. To obtain flush ends suitable for ligation the PCR products were treated 
with an enzyme cocktail as follows: 
DNA 20j.tl 
T4 polynucleotide kinase buffer 5!.tl 
2mM ATP 5pJ 
10mM dNTPs 1g] 
T4 DNA polymerase (NEB) 1 unit 
T4 polynucleotide kinase 	(NEB) 1 unit 
Klenow (NBL) 1 unit 
Sterile distilled water to 50p.l 
37°C for 30 minutes 
The PCR products were separated on 0.8% agarose gels, the bands excised and the 
DNA purified with Qiaex (7.5.4.4). A ligation reaction was prepared and used to 
transform E coli XL1-Blue cells using the cold CaC1 2 method. The cells were plated on 
LB-agar + ampicillin supplemented with X-Gal and IPTG for blue-white selection 
purposes. Several ligation-transformation attempts yielded only one colony containing 
an insert. This recombinant plasmid, pNBperl, was used only for sequencing 
purposes with the emphasis shifting to use of cloned genomic DNA and RT-PCR 
methods for determining the remaining coding sequence as described later. 
We 
2.2.9 Summary of Library Screening 
As stated above, all libraries in the laboratory were screened for presence of the 
myosin V cDNA. Results for the X.ZAP and NB40 cDNA libraries, and AFIX 
genomic library have been presented. Screening of other libraries was unsuccessful. 
Table 2.2 lists all libraries screened and summarises the results. 
Table 2.2 Summary of cDNA and Genomic Libraries Screened 
Tissue Vector Result Comments 
Adult Whole XNMI 149 1.6kb The original cDNA isolated 
body 
Ovary' ?ZAP 2.2kb and 1.4kb EcoRI sites not protected, 
truncated cDNAs 
Ovary2 ?gt22 no positives 
Testes 	xgti 1 	-20 primary 	no positives on secondary 
positives screen 
Embryonic 	?gt1 I 	no positives 
Embryonic 3 	NB40 	cDNAs present 	isolated some 5' sequence 
(plasmid) by PCR 
3rd instar larval 	 no positives 	screened by A McCormack 
Genomic 	?FIX 	6 positives 	all lack 5' sequence, 2 
DNA appear identical 
Notes 1 source D Zhao, Stratagene commercial library 
2 source P Tolias (Stroumbakis et al, 1994) 
3 source N Brown (Brown and Kafatos, 1988) 
4 source Stratagene commercial library 
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2.2. 10 Refinement of the FIX- lA Map 
The physical map of FIX-i A could not be obtained from the restriction endonuclease 
digest information. Therefore, it was decided to subclone fragments to resolve the 
physical map of FIX-IA by more detailed restriction mapping and by hybridisation. 
This work was done in conjunction with A McCormack. 
A 'shotgun' approach was used to subclone EcoRI, XbaI and EcoRI-NotI fragments 
from the cloned genomic DNA in FIX-i A. DNA prepared from FIX-i A was digested 
with the appropriate restriction endonucleases (Nod and EcoRI used an identical buffer 
system), then the endonucleases removed by phenol/chloroform extraction and the 
DNA recovered by ethanol precipitation before being ligated to a suitably prepared 
pBluescript vector (EcoRI, XbaI or EcoRI-NotI with ClAP treatment). These ligations 
were used to transform XL-! Blue E coli by the cold CaC1 2 method (7.3.1). White 
colonies recovered from the transformation were analysed for piasmid content by small 
scale DNA preparations (7.6.2.1) and digestion with the appropriate restriction 
endonuclease (eg EcoRI for EcoRI subcloning, etc). This series of subcloning 
experiments yielded four distinct EcoRI and two distinct XbaI recombinant plasmids. 
No EcoRI-NotI recombinant plasmids were recovered. The recombinant plasmids 
obtained are listed in Table 2.3 with restriction maps shown in figure 2.16 
Sequence information was obtained from each recombinant plasmid using T3 and T7 
primer sites in the vector and compared to the myosin cDNA sequence. These 
comparisons allowed a partial map of the genomic DNA to be built up and revealed that 
the FIX-IA cloned genomic DNA contained sequences matching the cDNA from 
nucleotide 532 of the cDNA, that is, the cloned genomic DNA contained no further 5' 
sequence , see figure 2.17. 
M. 
Table 2.3 Recombinant Plasmids Subcloned from FIX-i A 
Plasmid Name 	Restriction 	Insert size 	Comments 
Endonuclease 
pEl 	 EcoRI 	 -1kb 
pE3 	 EcoRl 	 -3kb 	 cloned in both 
orientations 
pE5 EcoRI -5kb cloned in both 
orientations 
pE7 EcoRl -7-8kb cloned in both 
orientations 
pX2.8 XbaI -2.8kb 
pX3 XbaI -3kb cloned in both 
orientations 
X 	 E 	EX 
1 I Lj 	pX2.8 1 kb 
X 	E 	 X 
i pX3 
E 	E 
I I 	 pEl 
E 	X 	 E 
I I I 	pE3 
EX 	 B 	E 
II I I 	pE5 
E 	 X 	 BB 	E 
I I I 	I I 	pE7 
Figure 2.16 Restriction maps of recombinant plasmids obtained from subcloning 





- - 	 1kb 
5 ' 	 3' 
unconventional myosin gene 
Figure 2.17 Genomic map of the myosin V gene determined from sequencing and 
restriction mapping of plasmids subcloned from FIX- IA. Restriction endonuclease; 
E: EcoRI, X: XbaI. The XbaI site marked with an asterisk (*) is part of the AFIX 
bacteriophage multiple cloning site. 
2.2.11 Further Screening of the Genomic AFIX Library 
The XFIX genomic library was screened again to isolate further phage that it was 
hoped would contain sequence 5' to that obtained from FIX-i A. The library was re-
screened using the 2.2kb cDNA as probe as has been described previously. This 
screen yielded 2 positive recombinant phages which have been called FIX-2C and 
FIX-217. DNA was prepared from these phage (7.6.2.5) and restricted with BarnHI, 
BamHIINotI, BainHIJEcoRI, EcoRI EcoRIJNotI and XbaI, separated on a 0.8% 
agarose gel, transferred to Hybond-N+ and probed with the cDNA. The result is 
shown in figure 2.18 and it was apparent that FIX-217 contained a further -1kb of 
genomic DNA while FIX-2C contained less genomic DNA spanning the putative 
unconventional myosin gene. A schematic representation of the relationship between 
the 3 recombinant phages is shown in figure 2.18. The ?.FIX library was screened 
once more but the probe used in this screen was a -460bp EcoRV fragment from the 5' 
end of the cDNA (see figure 2.5) in order to improve chances of isolating phage which 
contained 5' sequence. A total of 3 phage were isolated and termed FIX-4A, FIX-4B 
and FIX-4D. Partial mapping has shown that FIX-4B is identical to FIX-2F while 
FIX-4A contains a further -3-4kb of 5' DNA compared to FIX-IA, and F[X-413 
breaks within the existing cDNA. 
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A 	I 	I II I FIX-lA X* E EX E 
I 	I I II I FI72F 
X*E 	 E EX E 
I 	I II I FIX-2C X* E EX E 
probe 2.2kb cDNA 
I 	I I II I FI7-413 
X*E 	 E EX E 
I 	I 	1 II IFI7-4A 
X* 	BE E EX E 
FIX-41D 
E 	EX 	 E 
probe EcoRV fragment 
-* 	 1kb 
5' 	unconventional myosin gene 	3' 






Figure 2.18 A) Restriction maps of all 
recombinant phages from the ?FIX library. 
B) Southern of FIX-2C and FIX-2F probed 
with 2.2kb cDNA. Restriction endonuclease; 
B: BamHI, E: EcoRI, X: XbaI. The XbaI site 
marked with an asterisk (*) is part of the 
?.FIX multiple cloning site. 
4ft4-2.lkb 
48000 4-pEl 
These phage from the 3rd screen have been superseded by genomic DNA subcloned 
from bacteriophage P1 recombinant. 
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2.2.12 Screening Cosmids and Recombinant Pis 
The chromosome position had been determined as 43BC from in situ hybridisation to 
3rd instar larvae salivary gland chromosomes as described in Chapter 3. This 
information was used to obtain recombinant cosmid and bacteriophage P1 Is containing 
cloned genomic DNA as described in Table 2.4 from Drosophila resource centres. 
Table 2.4 Recombinant Cosmid and P1 Bacteriophage Screened 
Name 	 source 	 Hybridisation position 
33H2 	 Crete 	 43AC 
140C2 Crete 43B 
194A4 	 Crete 	 43B 
P1 DSOO 126 	 Cambridge 	 43B 
P1 DS00574 Cambridge 43C 
P1 DS08719 	 Cambridge 	 43B 
The cosmids were obtained prior to the recombinant P1 s and were screened by a dot 
blot of a small scale DNA preparation (7.6.2.1 - kanamycin at 50p.g/mI was used for 
culturing the E coli). A positive control of FIX-217 DNA was included. No 
hybridisation was obtained with the cosmid DNA (result not shown). A similar 
procedure was used to screen the recombinant P1 Is when they were obtained with P 1 
DS00574 showing a positive result. 
The recombinant Pis contain a large amount of genomic DNA, in the order of 80-90kb 
(Harti et al, 1994). It was decided to undertake a "shotgun" sub-cloning experiment 
and isolate subcloned recombinant plasmids that hybridised with the cDNA. A 
medium scale DNA preparation (Promega Wizard, 7.6.2.3) yielded very low 
amounts of DNA. 
Approximately lj.tg of the P1 DS00574 DNA was restricted with EcoRI and XbaI in 
50tl volumes with the restriction endonucleases removed by phenol/chloroform 
extraction. These digests were added to a ligation reaction containing pBluescript cut 
with the appropriate restriction endonuclease and treated with phosphatase (7.5.2). 
Half the ligation was used to transform E coli XL1 Blue (7.3.1) and colonies 
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containing inserts were selected on L-agar plates containing ampicillin, X-Gal and 
IPTG. All white colonies were picked with small scale DNA preparations made from 
all 15 XbaI subclones and 7 EcoRI subclones. These preparations were cut with the 
restriction endonucleases EcoRI or XbaI, to isolate the insert, separated on an 0.8% 
agarose/TBE gel, transferred to Hybond-N+ and probed with the -460bp EcoRV 
fragment from the cDNA. A subcloned recombinant plasmid containing a -7kb XbaI 
fragment was identified. This plasmid has been called pPl-X7 
A small scale (Promega Wizard, 7.6.2.3) DNA preparation was made from pPl-X7 
and sequenced using automated sequencing procedures (7.7.2.2) with the T3 and T7 
primers. The sequence from the T3 end matched that of the cDNA and genomic DNA 
sequenced to date from the XbaI site in the 3'UTR. The sequence from the T7 end 
was new and did not match any existing cDNA sequence. A comparison of the 
predicted amino acid sequence from the T7 DNA sequence showed strong similarity 
(>44%) to the mouse dilute unconventional myosin from amino acids 10 to 170 in the 
1st reading frame as shown in figure 2.19. Thus it was concluded that most of the 
remaining coding sequence for the Drosophila unconventional myosin lay within the 
subcloned 7kb XbaI fragment. 
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SCORES Frame: (I) Initl: 528 lnitn: 528 Opt: 588 
44.7% identity in 228 aa overlap 
10 	20 	30 	40 
mdi imy 	 MMSELYTKFARVWIPDPEWKSAELLKDYKPGDKVLLL}EEGKD 
I: 
x7 t7 . s SRGGSGITPIBKTCXFrSLLSQGAKIWVPHADLVWESATLEESYRKGAGFLKICTDSGKL 
	
10 	20 	30 	40 	50 	60 
50 	60 	70 	80 	90 	100 
mdi imy 
I 	:1:::::: 11:111:11 	1:1 111:111 	I 	1:1111111 	I 	::::I H I 	11:1 
x7 t7 . S KVKLKASDLPPLRNPAILVGQNDLTrLSYLHEPGVL}LRVpFCERQIfl'TyCGIIL 
70 	80 	90 	100 	110 	120 
110 	120 	130 	140 	150 	160  
mdi lmy VAINPYEQLPIYGEDIINAYSGQNMGDMDPHIFAVAEEAYKQMARDERNQSIIV 
111111::: 1:11 	:11:1:1:: II 	:1 	111:1111:::: I:: 	I 	:11: 	II 
x7 t7 . s VAfl PYAPLYGPSIIRAYRGHNGDLEPHIFALAEEA'X"rKLERENCNLNII iGEsGAI 
130 	140 	150 	160 	170 	180 
170 	180 	190 	200 	210 	220 
mdi lmy V4A} YAMRYFATVSGSASEMVEE2CVLASNPmESIGN -AKTrRNDNSSRFGKYIEI 
I:: 	: 	:1:111 	: 	::I: 	: : 	:1::: 	:1:: 
x7 t7 . s GQKSVRQIPYFARCKFQIRNQVQPRcLPQSLErLRKCQKPEQFPPLGKFyQr 
190 	200 	210 	220 	230 	240 
230 	240 	250 	260 	270 	280 
mdi imy GFDKRYRIIGNIZLLEKSRVVFQ?EEERNYHIF1QLCASPKLPEFRLGNADSFH 
x7t7 . s AFPRNQNGFLIF 
250 
SCORES 	Frame: (2) Initl: 	50 Initn: 	50 Opt: 	76 
32.8% identity in 67 aa overlap 
140 	150 	160 	170 140 	190 
rndilmy GDPHIFAVAEEAYKQMARDERNQSIIVSG4SGAOKWSXYMR4FATvSGSAsEANv 
x7t7 . s 
150 	160 	170 	180 	190 	200 
200 	210 	220 	230 	240 	250 
mdi irny EEKVLASNPDSIGNAKTrRNDNSSRF-GKYIEIGFDKRYRIIG2TYL.LEKSRVVF 
x7t7 s NPGAGISPNWKPSGNAKTQNNSPLTKLLFPETGF' 
210 	220 	230 	240 	250 
Figure 2.19 TFASTA results comparing mouse dilute myosin V with open 
reading frames from pPl-X7 sequenced with the 17 primer. A significant amount 
of identity is seen in two frames as a result of a frame shift occurring after about 
540nt. The ATP-binding domain is boxed in both frames. 
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2.2.13 Determining the Genomic and eDNA Sequence 
The identification of genomic DNA which contained coding sequence near the 5' end 
of the gene enabled a reverse-transcription-PCR (RT-PCR) based sequencing strategy 
to be adopted in order to obtain most of the coding sequence. This strategy did not 
yield the most 5' sequence as this sequence extended beyond the pPl-X7 recombinant 
plasmid, SO 2 new primers were designed for a 5'RACE procedure. The 3 primers 
initially synthesised were designated Race3 and Race4 for the 5'RACE procedure and 
did2 for the PCR sequencing procedure. The did2 primer was designed based on 
genomic sequence that, upon translation, showed amino acids identical to those from 
the mouse dilute peptide sequence. It was also decided that the sequence of pPl-X7 
would be determined in full. At this time, the PCR fragment obtained from the NB40 
library (section 2.2.8.3) had been subcloned into pBluescript and was also being 
sequenced. 
The gene has been given the working name didum, an acronym from dilute-like 
Drosophila unconventional myosin. All primers designed specifically for sequencing 
have been given a 'did' notation. 
2.2.13.1 RT-PCR and 5'RACE 
Total ovary RNA was prepared using the Trizol method (7.10). Two reverse 
transcription reactions were prepared using approximately 5j.tg of RNA and either 
Race 1 primer or Race3 primer. Material from the Race3 reaction was used to perform 
the 5'RACE procedure using a Gibco-BRL kit. The Racel reaction was used to 
perform normal PCR in combination with the did2 primer. A product of 
approximately 400bp was obtained from the 5'RACE procedure as shown in figure 
2.20. This product was re-amplified and sequenced directly after agarose gel 
purification. A primer, did7, was designed using the GCG PRIME program to match 




Figure 2.20 Result of 5'RACE PCR. A major 400bp band was obtained. Marker 
sizes are in kb. 
2.2.13.2 PCR Sequencing 
Primers were designed using the GCG PRIME program to obtain an optimal primer 
with constraints of 50% G/C content, Tm  at least 50°C, and 3' base either G or C. 
Primer length was set at 18 nucleotides. Initial sequence obtained from the Race 1-did2 
PCR product and the NB40 cloned PCR product allowed further primers to be 
designed. Successive rounds of sequencing and primer design was used to determine 
the cDNA sequence generated by RT-PCR. These primers were also used to 
determine the genomic DNA sequence from recombinant pPl-X7. 
2.2.13.3 Subcloning pPl-X7 
Approximately 2.8kb of sequence from pPl-X7 had been obtained from the FIX-IA 
recombinant plasmids pEl, pE5 and pX2.8, (see also figure 2.17) A restriction map 
of pP 1 -X7 showed that a number of smaller fragments were obtained with the 
restriction endonucleases EcoRV and XhoI. The known sequence contained mapped 
EcoRV and XhoI sites and enabled an approximate map of the remaining sites in pP 1-
X7 to be determined. The EcoRV digest yielded 5 fragments of 0.4kb, 0.5kb, 0.9kb, 
1.0kb and 1.2kb in addition to the fragment remaining with the vector. These 5 
smaller fragments were successfully subcloned into pBluescript digested with EcoRV 
and treated with ClAP using identical methods described previously. A concurrent 
attempt to subclone the 0.5kb, 1.3kb (doublet) and 1.5kb XhoI fragments was not 
successful possibly to nuclease contamination resulting in damaged restriction 
endonuclease 'sticky ends' preventing ligation. 
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Figure 2.21 shows a schematic representation of pPl-X7 with subcloned fragments 
indicated along with primers used for sequencing using RT-PCR. 
did2 did8 did5 did9 dèd4 	didil * 
X 	EVXhEV 	EVXhBEV E EVXh 	 E 	EX 
I III 	I 	II I I * 
did12 did6 	didlO 	did3 didi 	Racel 
Race3 	 Race2 
Race4 








Figure 2.21 Schematic map of pPl-X7. Primers used for sequencing of genomic 
DNA and RT-PCR cDNA are shown. Subcloned EcoRV recombinant plasmids are 
shown as bars with their respective pBMF number indicated (pBMF50 - pBMF54). 
Cloned cDNA and the region spanned by the PCR product obtained from the NB40 
library, pNBperl, are represented by dashed lines. Restriction endonucleases; B: 
BaniHI, E: EcoRI, EV: EcoRV, X: XbaI, Xh: XhoI. 
2.2.14 The RACE Product may not be the 5' End 
The 400bp PCR product obtained from the 5'RACE procedure was sequenced using 
the Race4 primer by direct PCR sequencing. The sequence obtained allowed a new 
primer, did7, to be designed as near as possible to the 5' end using the PRIME 
program. This primer has been used in conjunction with did6 for RT-PCR using 
single stranded template primed from both did6 and Race 1. The product of this PCR 
is about 950bp and produces sequence with did7 primer but only very poor sequence 
with did 12 primer. The did 12 primer should produce sufficient sequence information 
to provide an overlap between the sequence obtained from the did2-Race 1 RT-PCR 
and the 5'RACE PCR, but no overlap was obtained. The electrophoretogram from 
did 12 shows many positions with 2 possible base calls suggesting that two different 
but related PCR products may be present. 
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2.2.15 Sequence Analysis 
The cDNA sequence determined to date is shown in Appendix I and has been 
submitted to the GenEMBL database with accession number Y08160. The genomic 
sequence is shown in Appendix H. All primers used in this work have been noted on 
the sequence in Appendix I. 
The essential features of the class V unconventional myosins are; a myosin head 
domain with ATP-binding and actin-binding domains, a series of 'IQ' repeats, and a 
tail domain with regions that are predicted to form coiled-coil (X-helices. Analysis of 
the predicted amino acid from 5940bp of cDNA sequence demonstrates all features of a 
class V unconventional myosin. Figure 2.22 shows the predicted amino acid sequence 
with these features highlighted while figure 2.23 is an alignment of all class V myosins 
using the GCG PILEUP program with the mouse 'GAD' sequence also included. 
The coiled-coil regions were predicted using the algorithm of Lupas et al (199 1) in the 
form of the Macstripe program adapted for Apple Macintosh computers by Knight 
(1994). Coiled-coils show a heptad repeating unit containing hydrophobic and 
hydrophilic residues and are considered to represent regions of protein-protein 
interaction. Figure 2.24 shows a sample of the output from the Macstripe program. 
Comparison of the genomic DNA and eDNA reveals that the gene contains at least 16 
exons. A representation of this genomic structure is shown in figure 2.25. 
It was observed that the original cDNA sequenced, NMC7, included a 3' untranslated 
region of 661 bp These UTRs are responsible for the localisation of RNA transcripts 
from a number of genes involved in oogenesis and embryogenesis, for example, hu-li-
tao-shao (Yue and Spradling, 1992), bicoid and oskar (St Johnston and Nusslein-
Volhard, 1992). The transcript is seen localised to the developing oocyte by in situ 
hybridisation to whole mount ovaries, see figure 2.1. Analysis of the 3'UTR and its 
role in localisation of the transcript has been carried out by A McCormack. 
2.2.15.1 A Polymorphism in the 3'UTR 
A comparison of eDNA and genomic sequence showed a 20bp region missing from 
the genomic DNA within the 3'UTR. This genomic sequence was obtained from the 
pE5 plasmid subcloned from FIX- lA. Sequence from pPl-X6, subcloned from P1 
DS00574, showed this 20bp to be present. The XFIX library was prepared from a 
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Canton-S fly line and while the DNA source for the P1 library is unknown, it is 
presumably not Canton-S. This 20bp of sequence represents a polymorphism between 
fly lines and would suggest that this region of the 3'UTR is not critical for its function. 
79 
CA 
1 VKEVELKADG SDLPPLRNPA ILVGQNDLTT LSYLI-IEPGVL HNLRVRFCKR 
51 QIIYTYCGII LVAINPYAEM PLYGPSIIRA YRGHANGDLE PHIFALAEEA 
101 YTKLERENCN LSIITSGESG_AGKTVAKYA MRYFAAVGGS ESETQVERKV 
151 LASSPIMEAF GNAKTTRNDN SSRFGKFTNL LFRNQMGVMF LQGPTMHTYL 
201 LEKSRVVYQA QGDRNYHIFY QLCAARSKYP ELVLDHQDKF QFLNMGGAPE 
251 IERVSDAEQF NETVQAMTVL GFSIQQIADI VKILAGILHL GNIQVSKKFN 
301 EGSEEEDSDS CDIFHNDIHL QITADLLRVS ADDLRRWLLM RKIESVNEYV 
351 LIPNSIEAAQ AARDALAKHI YAKLFQYIVG VLNKSLNNGS KQCSFIGVLD 
401 IYGFETFEVN SFEQFCINYA NEKLQQQFNQ HVFKLEQEEY LKEGITWTMI 
451 DFYDNQPCID LIESRLGVLD LLDEECRNPK GSDESWAGKL IGKCNKFPHF 
501 EKPRFGTTSF FIKHFSDWE YDVNGFLEKN RDTVSKELTQ VLSESNNSLA 
551 KQVMTLEEID TLCVDSAKSS TLGGRVVISA GRKQVVPSKQ HRKTVGSQFQ 
601 ESLI$LISTL. HATIPHYVRC IKPNIjDKVAF KWETAKIIQQ LRACGVLETV 
651 RISAAGFPSR WLYPDFYNRY QIiLVYRSKLD KNDMRLSCRN IVMKWIQDED 
701 KYRFGNTQIF FFAGQVAFLE QVRANLRKKY ITIPJQSVVRR_FVYRQVLRI 
751 QKVINGQKH ARGYLARRT QKNREARAGL IISKYARGWL CRRYLRLRH 
801 SI SG1EQTYAR GMLAB*FHA MRDHYRAVQfr QRFVRGALAR *tYQKRRRNI 
851 I]ICQAAIRRF LAB*(FKRNK AEAKTISIE NKYM(;LENKI ISMOORIDEL 
Figure 2.22 A) The deduced peptide sequence for the Drosophila class V 
unconventional myosin. The sequence lacks approximately the first 50 amino acids 
(based on the alignment in figure 2.23). The boxed region beginning at residue 115 
represents the ATP-binding domain, that beginning at residue 604 represents the 
actin-binding domain. The open boxes with residues highlighted are the IQ motifs. 
The highlighted underlined residues show a very high probability (>90%) of 
forming a coild-coil (x-helix based on the algorithm of Lupas et al (1991). B) An 
alignment of the IQ motifs showing the consensus residues. 
901 NRDNSNLEHX TSEI SVLKNK LEIKKTLEAE FKNVKAAgQD KDKLIEALNK 
951 QLEAERDE1 OLLEENGHAQ EEWISOKQTW ROENEELRRQ IDEIIDMAN 
1001 AQRNQED RNLAEIDNRE LNEAYQRAIK DKEVIENENF MLKEELSRLT 
1051 AGSFSLHGRK ASNASSQNED DVGYASAKNT LDINRPPDLL SKNYSYNDST 
1101 SLVVKLRSIL EEEKQKHKVL QEQYIKLSSR HKPTEDSFRV SELEVENEKL 
1151 RRRTDOLRTS IKHGVEINEL NAQHAALQEE VRRRREECIQ LKAVLLQQSQ 
1201 SMRSLEPESL QMRGNDVNEL MEAFHSQKLI NRQLESELKA ITEEHNSKLV 
1251 EMTQEIERLN NEDELQKVM FESIDEFEDS NVDTLRQNDR YLRRELQKAV 
1301 AQFLLVQEEL KLANAKLKAY RQDGGQIJEHK IEEEMIRNKS NGTSADVGAN 
1351 VTKQKSQNPQ GLMKFHSSDL DKILQRLLSA LTPRTVVGLL PGFPAYLIFM 
1401 CIRYTDLTNA DDDVRELLSK FVIQIKKMHR TPHPIENRVI WLVNSITLLN 
1451 LMKQYGDVDE YVKFNTEKQN QQQLKNFNLF EYRRVILDLF VNLYQALIMQ 
1501 IQGLLDPKIV PAILNNDEIQ RGRQAHGMRS PATSIGASSS PEHGGGPAWK 
1551 QLIGQLEHFY KQFQHFGLDN CYAEQIFHQL LYFICAVALN CLMLRGDICI 
1601 WETGMIIRYN IGCIEDWVRS KKNSNDVLTA LAPLNQVSQLI LQSRKSEQDV 
1651 QTICDLCTSL STAQVLKVMK SYKLDDYESE ITNVFLEKLT EKLNARQMQK 











RLRHS I SGIQTYARGMLANKFHAN 
RDHYRAVQIQRFVRGALABRAYQ 
KRRRNI I ICQAAIRRFLARRKFKRM 
3ensus 	IQ RG PR 






ymyo2 . . . .msfevg 
yrnyo4 . . . .msfevg 
myal .maapviivg 
50 
arvwipdpee vwksaellK. dykpGdkvLl LhlEeGkdl. 
arvwipdpee vwksaellK. dykpGdkvLq LrlEeGkdl. 
.......... 	....... vk. 
trcwyphkel gwigaeviKn efndGkyhLe LqlEddeivs 
tkcwyphkeq gwiggevtKn dffeGtfhLe LklEdGetvs 
shvwvedphl awidgevtri d .... ginvh vktkkGktv. 
51 	 100 
dilute ... .eyrlDp ktgeLPhLRN PdILvGenDL TaLSYLhEPA VLHNLrvRfi 
chpl90 .... eyclDp ktkeLPpLBN PdILvGenDL TaLSYLhEPA VLHNLkvRfi 
mgad.................................................. 
didusn .... evelka dgsdLPpLRN PaILvGqnDL TtLSYLhEPg VLHNLrvRfc 
ymyo2 vdtkdlnnDk dqs.LP1LRN PpILeateDL TsLSYLnEPA vlhaikqRys 
ymyo4 ietnsfenDd dhptLPvLRN PpILestdDL TtLSYLnEPA vlhaikkRym 
myal vtnvyfpkDt eaps ...... .... gGvdDm TkLSYLhEPg VLRNLetRye 
101 
dilute dsklIYTYcG IVLvaiNPYe 
chpl90 dsklIYTYcG IVLvaiNPYe 
mgad.................... 
didum krqiIYTYcG IiLvaiNPYa 
ymyo2 qln.IYTYsG IVLiatNPfd 
ymyo4 ngq.IYTYsG IVLiaaNPfd 
myal lne.IYTYtG niLiavNPfq 
150 
qlp.iygedi InAYsGqnmG dindPHiFAvA 
qlp.iygedi InAYsGqrimG dxndPHiFAvA 
emp.lygpsi IrAYrGhamG dLePHIFA1A 
rvdqlytqdm IqAYaGkrrG eLePH1FAiA 
kvdhlysrem IqnYsskrkd eLePH1FAiA 
rlphiyetdm meqYkGialG eLsPHvFAig 
151  
dilute EEAYkqMard erNQSI4TSG ESGAGK 
chpl90 EEAYkqMard erNQSI4TSG ESGAGKqV  
mgad .................. 
didum EEAYtklere ncNlSIISG ESGAGK 
yrnyo2 EEAYr1Mknd kqNQtIvjVSG ESGAGK 
yrnyo4 EEAYrfMvhe kaNQtvv}ISG ESGAGK 





SA KYaMRYFAaV gGseset... 
SA KYiMRYFAsV eeensatvqh 
SA KY1MRYFAsV qesnn. . reg 
tt Km1MRY1Af 1 gGrsg ..... 
Figure 2.23 Alignment of class V unconventional myosins using the GCG PILEUP 
program. Positions where amino acids are greater than 50% identical have been 
highlighted by capitalising. The ATP-binding domain, actin-binding domain and IQ 
motifs have been boxed. The sequences compared are; dilute from mouse (Mercer 
et a!, 1991), chpl90 from chicken (Espreafico et a!, 1992), mgad from mouse 
(Huang et al, 1990), didum, the new Drosophila sequence (this work), ymyo2 from 
yeast (Johnston et al, 1991), ymyo4 from yeast (Haarer et al, 1994) and myal from 
Arabidopsis (Kinkema and Schiefelbein, 1994) 
FM 
201 
dilute 	. nvEeK VLASNPIMEs 
chpl90 ..... nvEeK VLASNPIMEs 
mgad .................... 
didum ..... qvErK VLASsPIMEA 
ymyo2 qvemsetEqK iLAtNPIMEA 
ymyo4 evemsqiEsq iLAtNPIMEA 















dilute . . . GAnXnRTY LLEKSRVVfQ aeeERNYHIF YQLCAsak1p efkmLrLgria 
chpl90 . . . GAnInRTY LLEKSRVVfQ aeeERNYHIF YQLCAsaalp efktLrLgna 
mgad 
diduxn flqGptrnhty LLEKSRVVyQ aqgdRNYHIF YQLC. .aars kypeLvLdhq 
yrnyo2 . . . GAriRTY LLErSR1VyQ ppiERNYHIF YQLmAglpaq tkeeLhLtda 
ymyo4 - . . GskiRTY LLEKSR1VyQ petERNYHIF YQilegipep vkqeLhLssp 
myal . . .GAaiRTY LLErSRVcqi sdpERNYHcF YLLCAapped ikk.ykLenp 
301 	 350 
dilute dsfHYtkQGG spmIeGvDDA kEmahTrqAc TL1GISesyQ mgIFrILAGI 
chpl90 nyfHYtkQGG spvIdGiDDA kEmvnTrqAc TL1GISdsyQ mgIFrILAGI 
rngad 
didum dkfqflNmGG apelervsDA eqfneTvqAm TvlGfSiqqi adIvkILAGI 
ymyo2 sdyfYmNQGG dtkInGiDDA kEykiTvdAl TLvGItketQ hqIFkILAal 
ymyo4 kdyHYtNQGG qpnlaGiDeA rEykiTtdAl sLvGlnhetQ 1gIFkILAG1 
myal hkfHYlNQss cykldGvDDA sEyleTrrAm dvvGlSneeQ ealFrvvAal 
351 	 400 
dilute LHLGNvgfas r ........ D sdsctippkh epltifCdLm gvDyeernchW 
chp190 LHLGNvefas r ........ D sdscaippkh dpltifCdLm gvDyeemahW 
mgad 
didum LHLGNIqvsk kfnegseeeD sdscdifhnd ihlqitadLL rvsaddlrrW 
ymyo2 LHIGNIeikk ..... trn.D asisadep.. .nlklaCeLL giDaynfakW 
ymyo4 LHIGNIemkm ..... trn.D aslsseeq.. - niqiaCeLL giDpfnfakW 
myal LHLGNIdfgk ..... geeiD ssvikdkdsr shlninaaeLL mcnaqsleda 
401 	 450 
dilute Lchrklatat Etyikpiskl qAtnARDaLA KhIYakLFnW IVdhvnq... 
chp190 Lchrklatat Etyikpiskl hAinARDaLA KhIYanLFnW IVdhvnk... 
mgad 
diduxn Llmrkiesvn Eyvlipnsie aAqaARDaLA KhIYakLFqy IVgvink... 
ymyo2 vtkkqiitrs Ekivsnlnys qAlvAkDsvA KfIYsaLFdW LVenintvlc 
yrnyo4 ivkkqivtrs Ekivtnlnyn qAliARDsvA KfIYstLFdW LVdninktly 
myal Lirrvmvtpe Eiitrtldpd nAiasRDtLA KtIYshLFdW IVnkint... 
Figure 2.23 continued 
451 	 500 
dilute . . aLhsavkq hSFIGVLDIY GFEtFEiNSF EQFCINYANE KLQQqFNmhv 
chpl90 . . aLhstvkq hSFIGVLIDIY GFEtFEINSF EQFCINYANE KLQQqFNmhv 
mgad 
diduxn . . sLnngskq CSFIGVLDIY GFEtFEvNSF EQFCINYANE KLQQqFNQHV 
ymyo2 npavn. . dqi sSFIGVLDIY GFEhFEkNSF EQFCINYANE KLQQeFNQHV 
yntyo4 dpeL,dqqdhv fSFIGiLDIY GFEhFEkNSF EQFCINYANE KLQQeFNQHV 
myal . . sigqdprs kSiIGvLDIY GFEsFkcNSF EQFCINftNE KLQQhFNQHV 
501 	 550 
dilute FKLEQEEYmK EqIpWtlIdF yDNQPCINLI EskL.giLdLLDEECkmPKG 
chpl90 FKLEQEEYmK EqIpWtlIdF ydNQPCINLI Eakm.gvLdL LDEECkInPKG 
mgad 
didurn FKLEQEEY1K EgItWtmIdF yDNQPCIDLI EsrL.gvLdL LDEECrmPKG 
ymyo2 FKLEQEEYvK EeIeWsfIeF nDNQPCIDLI EnkL.giLsL LDEEsr1PaG 
ymyo4 FKLEQEEYvK EeIeWsfIeF sdNQPCIDLI EnkL.giLsL LDEEsr1PsG 
myal FKmEQEEYtK EelaWsyieF iDNQDv1eLI EkkpggiisL LDEaCmfPks 
551 	 600 
dilute tDdtWaQKLY nthlnkca.. lFeKPRmsnk aFIikHFAdk VEYqcEGF1E 
chpl90 SDdtWaQKLY nthlnkca.. lFeKPRlsnk aFIikHFAdk VEYqcEGF1E 
mgad 
diduxn SDEsWagkli gkc.nkfp.. hFeKPRfgtT sFfikHFsdt VEYdVnGF1E 
ymyo2 SDEsWtQKLY qtldksptnk vFsKPRfgqT kFIvsHYald VaYdvEGFiE 
ymyo4 SDEsWasKLY safnkppsne vFsKPRfgcjT kFIvsHYAvd VEYevEGFiE 
myal thEtfsQKlf qtfke... he rFaKPklsrT dftisHYAge VtYqsnhFid 
601 	 650 
dilute KNkDTVfeeq ikVLKss.kf kmlpeLfqdd ekaisptsat ssgrtpltrv 
chp190 KNkDTVyeeq ikVLKsskkf kllpeLfqde ekaisptsat psgrvplsrt 
mgad 
diduxn KNrDTVske1 tqVLsesnrns lakqvmtlee idticvdsak sst... lggr 
ymyo2 KNrDTVsdgh leVLKastne tliniLegle kaakkleeak kleleqagsk 
ymyo4 KNrDsVslgh ldVfKattnp if kqiLdri ..... relrsdd apeegntekk 
myal KNkDyivaeh qalftasnck fvaglfhalh edssr ............... 
651 	 700 
dilute pvkptkgrpg qtakehKkTv GhgFrnsr l LMeTLnaTtP HYvRCIKPI d 
chpl90 pvkpakarpg qtskehKkTv GhqFrnsr i1 LMePtnaTtP HYvRCIKP1 d 
mgad 
didum vvisagrkqv vpskqhrkTv GSqFqesL5t s lisTLhaTtp HYvRCIKP1 d 
ymyo2 kpgpir .... .. tvnrKpTl GSmFkqsI e LMtiTinsTnv flYiRCIKP1 a 
ymyo4 imipar .... .. lsqkKpTl GSmFkksI je LMaiinsmv HYiRCIKP1 s 
myal .......... ... sskfssi GSrFkqqI is LMesLnqteP HYIRCIKP1 n 
actin-binding domain 
Figure 2.23 continued 
701 	 750 
fkfPftFDek ravqQLPACG VLETIRISar GFPSRWTyqE FfsRYrvL. - 
fkfPftFDek ravqQLRACG VLETIRISaA GFPSRWTyqE FfsRYrvL.. 
dkvafkweta kiiqQLRACG VLETVRISaA GFPSRW1ypd FymRYq1L.. 
dkeawqFDnl mv1sQLRACG VLETIRIScA GFPSRWTfeE FvlRYyiLip 
ekkPweFDnl mv1sQLRACG VLETIRIScA GFPSRWTfdE FvqRYflLtd 
vlkPgiFenf nvihQLRcgG VLEaIRIScA GyPtRlafyd FldRfglLap 
751 	 800 
m.k qkdvlgdrkq tCknvLekli ldkdKYQfGk TKIFFrAGQv 
m.k qkdvlsdrkq tCknvLekli ldkdKYQfGk TKIFFrAGQv 
.................................................. 
vyr skldkndmrl sCrnivmkwi qdedKYrfGn TqIFFrAGQv 
heqwdlifkk ketteediis vvkmiLdatv kdksKYqiGn TKIFFkAGxn1 
yslwsgilyn pdlpkeaivn fCqsiLdati sdsaKYQiGn TKIFFkAGm1 
evl ....... . egnyddkva CqmiLdk. ksltdYQiGk TKIF1rAGQm 
801 
AyLEK1RadK lraacirl t 1 r Ylcmqraait 
850 
R R TC ry1jqA 
AyLEKiRadK lraacirijQ1 t]RcwlrtRFk Ymrmrraait 
AfLEqvRanl rkkyiti1QthI Rf R q vlriqkving iCkhaR6ylA 
AyLEK1RsnK mhnsivmllQKl k]RekyyRFq Ylqisqaiky 
AfLEK1RtnK mneiciilQli k R r R q Ylgtmesikk 
anikbfii 
q±R4.iv 
AeLdarraev lgnaarv1J q R cm P. Yrsirnaaiv f1iA 
851 
	 Em 
Rc a.kfLRr tkAattJIy 	P. rY kirRaatii 
P.0 a tfLRr trAai1iQ1kf Rk rY qcmRdatia 
	
1 
Re t.qkmRe arAgLiJl4y zRgalcRrrY lrlRhsisg 
Rqrvndemkv ncAtL.IlQa  RghsiRanv fsvlrtitr. 
R vdheLkt raAiL I1QItn R w R Y raaigqii} 































Hryrkilrey  kaVi r 1 ykR tmkai c f mrnZ 
950 
Q P. 1 RI, k 
chpl90 frkyqmmlreh ksii Q hvR C-'wlERuhyhR tlkaivl - lC= c K 
mgad 
didum rkfhamrdhy rAVqIQ fvR al ayqk rrrniiffcCa a fi r 
ymyo2 xqlkqeheyn aAVt Q k fe RrflR tkkdt l q 
ymyo4 
defrlrrqrk
s\mrkfm1m aAVi Q y g k dyrt lkrssi v 1 r 
myal  aM Q h rq f tR lqkaai t a R 1 r 
Figure 2.23 continued 
951 	 1000 
dilute vKkLKiEars veryKklhiG mENKimqLqr kvdeqnkdyk cimekitnie 
chpl90 lKkLKiEars veryKklhiG LENKimqLqr kideqnkeyk sllekmnnle 
mgad 
didurn fKrmKaEakt ishxnenkymG LENKiismqq ridelnrdns nlkhk ..... 
ymyo2 lKqLKadaks vnhlKevsyk LENKvieLtq ni ........ ... askvken 
ymyo4 yivLqkEvee rnirasygiG Lleeaiefkn sf .................. 
myal lrmLKmaard tgalKdaknk LEqrveeLsl rlhlekrlrt dleeakvqev 
1001 	 1050 
dilute gvynsEtekL rndvErlqls EeeaKvatgr vlslqeelak LrKdLeqtrs 
chpl90 itystEtekL rsdvErlrms EeeaKnatnr vlslqeelak LrKeLhqtqt 
mgad 
didum ... tsEisvL kmklElkktl EaefKrivkaa cqdkdkllea LnKqLeaerd 
	
yrnyo2 	kemterikeL qvqve ................................... 
yrnyo4 ...... ilnL emind ..... 	 .......... 	 .......... 	 .......... 
myal 	aklqealhtm rlqlk ................................... 
1051 	 1100 
dilute EKksieErad kykqEtdqlv snLkeentll kqeketlnhr ive.qakemt 
chpl90 EKktieEwad kykhEteqlv seLkeqntll ktekeelnrr ihd.qakeit 
rngad 
didum EKmq11E ... .... Enghaq eewisqkqtw rqeneelrrq ideiidmakn 
ymyo2 .......... .... Esaklq etLeninkkeh lididnqksk dmelqkt.ie  
ymyo4 .......... .... sytrit qlLqg ..... .. dlsnipsk qrqeyet.iv 
myal .......... .... Ettamv vkeqeaarva ieeassvnke pvvvedteki 
1101 	 1150 
dilute etmerkivee tkqlElDlnd erlrYQnlln efsrlEeryd dLKeEmtlml 
chpl90 etmekklvee tkqlElDlnd erlrYQnlln efsrlEeryd dLKdEmnlmv 
mgad .......... 	 .......... 	 .......... 	 ......... m eLrdEqt... 
didum aevnqrnqed rmlaEiDnre lneaYQraik dkeviEnenf mLKeElsrlt 
ymyo2 	nnlqsteq .. 	.......... 	 .......... 	 .......... 	 .......... 
ymyo4ngyndki s .......................................... 
myal 	dslsneid .. 	.......... 	 .......... 	 .......... 	 .......... 
1151 	 1200 
dilute nvpkPGHkRt dSthSS.NES eytfs .... S EfaetEDiap rtE.epiEkK 
chpl90 sipkPGHkRt dSthSS.NES eytfs .... S EiteaEDlpl rmEqepsEkK 
mgad . . . .PGHrkn pSnqSS.1ES dsnypsistS EigdtEDalq qvEeigiE.K 




Figure 2.23 continued 
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1201 	 1250 
dilute Vp1DMSLFLK LqkrvtEleQ ekqlmQdeLd r. .keeqvfr skaKeeerp. 
chpl90 ap1DMSLFLK LqkrvtEleQ ekqsLQdeLd r. .keeqaLr akaKeeerp. 
mgad aamDMtvFLK LqkrvrEleQ erkkLQaqLe k. .gqqdskk gqveqqnngl 
didum yndstSLvvK LrsileEekQ khkvLQeqyi k .......Ls srhKpte... 
yrnyo2 .........t Lk ........ ... daqleLe &nvkqhdeLk eesKkqleel 
yrnyo4 .........K Lk ........ ... tLQveim ntlnkknaLk erkKkqssli 
myal .........r Lkgllsseth kadeaQhayq salvqneeLc kkleeagrki 
1251 	 1300 
dilute .qirgaeleY esLKrqELES ENKKLKnEIn elrkalseks apevtapgap 
chpl90 .pirgaeleY esLKrqELES ENKKLKnE1n elqkaltetr apevtapgap 
mgad dvdqdadiaY nsLKrqELES ENKKLKnd1n elrngvadqa mqdnsthssp 
didurn ..........dsfrvsELEv ENeKLrrryd qlrtsikhgv eine ...... 
yrnyo2 eqtkktiveY qtLn.gdLqn EvKsLKeE.. . i. .arlqta mslgtvttsv 
ymyo4 qshinqslaai kgnKpsrLsd EvKsmKqE.. .1. .afienv iaqdfttt.. 
myal dqlqdsvqrf qe.KvfsLES EnKvLrqqtl ti. .spttra lalrpkttii 
1301 	 1350 
dilute .ayrvLmeQl tsvsEEldvR kEEvliLrsq LvsQKeaiqp kddkntmtds 
chpl90 .ayrvLldQl tsvsEElevR kEEvliLrsq LvsQKeaicjp kedkntmtds 
mgad dsyslLlnQl klanEElevR kEEaliLrtg imnadqrrls gknmepnina 
diduin .....LnaQh aalqEEvrrR rEEciqLkav LlqQsqsmrs lepeslqmrg 
ymyo2 lpqtpLkdvm gggasnfnrim mlEnsdLspn dlnlKsrstp ssgnnhidsl 
ymyo4 ........ys ankndkvkgl giagqqvkpk Lvnv ...... .......... 
myal qrtpekdtfs ngettqlqe. .pEtedrpqk slnQKqq... enqelllksi 
1351 	 1400 
dilute tilledvqkm kDkgeiaqAY iG1keTNRLL EsqLqsqkrs HeneaeaLrg 
chpl90 tilledvqkm kDkgeiagAY iG1keTNRLL EsqLqsqkks HeneLesLrg 
mgad rtswpnsekh vDqedaieAY hGvcqTNRLL EaqLqaqsle HeeevehLka 
diduxn ..........nDvnelmeAf hsqkliNRqL EseLkaitee HnskLverntq 
ymyo2 sv ........ .......... .......... drengvnatq ineeLyrLie 
ymyo4 .i ........ .......... .......... rresg......npdLleLlm 
myal se ........ .......... .......... digfsegkpv aacliykcli 
1401 	 1450 
dilute eiqsLkeEnn rQQQ11aQnL qLpPEAriEa slQheItRLT NENLyfeely 
chp190 eiqsLkeEnn rQQQ11aQnL qLpPEAriEa slQheItRLT NENL ...... 
rngad qveaLkeEmd kQQQtfcQtL 1LsPEAqvEf gvQqeIsRLT NENL ...... 
diduxn eierLnnEkd elQkvmfesi defedsnvdt lrQnd. .Ryl rreL ...... 
	
yrnyo2 	dteiLnqEit e ....................................... 
ymyo4 	dlncytlEvt e ....................................... 
myal 	hwrsfevErt s ....................................... 
Figure 2.23 continued 
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1451 	 1500 
dilute addpkkyqsy rislykrmiD 1mEqLEKqdK tvRKLKKQLK vfaKKlgelE 
chpl90 .......... ......... D 1mEqLEKqdK tvRKLKKQLK vfaKKIgelE 
mgad .......... ......... D fkElvEKleK neRKLKKQLK iymKKvqdlE 
didum .......... .qkavaqf 11 vqEeLklana klkayrqdgg qlehKleeem 
	
ymyo2 	.......... .......... .......... .......... gllKgfevpd 
ymyo4 	.......... .......... .......... .......... gylKKvnvtE 
myal 	.......... 	.......... 	.......... 	.......... ifnriletia 
1501 	 1550 
dilute vgqmenispg qiidepirpv niprKEKDFQ GMLEYkrEde qkLvkNLiie 
chpl90 vgqxnenispg qiidepirpv niprKEKDFQ GMLEYkkEde qkLvkNLile 
mgad aaqalaqs.d rrhheltrqv tvqrKEKDFQ GMLEYhkEve alLirNLvtd 
diduin irnksngtsa dvganvtkg ..... KSqrIPQ Glmkfhssdl dkilqrLlsa 
ymyo2 agvaiqlskr dv ...................................... 
ymyo4vngd ...... nv ...................................... 
myal saieinq.ens dv ...................................... 
1551 	 1600 
dilute LKPrgvavnL iPglPAYilf MCvRhaDy1N dDqkVrsLLt stInsIKKvL 
chpl90 LKPrgvavnL iPglPAYilf MCvRhaDy1N dDqkVrsLLt stIngIKKvL 
mgad LKPq.mllgt vPclPAYily MCiRhaDytN dDlkVhsLLs stIngIKKvL 
didurn LtPrtv.vgL lPgfPAYlif MCiRytD1tN aDddVreLLs kfviqlKK.m 
ymyo2 .........v yPariliivl semwrfgltk qsesflaqvl ttlqkvvtqL 
ymyo4 ......... L gPihvittvv sslvrnglli qsskfiskvl ltvesivmsL 
myal 	......... L c ......... ... ywlsnsa tllmflqrtl kagatgsitt 
1601 	 1650 
dilute KKrgddfEtv sFWLSNtcrf . . LhcLKQYS geegfmkhNt srQNehcLtN 
chpl90 KKrgddfEtv sFWLSNtcrf . . LhcLKQYS geegfmkhNt prQNehcLtN 
mgad KKhnddfEint sFWLSNtcrf . . LhcLKQYS gdegfintqNi akQNehcLkN 
didum hrtphpiEnr viWLvNsitl . . Ln1mKQYg dvdeyvkfNt ekQNqqqLkN 
ymyo2 Kgndlipsgv .FWLaNvrel ysfvvfalnS ilteetfkNg mtdeeykeyv 
ymyo4 pKdetmlggi .FWLSN. - .1 srLpafaan. . .qktlyean ggdekdkLtl 
myal prrrgmpssl fgrvsg. . sf rgspgsagfp fmtgraiggg ldelrqveak 
1651 	 1700 
dilute FdLaEYRqVL sDLaiqIYQq LvrvleniLQ PmlVsgmLeh EtlQgvsGvk 
chpl90 FdLaEYRqVL sDLaiqIYQq LvrvleniLQ PmlVsgmLeh EtlQgvsGvk 
mgad FdLtEYRqVL sDLsiqIYQq LikmpeglLQ PmlVsamLen EsIQglsGvr 
didum FnLfEYRrVi 1DLfvnLYQa LimqiqglLd PklVpaiLnn deIQ. . rGrq 
ymyo2 sLvtelkddf eaLsynlYni wlkklqkqLQ kkainav... vi ..... ses 
ymyo4 iylndlenet lkvfdklYst wlvkfmkh.. . .asahi... Ei ..... f din 
myal ypallfkqqL tafleklYgm irdkmkkeis Pilasci... qvprtprsgl 
Figure 2.23 continued 
1701 	 1750 
dilute ptGlrkRtsS ia ......de Gtytldsllr qLNSFhsvmC qhGmDpElIk 
chpl90 ptGlrkRtsS ia ......de Gtytldslir qLNSFhsvmC qhGmflpEllk 
mgad ptGyrkRssS my ...... dg e ......... ..NSFhtv1C dqGlDpEiIl 
didum ahGmrsRatS igassspehg Ggpawkqlig qLehFykqfq hfGlDncyae 
ymyo2 lpGfsagetS gflnkifarit eeytmddllt ffNSiywcmk sfhienEvfh 
ymyo4 v ......... .lneklfkns Gdekfaklft fLNeFdavlC kfqvvdsmht 
myal vkGrsqntq. . nnvvapkp miahwqnlvt cLNghlrtmr anyvpsllls 
1751 	 1800 
dilute QVvkQmFYiv gAitLNnL1L RkDmCSWskG MqiRYNvsqL EEW1rdKn=lm 
chpl90 QVvkQmFYiI gAvtLNnL1L RkDmCSWskG MqiRYNvsqL EEWlrdKnlm 
mgad QVfkQ1FYmI nAvtLNnL1L RkDaCSWstG Mq1RYNisqL EEWlrgKnlh 
didum QifhQllYf I cAvaLNcLmL RgDiCiWetG MiiRYNigci EdWvrsKkms 
ymyo2 aVvttllnyv dAicfNeLim krnflSWkrG lqlnYNvtrL EEWckthg.. 
ymyo4 kifndtlkyl nvmlfNdLit kcpalnWkyG yevdrNierL vsWfepr... 
myal kvfgqiFsfl nvqlfNsLlL RreccSfsnG eyvktglaeL EkWchdatee 
1801 	 1850 
dilute n.sgaketLe PLIQ?AQLLQ vKKKtddflae aI.CsmCnal tTAQIvKvLn 
chpl90 n.sgaketLe PLIQAAQLIiQ vKKKtdeDae aI.CsmCnal tTAQIvKvLn 
mgad q.sgavqtme PLIQAAQLLQ lKKKtheDae aI.CslCtsl sTqQIvKiLn 
didum n. .dvltaLa PLnQvsQLLQ .srKseqDvq tI.CdlCtsl sTAQvlKvmk 
ymyo2 .ltdgtecLq hLIQtAkLLQ vrKytieDid .IlrgiCysl tpAQlqKlis 
ymyo4 .iedvrpnLi qiIQavkiLQ lKisnlnefk .11fdfwyal npAQIqaiLl 
myal fvgsawdeLk hirQavgfLv ihqKpkkslk eittelcpvl siqQlyrist 
1851 	 1900 
dilute lytpvnefEe rvsvsFirti qmrLrdrk.. . . dspqllmD aKhifPvtfp 
chp190 lytpvnefEe rvlvsFirti qlrLrdrk.. . . dspqllmD aKhifPvtfp 
mgad lytpinefEe rvtvsFirti qaqLqern.. . . dpqqlll]D sKhvfPvlfp 
didum syk.lddyEs eitnvFlekl tekLnarqmq ksnsdeftiD qKfiqPfkvv 
ymyo2 qyqvady.Es pipqeilryv adivkkea .. ....... als ssgndskghe 
ymyo4 kykpankgEa gvpneilnyl arivikrenls lpgkmeimls aqfdsaknhl 
myal mywddkygth svsteviatm raevsdvsks aisn. . . sf1 ldddssipfs 
1901 	 1950 
dilute 	fnpSslalet IqiPasLgL. gFlarv* ....................... 
chpl90 fnpSslalet IqiPasLgL. gFlsrv* ....................... 
mgad ynpSaltmds IhiPacLnL. eFlnev* ....................... 
didum frySdikied IelPshLnLd eFltki* ....................... 
yrnyo2 h. .Sssif it petgpftdpf slIk.trkfd qyeayipawl slpstkrivd 
ymyo4 rydtsaitqn snteglatvs kilkldrk* 
myal lddisksmqn vevaev.dpp pllrqnsnfm fllersd* ............ 
1951 	1962 
ymyo2 lvaqqvvqdg h* 
Figure 2.23 continued 
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1234 	5 	6 	1234 	5 	6 
	
855 A 5 d 1.179511 0.020656 	897 I 1 a 1.840007 0.996441 
856 A 5 e 1.179511 0.020656 898 D 1 b 1.840007 0.996441 
857 I 5 f 1.179511 0.020656 	899 E 1 c 1.840007 0.996441 
858 R 5 g 1.179511 0.020656 900 L 1 d 1.840007 0.996441 
859 R 5 a 1.179511 0.020656 	901 N 1 e 1.738845 0.982383 
860 F 5 b 1.179511 0.020656 902 R 1 f 1.738845 0.982383 
861 L 5 c 1.179511 0.020656 	903 D 1 g 1.738845 0.982383 
862 A 5 d 1.259497 0.055190 904 N 1 a 1.738845 0.982383 
863 R 5 e 1.259497 0.055190 	905 S 1 b 1.738845 0.982383 
864 R5 f 1.259497 0.055190 906 N 1 c 1.738845 0.982383 
865 K 5 g 1.259497 0.055190 	907 L 1 d 1.738845 0.982383 
866 F 1 e 1.263676 0.058086 908 K 1 e 1.646830 0.931083 
867 K 1 f 1.486036 0.559921 	909 H 1 f 1.547187 0.754389 
868 R 1 g 1.502049 0.615287 910 K 1 g 1.547187 0.754389 
869 M 1 a 1.533937 0.716957 	911 T 1 a 1.547187 0.754389 
870 K 1 b 1.544777 0.747823 912 S 1 b 1.547187 0.754389 
871 A 1 c 1.544777 0.747823 	913 E 1 c 1.547187 0.754389 
872 E 1 d 1.544777 0.747823 914 I 1 d 1.514030 0.655133 
873 A 1 e 1.544777 0.747823 	915 S 1 e 1.404267 0.288094 
874 K 1 f 1.544777 0.747823 916 V 3 d 1.329672 0.128225 
875 T 1 g 1.544777 0.747823 	917 L 3 e 1.395349 0.263607 
876 I 1 a 1.544777 0.747823 918 K 3 f 1.395349 0.263607 
877 S 1 b 1.544777 0.747823 	919 M 3 g 1.395349 0.263607 
878 H 1 c 1.630408 0.913367 920 K 3 a 1.395349 0.263607 
879 M 1 d 1.752887 0.985820 	921 L 3 b 1.395349 0.263607 
880 E 1 e 1.840007 0.996441 922 E 3 c 1.495420 0.592596 
881 N 1 f 1.840007 0.996441 	923 L 3 d 1.495420 0.592596 
882 K 1 g 1.840007 0.996441 924 K 3 e 1.495420 0.592596 
883 Y 1 a 1.840007 0.996441 	925 K 3 f 1.495420 0.592596 
884 M 1 b 1.840007 0.996441 926 T 3 g 1.495420 0.592596 
885 G 1 c 1.840007 0.996441 	927 L 3 a 1.495420 0.592596 
886 L 1 d 1.840007 0.996441 928 E 3 b 1.495420 0.592596 
887 E 1 e 1.840007 0.996441 	929 A 3 c 1.495420 0.592596 
888 N 1 f 1.840007 0.996441 
889 K 1 g 1.840007 0.996441 	1 Residue number 
890 I 1 a 1.840007 0.996441 
891 I 1 b 1.840007 0.996441 	2 Amino acid 
892 S 1 c 1.840007 0.996441 3 Heptad frame (1-7) 
893 M 1 d 1.840007 0.996441 	4 McLachlan position (abcdefg) 
894 Q  1 e 1.840007 0.996441 5 Score from Lupas method 
895 Q  1 f 1.840007 0.996441 
896 R 1 g 1.840007 0.996441 	6 Probability from Lupas method 
Figure 2.24 Example of output from the Macstripe program (Knight, 1994) for 
predicting coiled-coil structures in peptide sequences. Residues 876 to 910 are 
highly likely to form a coiled-coil domain. 
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Figure 2.25 Schematic diagram of genomic structure of the class V myosin (didum) gene. Primers used for determining the 5' cDNA 
sequence are shown. The shaded part of the last exon represents the 3'UTR. The open triangle represents the position of the 20bp 
polymorphism within the 3'UTR. The 5'RACE product is also represented. Restriction endonucleases; B: BamHI, E: EcoRI, EV: EcoRV, 
X: XbaI, Xh: XhoI. 
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2.3 The Mouse "GAD" is a Class V Myosin 
It was clear that the mouse "GAD" described by Huang et a! (1990) was unique among 
the glutamate decarboxylase from the sequences that were deposited in the GenEMBL 
database, see figure 2.26. In particular, all glutamate decarboxylases show a 
requirement for the cofactor pyridoxal phosphate, apart from the Huang "GAD" (for 
review, see Erlander and Tobin [1991], see also Bu et a! [1992]). The cofactor-binds 
to a conserved motif with amino acid sequence NPHK (binding is to the lysine [K]), a 
sequence motif not found in the Huang "GAD". The sequence identity between the 
Huang "GAD" and the class V myosins strongly suggested that the original sequence 
reported was a truncated cDNA. 
98%  
I 	INPHKI 	*•-øI 	 I 17% 
mammalian GAD 67 	 Huang "GAD" 
594aa 
Figure 2.26 Schematic representation of glutamate decarboxylases and the Huang 
"GAD". Mammalian GADs fall into 2 classes, a 65kDa group and a 67kDa group. 
Homology within each group is 96% and 98% respectively at the amino acid level. 
There is also significant sequence similarity between the mammalian GADs and the 
Drosophila GAD (Jackson et al, 1990). The Huang "GAD" shows no obvious 
sequence similarity to any of these GADs. Comparisons done with the GCG GAP 
program. 
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2.3.1 Isolation of Mouse Myosin V cDNAs 
A project was carried out by an udergraduate, A Wilke, and continued by a 
postgraduate on rotation, P Loke, to isolate and characterise cDNAs from a mouse 
brain library that were homologous to that described by Huang et al (1990). A 
summary of this project is given below. 
Two oligonucleotide primers, Mgadl and Mgad2, were designed based on the 
sequence described by Huang et al (1990) to produce a product of 1.2kb by PCR. 
Total RNA was isolated from liver dissected from mice by the Trizol method (7.10). 
Liver tissue was chosen as there was an abundance of material but it was not known if 
the gene was expressed in the liver. 
A reverse transcription reaction was performed with Mgad2 primer followed by PCR 
with both primers and a 1.2kb product was obtained. Restriction with the 
endonuclease Sacl produced a 600bp doublet as seen on agarose gel electrophoresis, a 
strong indication that this product was derived from the same gene as the Huang 
sequence. The PCR product was purified, labelled with a- 32P-dCTP and used to 
screen a mouse brain cDNA library in the AZAP vector (Stratagene commercial 
library). A mouse brain library was chosen to screen as the Huang sequence was 
isolated from a brain cDNA library. Approximately 4 x 10 5 recombinant bacteriophage 
were screened with 17 initial positives identified. Of these positives, 7 were able to be 
plasmid rescued after sucessive rounds of screening. These recombinant plasmids 
have been analysed by restriction mapping and DNA sequencing. 
The insert from the plasmid named ZAP-12 is approximately 4.5-5kb and DNA 
sequencing has shown that this plasmid contains a region that codes for an actin-
binding domain. This finding is sufficient proof that the Huang "GAD" is indeed a 
class V myosin. However, further evidence comes from a recent publication by Zhao 
et al (1996) who describe a sequence from rat which encodes a class V myosin and 
which shows 96% identity at the amino acid level to the Huang "GAD". An alignment 
between these two sequences is shown in figure 2.27. 
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mgad 	 . MELRDE.QTPGHRKNP 15 
	
:1111 	111111111 
myr6 SSVEENLLIKKELEEERSRYQNLVKEYSQLEQRYENLRDEQQTPGHRKNP 1100 
rngad SNQSSLESDSNYPSISTSEIGDTEDALQQVEEIGIEKAAMDMWFLKLQK 65 
III 	IllilIlIll) 	liii 	liii 	liii 	111111111 
myr6 SNQSSLESDSNYPSISTSEIGDTEDALQQVEEIGIEKAANDMTVFLKLQK 1150 
ingad RVRELEQERKKLQAQLEKGQQDSKKGQVEQQNNGLDVDQDADIAYNSLKR 115 
myr6 RVRELEQERKKLQVQLEKEQQDSKKVQVEQQNNGLiDVDQDADIAYNSLKR 1200 
mgad QELESENKKLKNDLNELRNGVADQANQDNSTHSSPDSYSLLLNQLKLANE 165 
111111 	111111111 	:.: 	IIIIIIIIlIlIIIlI 	11111 	I 	III 	II 
myr6 QELESENKKLKNDLNERWKAVADQANQDNSTHSSPDSYSLLLNQLKLANE 1250 
mgad ELEVRKEEALILRTQIMNADQRRLSGKNMEPNINARTSWPNSEKHVDQED 215 
myr6 ELEVRKEEVLILRTQfl4NADQRRLSGKNMEPNINARTSWPNSEKHVDQED 1300 
mgad AIEAYHGVCQTN .......................... RLLEAQLQAQSLJ 239 
III 	I II 	1111111. 
myr 6 AIEAYHGVCQTNSQTEDWGYLNEDGELGLAYQGIjKQVARLLEAQLQAQNL 1350 
mgad EHEEEVEHLKAQVEALKEEMDKQQQTFCQTLLiLSPEAQVEFGVQQEISRL 289 
liii 	111111111111111111111 
myr6 KHEEEVEHLKAQVEAMKEEMDKQQQTFCQTLLLSPEAQVEFGVQQEISRL 1400 
ingad TNENLDFKELVEKLEKNERKLKKQLKIYNKKVQDLEAAQALAQSDRRHHE 339 
1111111111111 	1111:1111111 	I 	11111111111111 	11111111 
myr 6 TNENLDFKELVEKLEKNEKKLKKQLKIYNKKVQDLEAAQALAQSDRRHHE 1450 
mgad LTRQVTVQRKEKIDFQGMLEYHKEVEALLIRNLVTDLKPQMLLGTVPCLPA 389 
11111 	11111111111111111 	11111 	111111111 	I 11111111 
myr6 LTRQVTVQRKEKDFQGMLEYHKEDEALLIRNLVTDLKPQMLSGTVPCLPA 1500 
Figure 2.27 Comparison of the Huang "GAD" (ingad) deduced amino acid 
sequence to that from myr6, a class V myosin from rat (Zhao et al, 1996) using the 
GCG GAP program. Identity is 96%. 
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ad YILYNCIRHADYTNDDLKVHSLLSSTINGIKKVLKKHNDDFEMTSFWLSN 439 
liii 	11111111 	11111111111111111111111:1111111111 	I 
r6 YILYNCIRHADYTNDDLKVHSLLSSTINGIKKVLKKHNEDFEMTSFWLSN 1550 
ad TCRFLHCLKQYSGDEGFMTQNIAKQNEHCLKNFDLTEYRQVLSDLSIQIY 489 
111:1 	IlIllIllIllIlli. 	11111111 	1111111111111 	I 	II 
r6 TCRLLHCLKQYSGDEGFMTQNTAKQNEHCLKNFDLTEYRQVLSDLSIQIY 1600 
ad QQLIKMPEGLLQPMIVSANLENESIQGLSGVRPTGYRKRSSSMVPGENS. 538 
11111:: 	111111111 	1111111111111111111111 	I 	I 	I 111111 
r6 QQLIKIAEGLLQPMIVSANLENESIQGLSGVRPTGYRKRSSSMVDGENSY 1650 
ad ...........FHTVLCDQGLDPEIILQVFKQLFYNINAVTLNNLLLRKD 577 
II 	111111 	111111111111111111 	11111 	1111 
r6 CLEAIIRQ}4NFFHTVIJCDQGLDPEIILQVFKQLFYMINAVTLNNLLLRKD 1700 
ad ACSWSTGMQLRYNISQLEEWLRGKNLHQSGAVQTMEPLIQAAQLLQLKKK 627 
I 	111:11111111111111111 	11111 
r6 ACSWSTGMQLRYNISQLEEWLRGKNLQQSGAVQTMEPLIQAAQLLQLKKK 1750 
ad THEDAEAICSLCTSLSTQQIVKILNLYTPLNEFEERVTVSFIRTIQAQLQ 677 
III 	1111:111111 	11111111111 
r6 TQEIJAEAICSLCTSLSTQQIVKILNLYTPLNGFEERVTVSFIRTIQAQLQ 1800 
ad ERNDPQQLLLDSKHVFPVLFPYNPSALTMDSIHIPACLNLEFLNEV* 724 
11.1111 	111111:111111:1111111111111111111111111 
r6 ERSDPQQLLLDSKHMFPVLFPFNPSALTMDSIHIPACLNLEFLNEV* 1847 
Figure 2.27 continued 
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2.4 Summary 
A reverse genetics screen based on P-element enhancer traps led to the isolation of a 
cDNA which showed an interesting expression pattern in the ovaries by in situ 
hybridisation. This pattern showed that the gene was expressed early in oogenesis 
with the transcript localised to the developing oocyte. Localisation was seen as an 
anterior band in the oocyte during mid stages of oogenesis with strong expression seen 
in the nurse cells at late stages and loss of localisation in the oocyte. However, the 
gene is not associated with the P-elements present in the line originally examined. 
The original cDNA showed similarity to the class V unconventional myosins. Further 
cDNAs were isolated from an ovarian library to give a total of 3.2kb but Northern 
analysis showed a transcript size of approximately 6kb. Further screening of cDNA 
libraries failed to yield any additional cDNAs. Screening of a genomic library resulted 
in 6 recombinant phage being isolated from 3 separate screens. However, a more 
useful subcloned genomic DNA fragment came from a recombinant P1 phage. 
Sequence analysis showed that this recombinant plasmid contained most of the 5' 
sequence absent from the cDNAs. A 5'RACE experiment yielded, potentially, the 
remaining cDNA sequence but it has not been possible to merge this to the bulk of the 
cDNA sequence. 
Analysis of the sequence confirms that the predicted protein shows all the major 
features of a class V myosin with an ATP-binding domain, an actin-binding domain, 
IQ motif repeats and regions within the carboxyl tail which show a high probability of 
forming coiled-coil a-helices. 
Attempts to isolate further cDNAs resulted in the identification of two unrelated genes 





This project used a reverse genetics approach that resulted in the isolation of an 
class V unconventional myosin and a putative inorganic phosphate cotransporter 
(cDNA-34, see Chapter 5) from Drosophila. To characterise these genes further, it 
is essential to undertake a genetic analysis with the aim being to match the cloned 
genes to mapped genes. Mutations that exist in the mapped genes would enable 
experiments to be undertaken to investigate the role of these genes in the organism. 
All the work in this chapter was done in collaboration with A McCormack. 
3.2 Chromosome Position of the Unconventional Myosin 
Salivary glands were dissected from third instar OregonR larvae and chromosomes 
prepared as described in the materials and methods (7.15). A digoxigenin labelled 
probe was prepared from the 2.2kb cDNA as described (7.5.5.3) with 
approximately lOOng of probe used per slide in a 20jtl volume. Hybridisation was 
carried out overnight at 55°C. Detection was carried using HRP-conjugated anti-
digoxigenin antibodies and the DAB detection system. The chromosomes were 
then counterstained with giemsa. 
Analysis of the chromosomes using brightfield and phase contrast microscopy 
indicated that the myosin gene position was on the right arm of the second 
chromosome. Use of the published cytological maps refined the position to the 
43BC region (Lindsley and Zimm, 1992). This position was corroborated by R 
Saunders (personal communication) on examination of the slides. Although the 
signal is readily identifiable under the microscope, it is difficult to detect on 
photographs and therefore, this result is not shown. 
The 43 region has been extensively mapped at the genetic level with 27 
complementation groups identified (Heitzler et al, 1993). This publication, along 
with the Drosophila Handbook (Lindsley and Zimin, 1992) and the Drosophila 
Database (Flybase - see references) were used to identify a number of deficiency 
lines, P-element insertions and candidate genes for further examination. A 
schematic representation of the 43 region is shown in figure 3.1. Deficiency lines 
obtained and used in this work are listed in Table 3.1. 
A 	 Ea 
Ba pwn 	 Eb scra 
	
Bb 	 Ed 
Bc so 	 Ee 
nec pk 	 cos 	Dri El Eq to  
sple Bd Ca 	 Eh 
hum 	CbCc Da Db 	 Eicn 
II 	I 	I I 	I I B 	C I I D 	E 	F 
43 44 
1594pk78k. 	- 	 - - 
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Figure 3.1 Schematic and complementation map of the 43 region modified from 
Heitzler et al (1993). Part A shows the overall map with genes shown above the 
main line and the large deficiencies shown below the main line. Complementation 
groups shown underlined are unordered with respect to each other. Part B shows a 
more detailed map of the 43BC region with further deficiencies indicated. Arrows 
indicate that the deficiency extends beyond the 43 region. The 2-767 deficiency is 
reported as mapping within 43B 1-Cl and thus is represented by a dashed line in this 
region. See also Table 3.1. 
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3.3 Deficiencies place the genes at 43B 
Deficiency breakpoints cause the alteration in size of restriction fragments which 
may be detected by Southern hybridisation as an additional band. A series of 
Southern blots were performed using chromosomal DNA from lines carrying 
chromosomes deficient for parts of the 43 region. 
Table 3.1 Deficiency Lines Used in this Work 
Line No Name Balancer Region Lost 
1594 Df(2R) 2k78k CyO 42E3; 43C3 
1888 Df(2R) ST1 (pr, cn?) SM6a? 43B3-5; 43E1-8 
1930 Df(2R) pk78s not known 42C1-2; 43175-8 
2467 Df(2R) P32 possibly cn 43A3; 43F6 
3136 Cn83c SM5 43C5-D1; 44135-C1 
3368 Cn9 Cy, Roi 42E3;44C3 
2-202 Df(2R) pwn 5 In(2LR)O [43B]; [4313] 
2-331 Df(2R) Ew60 In(2LR)O [43B]; [4313] 
2-353 Df(2R) NCX9 In(2LR)O 43C3-7; 43F2 
2-579 Df(2R) cos-2 In(2LR)O [4313]; [4313] 
2-580 Df(2R) cos-3 In(2LR)O 43131;43131 
2-676 hum2 bwD In(2LR)O + 
Df(2R) cnS6 
43C3-7; 43F2-8 
2-767 Df(2R) cn84h SM5 43B 1-Cl; 44A6-B1 
Genomic DNA was prepared from these lines (7.6.1), restricted with BamHI, 
EcoRJ and XbaI and separated on 0.8% agaroseiTBE gels. The DNA was 
transferred to Hybond-N and probed with labelled FIX-i A genomic DNA isolated 
from a NotI digest. The restriction endonuclease NotI cuts in the multiple cloning 
site of the ?FIX bacteriophage allowing ready isolation of all inserted genomic 
DNA. Standard hybridisation and washing procedures were used. The results are 
shown in figure 3.2A. 
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Two lines, 2-579 and 2-580, showed additional bands on both BamHI and EcoRI 
digests. The XbaI digest contained numerous bands possibly due to partial 
digestion and thus making identification of band shifts difficult. An additional 
EcoRI band was also observed in line 2467. However, no additional bands were 
seen in the BamHI digest of line 2467 and, therefore, this result was probably due 
to a partial digestion. 
Hybridisation of the same membranes, once stripped of the preceding probe, with 
the didum 2.2kb cDNA did not reveal the band shifts in lines 2-579 and 2-580 
(figure 3.2C - note the autoradiographs shown use genomic DNA spanning the 
myosin V as probe, but the result was the same). However, hybridisation with a 
1.8kb PstI fragment from cDNA-34 did reveal these band shifts (figure 3.2B). 
Both 2-579 and 2-580 are shown to break at the same point proximal to the 
centromere on the Heitzler map, consistent with the identical band size seen on the 
Southern blots (see figure 3.1 part B). These two lines are deficient for the 43Bc 
and costa genes with 43Bc being proximal to costa (figure 3.1). On the basis of 
this result the gene encoding cDNA-34 was placed at 43Bc and the myosin at 
43Bb. The possibility that the myosin was costa, and distal to 43Bc, was ruled out 
as costa has recently been cloned and encodes a kinesin heavy chain-related protein 
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Figure 3.2B Southern blots 
of genomic DNA from 
deficiency lines (see Table 
.4 3.1). Probe was a 1.8kb PstI 
fragment from cDNA 34 
The three restriction 
endonuclease digests were 
divided over two gels. 
Additional bands are marked 
with an arrow. Markers 
used were BRL 1kb ladder 
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Figure 3.2C Southern blots 
of genomic DNA from 
wr 
deficiency lines (see Table 
3.1). Probe was combined 
6kb and 7kb XbaI fragments 
from P1-X6 and PI-X7 
- covering the diduni gene. 
The three restriction 
- 
77, 
endonuclease digests were 
divided over two gels. 
Markers used were BRL 1kb 
S ladder. 
- 	 - 
a 
3.4 A PCR Based Approach 
To verify these results, a series of PCR reactions were carried out with deficiency 
lines. The hypothesis was that a cross between flies carrying Df/+ second 
chromosomes would produce one-quarter of the progeny as homozygotes with 
second chromosome deficiencies. These progeny would probably be embryonic 
lethal as the number of genes lost in the deficiencies was large (>10). DNA from 
these embryos could then be prepared and examined by PCR using gene specific 
primers. Absence of a gene specific band would indicate that the gene was located 
within the region covered by the deficiency. The two lines examined by this 
method were 1594 and 2467 (Table 3.1 and figure 3.1). Two controls were 
included. First, primers for a putative kinase gene located on the third 
chromosome (C MacDougall, personal communication) would indicate the 
presence of genomic DNA in the embryonic preparations. The second control 
consisted of primers designed against sequence reported for the So gene (Cheyette 
et al, 1994), a gene located distal to 43Bd and humilis and proximal to 43Ca (see 
figure 3.2) The So gene should not be present in the 2467 deficiency and appears 
close to the distal breakpoint in line 1594. The cross is shown in figure 3.3. 
3.4.1 Method 
The deficiency lines were balanced with a chromosome that results in a curly wing 
phenotype from the CyO gene. Initially, a cross was established between virgin 
females from the deficiency line and OregonR males. These flies were placed on 
vials of Staffan food at 18°C and changed to fresh food every 2-3 days. The 
progeny of this cross were either -t-/Df or -i-Ibalancer, with the flies carrying the 
balancer chromosome readily identified and removed on the basis of the curly wing 
phenotype. Vials were examined twice per day for newly eclosed flies with those 
showing a clear curly wing phenotype removed to separate vials from those 
showing wild-type straight wings. Flies exhibiting a Df/+ phenotype, that is, a 
straight wing, were separated on the basis of sex with vials containing females 
examined for the presence of larvae before being used in the subsequent cross. 
Any vial which contained larvae indicated that one or more females in that vial had 
mated before being collected. Flies not demonstrating a clear phenotype were 
placed individually into separate vials until their phenotype was obvious. When 
sufficient Df/+ flies had been collected (approximately 20 males and females), a 
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cross was established between these flies in a small cage with food supplied in the 
form of an Adh plate (7.4.2) supplemented with a small amount of yeast paste to 
encourage egg laying. The Adh plate was exchanged for a fresh plate every 24 
hours with the used plate incubated at 25°C for a further 24-36 hours to allow all 
viable embryos to hatch. The hatched larvae were collected and moved to vials to 
prevent excessive 'churning' of the food and loss of the unhatched embryos. The 
larvae were also a valuable control as any which developed into a fly with a curly 
wing phenotype would indicate that the balancer chromosome Was still present. 
Unhatched embryos were collected and rinsed with water to remove as much food 
as possible then stored in Ringer's solution at 4°C overnight. Genomic DNA was 
prepared using the same method as that used for adult flies, see materials and 
methods, section 7.6.1. 
F0 Deficiency 	x 	Wild-type 9 Balancer Wild-type 




F1 	Deficiency 	x 	Deficiency 	- discard Wild-type
+ 	
Wild-type 
Deficiency 	Deficiency 	Wild-type 
Deficiency Wild-type Wild-type 
Lethal 	 Viable 
Collect embryos 
- prepare gDNA 
Analyse by PCR 
Figure 3.3 Cross between Deficiency lines and OregonR wild type flies to remove 
the balancer chromosome (FO). Progeny from the F1 generation exhibiting straight 
wings were then crossed among themselves to give viable flies carrying a wild type 
chromosome or a homozygote deficiency resulting in embryonic lethality. 
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3.4.2 PCR amplification 
A standard 50j.tl PCR was set up using Promega lOx buffer and a final Mg 2 
concentration of 2mM. The primers used were 1806 and 2800 for the myosin gene 
(see figure 2.6), so! and so4 for the So gene. For the kinase gene on the third 
chromosome, primers 1240 and 1241 which produce a gene specific product of 
0.8kb were provided (C MacDougall, personal communication). 
The PCR conditions used were: 
94°C for 2 minutes and hold at 80°C for addition of Taq DNA Polymerase, 
thermal cycling for 35 rounds at 	94°C for 30 seconds 
55°C for 30 seconds 
72°C for 2 minutes 
final 'polish' step of 72°C for 10 minutes. 
The results are presented in figure 3.4 and show myosin gene specific bands 
present in the OregonR and 1594 lines but at a much reduced concentration in line 
2467. The So gene primers produced strong bands of about 0.9kb in both the 
OregonR and 1594 lines but also a number of spurious bands. 
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M 1 2 3 4 5 6 7 8 9 10 1112 13 M 
1 1 	Myosin gene 
2 I 0 r So gene 
2 	 3J 3R Kinase gene 
Myosin gene  
1 
1594 
6 - 3R Knase gene 
7 Df 	Myosin gene 
8 2467 So gene 
] 
9 3R  
10 Myosin gene 
OrR 	Df 	Df 	Control 	11 I Control 	So gene 
1594 2467 12 no gDNA3R Kinase gene 
M 	1 	2 3 	4 	5 6 7 8 	9 14 1516 17 M 	13JpBMF31 
DIlIlIlIllIllIll 
Myosin gene 
14 1 Df 	sQl primer 
15J 2467 so4primer 
16 pBMF31 Myosin gene 
17 Kinase and Myosin primers 
- no template DNA 
M = Markers 
 
II 	II 
OrR Df 	Df 	Control 
1594 2467 
Figure 3.4 PCR results from genomic DNA derived from homozygote deficient 
embryos. Panel A shows the results discussed in the text. Panel B shows two 
important controls in lanes 14 and 15; so] and so4 primers amplifying from 2467 
genomic DNA respectively. Controls were sets of primers with no template DNA, 
or pBMF3 I, representing 3.2kb of didum cDNA (see chapter 4), with 1806/2800 
primer combination as a positive control. Marker sizes are in kb. 
The So primers produced numerous bands in the 2467 line but the 0.9kb band was 
much reduced in concentration. According to the genetic maps the So gene should 
be lost in a 2467 homozygote deficient embryo. These results can be interpreted as 
showing both the myosin gene and the So gene falling within deficiency 2467. 
The presence of a gene specific band at reduced levels can be explained by a small 
amount of wild type DNA being present from wild type embryos that failed to 
HE 
hatch. Ashburner (1989) suggests that normal embryo mortality in wild type lines 
is in the order of 5-10%, supporting this conclusion. The presence of numerous 
additional bands in the So lanes can be explained by non-specific priming arising 
from each individual primer. A previous experiment utilising identical conditions 
but with each So primer used individually with 2467 genomic DNA resulted in 
numerous bands as shown in figure 3.4. It is reasonable to speculate that DNA 
from homozygous 2467 embryos is more likely to produce spurious bands as the 
designed gene target has been lost. - 
The result from the 1594 line is more difficult to interpret. The distal breakpoint 
for 1594 is shown to be between So and 43Ca on the Heitzler map (figure 3.1). 
However it is possible that the 1594 breakpoint occurs within the So gene 
removing essential So elements but leaving the two priming sites intact. This 
suggestion would enable the So primers to produce a gene specific product but 
would still result in deficiency 1594 failing to complement So mutant alleles in 
genetic tests. Another possibility is that the 1594 line had lost the deficiency but 
this was unlikely as the cross of 1594/+ flies produced embryonic lethals. 
3.5 Cytological Position of P1 Supports 43C Location 
The above PCR results indicate that the myosin gene is located in the 43C region. 
This result is supported by the reported position of 43C for P1 DS00574 (reported 
in Flybase) which was used to isolate 5' genomic sequence (see section 2.2.12 in 
Chapter 2). However, these results contradicted those obtained for the deficiency 
Southern blots. Additional results have clarified this situation 
3.6 Mapping of FIX-1A Shows It is Composed of Two 
Independent Recombinant Phage. 
As stated in Chapter 2, a definitive restriction map for the cloned genomic DNA 
from FIX-i A could not be generated from the restriction endonuclease digests 
because of the number of fragments generated and size inconsistencies. Table 3.3 
lists the fragments identified from digests of FIX-i A with the total amount of 
genomic DNA represented being 18-23kb depending on the digest examined. 
Figure 3.6 shows schematic maps of the subcloned genomic fragments and a 
restriction digest of FIX- lA DNA. In order to clarify the physical map, a series of 
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cross hybridisations with subcloned genomic fragments from FIX-1A were 
performed. 
Table 3.3 Restriction Fragments Identified from Digests of FIX-i A 
BamHI BamHIJ EcoRI 	EcoPJ/ 	XbaI 
NotI NotI 
8 	8-9 8(pE7) 8 6 
6-7 5(pE5) 5 3.5 
5.5 2.9(pE3) 2.9 3(pX3) 
2.1 (p2.1) 2.1 2.8 (pX2.8) 
1 (pEl) 1 2.2 
2.5 
1.6 
Total 	 19 kb 	23 kb 	17.5 kb 
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2 
1.6 
7kb EcoRl - pE7 
6kb XbaI 
5kb EcoRl - pE5 
3.5kb XbaI 	 - 
3kb XbáI - PX33kb EcoRI - pE3 
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Figure 3.5 Schematic representation of the restriction digest of FIX-i A taken from 
figure 2.11 to show the origin of the subcloned genomic fragments (also shown 
schematically) used in cross hybridisation experiments. Marker sizes are in kb. 
Restriction endonucleases; B: BamHI, E: EcoRI, X: XbaI. 
The 5kb genomic fragment from pE5 (contains sequences from the 3'UTR of the 
unconventional myosin gene) allowed the isolation of a -6kb XbaI fragment 
(named pPl-X6) and a -8kb BamHI fragment (named pPl-B8) from the P1 
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Figure 3.6 Part A) An initial map showing that the myosin V and cDNA-34 genes were 
thought to reside on a contiguous section of genomic DNA with the map of the intergenic 
region undefined - a hypothesis that was disproved by the cross hybridisation mapping 
experiments (figures 3.7 to 3.10). Part B shows the position of the 7kb Xbcil genomic DNA 
insert from pPl-X7 relative to the myosin V gene. Part C shows two further cloned 
genomic fragments, a 6kb XbaI fragments (pPl-X6) and an 8kb BamHI fragment (pPl-B8) 
obtained by screening P1 DS00574 mini-libraries with the 5kb EcoR[ insert from pE5. 
Use of the 6kb XbaI fragment (pPl-X6) identified overlapping 2. lkbEcoRI and 
6.5kb BamHI fragments and resolved the map 3' of the myosin gene as shown in 
figure 3.7. Cross hybridisation of fragments from pE3, pE7 and pX3 showed that 
these were related and encompassed the cDNA-34 gene, see figures 3.8 and 3.9. 
Thus for FIX- lA to be a contiguous section of genomic DNA, it was expected that 
the pE3 fragment would show some overlap with the 6.5kb BamHI fragment 
identified from genomic DNA, FIX-2 and FIX-4 Southern blots. However, no 
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cross hybridisation was observed. The mapped DNA from FIX-IA surrounding 
the myosin gene represented approximately 10.5kb while that surrounding cDNA-
34 represented approximately 11kb with 2 restriction fragments visible on the 
original agarose gel unaccounted for; a 3.5kb XbaI fragment and a 2.5kb 
EcoRI/NotI fragment. Thus the total amount of DNA from FIX-lA was at least 
25kb (11kb +10.5kb +3.5kb = 25kb) exceeding the maximum of 23kb of DNA 
that can be cloned into the XFIX vector (Sambrook et al, 1989). These results 
show that FIX-i A is a combination of two independent recombinant bacteriophage 
with didum 3' sequences residing on one phage and cDNA-34 being located on the 
second phage. Experiments have yet to be undertaken to separate the two 
recombinant bacteriophage. 
3.7 The az2 Gene 
A screen of the ovarian cDNA XZAP library with the 5kb EcoRI pE5 fragment to 
isolate further cDNAs representing the 3'UTR of the didum gene resulted in the 
discovery of a novel eDNA which has been given the working name az2 (A 
McCormack, personal communication). Sequence analysis indicates that the az2 
gene encodes a zinc-finger like protein and the transcript size is in the order of 
1.7kb (A McCormack, personal communication). The az2 gene appears to map 
entirely within the 5kb EcoRI fragment from pE5 with this finding supporting the 
conclusion that didum and cDNA-34 genes cannot be 43Bb and 43Bc, as originally 
proposed from the deficiency Southern blot results. 
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Figure 3.7 Reverse Northern membrane and FIX-202F Southern blot hybridised 
with pPl-X6. A 2kb EcoRl fragment (subcloned as pE2 from FIX-4A) and 6.5kb 
BarnHI fragment (on FIX-202F) were found to overlap (marked with arrows). 
Marker sizes are in kb and relate only to the Reverse Northern. 
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Figure 3.8 Hybridisation of the Reverse Northern membrane with a Psil fragment 
from cDNA-34. Overlapping fragments identified were 3kb XbaI (pX3), 6kb XbaI 
and 7kb EcoRl (pE7). The relationship between pX3 and pE7 was confirmed from 
their restriction maps see also figure 3.5. Marker sizes are in kb. 
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Figure 3.9 Refining the genomic map surrounding cDNA-34. Hybridisation to the 
Reverse Northern membrane with a combined pX3IpE7 probe identified an overlap 
with the pE3 fragment. Marker sizes are in kb. 
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Figure 3.10 Hybridisation of the Reverse Northern membrane with pE3. An 
overlap with a 2.2kb Xbal fragment was observed in addition to the expected 
overlap with pX3. The position of the BamHl sites was also confirmed with 0.5kb, 
1.9kb and —8kb fragments identified. Marker sizes are in kb. If FIX-IA was a 
contigous piece of genomic DNA then pE3 was expected to hybridise to an 
additional —6.5kb Barn HI fragment. Marker sizes are in kb. 
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3.8 Summary 
An in situ hybridisation to polytene chromosomes using didurn cDNA as a probe 
localises the didum gene to the 43BC region. This region has been extensively 
characterised genetically with a high probability that all complementation groups 
within this region being identified (Heitzler et al, 1993). Analysis of Drosophila 
lines carrying deficiencies for this region suggested that didum might be 43Bb as 
the cDNA-34 gene showed band shifts in lines deficient for 43Bc and costa. 
However, a PCR approach on genomic DNA from homozygote deficient embryos 
suggested the didurn gene was in 43C, a result supported by cytological data 
placing P1 DS00574 in 43C (from Flybase). 
Extensive cross hybridisation experiments to resolve the restriction map of FIX-i A 
cloned genomic DNA revealed that FIX-IA consisted of two independent smaller 
recombinant bacteriophage. This finding placed further doubt on the deficiency 
Southern blot result. The recent identification of a new gene, az2, adjacent to the 
didum gene also refutes the original 43Bb-43Bc hypothesis. 
It is most likely that the deficiency Southern blot result was due to a polymorphism 
in the chromosomes of lines 579 and 580 with the same chromosome being used to 
generate the deficiencies in these two lines. The 43C region has three genes 
mapped within it; 43Ca, 43Gb and 43 Cc, with 43Cb and 43Cc unordered with 
respect to each other (see figure 3.1). It is tempting to speculate that didum and az2 
will be either of 43Gb and 43Cc because these genes were unable to be separated 
on the Heitzler complementation map and map close together physically. 
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Figure 3.11 Summary of genomic mapping. FIX-
1A is divided into 2 independent components; FIX-
lA/myosin and FIX-1A/34. Part A shows the 
physical map surrounding the myosin V (didum) 
gene and the recently discovered az2 gene. Part B 
shows the FIX-i A component which includes 
cDNA-34. Restriction endonucleases; B: BamHI, 
E: EcoRJ, X: XbaI with X being part of the XFIX 
multiple cloning site. 
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An integral part of studying the function of a gene involved in oogenesis is to 
observe the distribution of the protein product in egg chambers. The use of current 
recombinant techniques allows the expression of all or part of the cDNA in 
Escherichia coli, the recovery of the recombinant protein via affinity 
chromatography and the use of this recovered protein to raise antibodies in an 
appropriate animal. This chapter describes the construction of several recombinant 
plasmids for expressing parts of the Class V myosin. Initially, an expression 
plasmid was constructed using a subcloned fragment from the first cDNA isolated, 
NMC7 (see chapter 2). However, expression was not obtained from this plasmid. 
An improved expression plasmid was constructed when further cDNAs were 
isolated and this plasmid proved successful for protein expression. 
4.2 Expression Plasmids pBMF1 and pBMF2 
The first set of plasmids prepared for expressing recombinant protein utilised the 
EcoRI fragment from pNMC7a (see figure 2.2). This fragment codes for about 
280 amino acids but lacks the very last 40 amino acids from the carboxyl terminus. 
The pRSET (Invitrogen) vector system was chosen to construct an expression 
plasmid. This system uses a fusion between the protein of interest and a small 
peptide at the amino terminus which contains a 6 histidine motif. This histidine 
motif chelates Ni ions and allows affinity purification of the recombinant protein 
by Ni-agarose chromatography. Transcription is driven from a T7 promoter. 
An in-frame fusion was made between the EcoRI fragment from pNMC7a and the 
expression vector pRSET-A. The vector was digested with EcoRI and 
dephosphorylated as described in section 7.5.2 while the EcoRI fragment was 
isolated from pNMC7a by EcoRI digestion and purification from agarose gel by 
Qiaex (7.5.4.4). A standard ligation reaction was prepared (7.5.1) and used to 
transform E coli XL1-Blue cells (7.3.1). Plasmids carrying the pNMC7a insert 
were identified by colony hybridisation. Small scale DNA preparations were made 
and fragments ligated in the correct orientation were identified using the restriction 
endonuclease PstI which cuts once in the vector and once in the pNMC7a derived 
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fragment. The correct orientation was identified by a PstI band of 670bp on an 
agarose gel while the opposite orientation gave a 200bp band (results not shown). 
Both orientations were selected with the correct orientation named pBMF1 and the 
reverse pBMF2. These plasmids were used to transform the E coli strain BL21 
DE3, a strain which supplies T7 RNA polymerase inducible by IPTG from a 
bacteriophage 7 lysogen. 
A number of experiments were conducted to determine if an approximately 35kDa 
protein was being expressed (280 amino acids + 40 amino acids from the vector 
fusion to give 320 amino acid residues, at an average molecular weight of 110 per 
amino acid residue = 35kDa). Whole cell and soluble cell fractions were examined 
by discontinuous SDS-polyacrylamide electrophoresis (SDS-PAGE). However 
expression was not observed (results not shown). 
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4.3 Construction of pBMF31, pBMF32 and pBMF33 
Prior to constructing an improved expression plasmid, it was necessary to combine 
the 2.2kb cDNA (pBMF10 = ZAP-A etc, see Chapter 2) with pNMC7b to produce 
a plasmid that contained all of the cDNA obtained to date. This plasmid 
construction was readily accomplished by inserting the 2.2kb cDNA from pBMF10 
into the EcoRI site of pNMC7bto create pBMF3 1. A diagrammatic representation 
of this construction is given in figure 4.1. 
(!::::=n pNMC7b 
Cut with EcoRl, isolate 2.2kb fragment 	 Cut with EcoRl 
Xh 	 L7p N :MC 7 nb 
Ligate 2.2kb fragment into pNMC7b 
E 	X  Xh 	 E 	 HXh 
pBMF31 
fragment in O:OSi:orientati2 	
H 5 
I 	I 	cloned DNA 
vector DNA 
Figure 4.1 Construction of pBMF3 1. cDNA from plasmids pBMF1 0 and pNMC7b 
were ligated together to form one cDNA to provide a contiguous open reading frame. 
Restriction endonucleases are; E: EcoRI, H: HiniflI, Xh: XhoI. 
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A medium scale preparation (7.6.2.2) of pBMF1O was made and 10J.tg digested 
with EcoPJ. The digest was separated on an agarose gel and the 2.2kb cDNA 
fragment identified and excised with a scalpel. The DNA was recovered by Qiaex 
with 10% of the final volume run on a gel to check recovery. A medium scale 
preparation of pNMC7b was made and also digested with EcoRI, followed by 
treatment with CLAP to prevent self ligation. Phenol/chloroform extraction and 
ethanol precipitation was used to remove the ClAP. A series of ligation reactions 
were set up in final volumes of 10j.tl and competent E coli XL1 cells were 
transformed with 5tl of the ligation reaction. 
Since the cDNA from pBMF1O is a 2.2kb EcoRI fragment, insertion into pNMC7b 
in both orientations was feasible. In order to determine the desired in-frame 
orientation, small scale DNA preparations were made from 8 colonies from the 
transformation and digested with XhoI An insertion of the 2.2kb fragment in the 
desired orientation would produce XhoI fragments of 0.3kb, 2.3kb and 3.5kb 
while the opposite orientation would produce fragments of 0.3kb, 1.3kb and 4.5kb 
(figure 4.1). Three of the 8 small scale preparations showed the correct orientation 
with one selected for further work and named pBMF3 1. 
4.3.1 Preparation of a Fragment for Use in an Expression 
Vector 
At the time of preparing the expression construct the DNA sequence at the 5' end of 
pBMF10 (5' most sequence = nt 1) had not been fully resolved and therefore, the 
extent of the open reading frame had not been confirmed. A continuous open 
reading frame had been identified from nt 415 to the stop codon at nt 2448. An 
EcoRV site had been identified at nt 457 and cleaved in-frame. This site, in 
combination with the Dral site, which coincided with the stop codon, produced a 
blunt-ended fragment of 1986bp suitable for cloning into an expression vector. 
The pBluescript vector contains 3 DraI sites at positions 1912, 1931 and 2623 
(Stratagene Inc). A digest of pBMF3 1 with EcoRV and DraI produced a total of 5 
bands of sizes 17bp, -680bp, -1660bp, -1720 and 1986bp, with the largest being 
the required fragment. However, this 1986bp fragment could not easily be 
resolved from the other larger fragments by gel electrophoresis. These interfering 
fragments were readily reduced in size by further digestion with the restriction 
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endonucleases BamHT and KpnI, both of which cut in the multiple cloning site of 
the pBluescript vector. The 4 way digest was done as follows: 
Approximately 25pg of pBMF3 1 was double digested with EcoRV 
and Dral in a volume of lOOp.! in BRL React2 buffer. These 
restriction endonucleases were heat inactivated at 65°C for 15 minutes, 
then 1 p.1 of 5M NaCl was added to raise the NaCl concentration of the 
reaction mix from 50mM to 100mM. The reaction was then digested 
with BamHI for several hours. Addition of 5p.l 2M KC1 and 2.5j.tl 
2M Tris-HC1 pH 7.2 in a final volume of 200j.iJ produced conditions 
suitable for digestion with KpnI. The results are shown in figure 4.2. 
This EcoRV-DraI fragment was then cloned into pRSET-C at the Pvull site to 
produce and in-frame fusion with the amino terminal histidine tag sequence using 
cloning procedures described above. The ligation reactions were used to transform 
E coli BL2 1 DE3. Again, insertion of the EcoRV-DraI fragment in either 
orientation was possible. Digestion with EcoRI was used to determine the 
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Figure 4.2 Construction of expression plasmid pBMF33 (and pBMF32 - not 
shown). An EcoRV-DraI fragment was isolated from pBMF31 (see gel) and cloned 
into pRSET-C at the PvuII site. The orientation of the inserted DNA was 
determined by digestion with EcoRI. Restriction endonucleases; B: BamHI, D: 
DraI, E: EcoRI, EV: EcoRV, H: Hindu!, K: KpnI. Marker sizes are in kb. 
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4.4 Expression From Recombinant Plasmid pBMF33 
Three clones of pBMF33 were selected for testing for recombinant protein 
expression along with pBMF32 and pRSET-C as controls. Initially 5nil cultures in 
LB-broth with 1004g/m1 carbenicillin as antibiotic (carbenicillin is a more stable - 
lactam than ampicillin) were prepared and grown to an 0D 650 of approximately 1.0- 
1.3  as judged by eye, apart from the pRSET-C culture which had only reached an 
0D650 of -0.5. These cultures were stored at 4°C overnight followed by 
centrifugation of 1.5m1 of each (3m1 of pRSET-C) to collect the cells. The cells 
were then resuspended in 1 ml of T-broth then added to a 50ml solution of T-broth 
in a 500m1 flask with carbenicillin at 100tg/ml. The cultures were incubated at 
37°C for about 3 hours whereupon 1 Oral samples were drawn and placed on ice, 
apart from the pRSET-C culture which was incubated for a further 1.5 hours as it 
continued to show a lower amount of growth. Each culture was induced with a 
200mM solution of IPTG to give a final concentration of 0.5mM. Samples of 
lOml were taken after 2 hours and 4.5 hours of further incubation and placed on 
ice. The pRSET-C culture was sampled at 3 hours post induction. All cultures 
were stopped at 6 hours post induction (about 4.5 hours for pRSET-C). 
An aliquot from each sample was used to determine the cell density at 013 650. Cells 
from 6m1 of each sample were collected by centrifugation and resuspended in 5m1 
buffer A (50mM Tris-HC1 pH 8.0, 2mM EDTA), then centrifuged once more. The 
supernatant was removed and the pellets stored frozen at -20°C. The pellets were 
thawed on ice then resuspended in lml of buffer A with a 100j.tl aliquot removed 
from each sample and lOOj.tl of 2xSDS-PAGE loading buffer added (7.12) 
followed by boiling for 3-5 minutes. A 12.5%/4% discontinuous SDS-PAGE was 
prepared and the samples loaded. To produce an even loading, the amount loaded 
was adjusted based on the 0D 650 readings, that is, less sample was loaded from 
cultures which had higher 0D650 readings. The SDS-PAGE was run overnight at a 
constant 60V then stained with the Pro-Blue system (7.12). The results, shown in 
figure 4.3, demonstrate that all 3 clones of pBMF33 produced recombinant protein. 
Induced samples produce a strong band at approximately 80kDA consistent with 
the expected size from a fusion protein of 702 amino acids. 
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3 pBMF33-3 Induced 4.5 hours 
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5 pBMF33-2 Induced 4.5 hours 
6 pBMF33-2 Induced 2 hours 
7 pBMF33-2 Uninduced 
8 pBMF32 Induced 4.5 hours 
9 pBMF32 Uninduced 
10 pRSET-C Induced 4.5 hours 
11 pRSET-C Uninduced 
12 Markers 
Figure 4.3 SDS-PAGE of the initial expression experiment. The expressed 
recombinant protein is marked with an arrow. Space did not permit the inclusion of 
induced 2 hour samples from clones pBMF33-3 and pBMF33-6. The markers were 
degraded. 
4.4.1 Expressed Recombinant Protein is Insoluble 
An experiment to obtain affinity purified protein by Ni-agarose chromatography 
demonstrated that the protein was produced in an insoluble form. Soluble and 
insoluble fractions were prepared from the remaining culture from clone pBMF33-
2 from the initial expression experiment. Cells were collected by centrifugation and 
resuspended in cold buffer X at half the original volume (10mM Tris-HCL pH 7.9, 
1mM imidazole pH 7.9, 500mM NaCl, 10%v/v glycerol, 0.1%v/v Tween 20). 
The cells were collected once more by centrifugation and resuspended in 5m1 buffer 
X. Lysozyme was added to give a final concentration of 1mg/mi and the 
suspension incubated on ice for 30 minutes. Lysis was accomplished by 
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sonication (MSE sonicator) using 30 second bursts with periods of incubation on 
ice between sonication to prevent the suspension warming. 
Soluble and insoluble fractions were separated by centrifugation at 10 000rpm for 
15 minutes in a Sorvall RC-5B (SS34 rotor). The soluble fraction (supernatant) 
was transferred to a fresh tube while the insoluble fraction was washed once with 
2.5m1 of buffer X with this wash added to the soluble fraction. Samples were then 
run on a 10%/4% SDS-PAGE at 1IOV for 5.5 hours with Pro-Blue staining as 
before. The results, presented in figure 4.4 show that the recombinant protein is 
present in the insoluble fraction. 
1 pBMF33 Soluble fraction 
2 pBMF33 Insoluble fraction 
3 pBMF33 Insoluble fraction 
4 Markers 
5 pBMF33 Induced 
6 pBMF33 Uninduced 
7 pRSET-C Induced 
8 pRSET-C Uninduced 
Figure 4.4 SDS-PAGE showing that the recombinant protein is a component of the 
insoluble fraction of the cell extract. Marker sizes are in kDa. 
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4.5 Preparation of Protein for Use as Antigen 
4.5.1 Inclusion Bodies 
The recombinant protein was expressed to a reasonably high level in E coli as 
shown by the SDS-PAGE results. Microscopic examination of the cells expressing 
from pBMF33 showed evidence of inclusion bodies when compared to cells 
expressing pBMF32 or the vector only (results not shown). It is possible to purify 
inclusion bodies for use as antigen Harlow and Lane (1988). The method 
described by Harlow and Lane (1988) (7.14) was used in an attempt to purify the 
inclusion bodies. However, this procedure produced a paste that resembled the 
original cell insoluble fraction and it was not considered suitable or safe to use as 
an immunogen in rabbits. 
4.5.2 Gel Fragments 
Ausubel eta! (1989) and Harlow and Lane (1988) suggest that polyacrylaimde gel 
fragments make a suitable adjuvant and that subcutaneous injection of crushed 
excised bands from an SDS-PAGE can be used to raise antibodies. In addition, 
use of Freund's complete adjuvant was discouraged due to the severe effect this 
adjuvant has on the animal while alternative commercial adjuvants were deemed too 
expensive. Thus, it was decided that the most expedient means of producing 
antigen was to use polyacrylamide gel fragments, a system which also dealt with 
the solubility problem of the recombinant protein. 
A lOOmI culture was prepared in T-broth, grown to an 013 650 of about 1.0 and 
induced with IPTG at a final concentration of 0.5mM. The cells were harvested by 
centrifugation in 5 aliquots. Soluble and insoluble fractions from one aliquot were 
prepared as described above. The insoluble fraction was suspended in lml of 
buffer X with 250.t1 of 5xSDS-PAGE loading buffer added followed by boiling 
for 2-5 minutes. Particulate material was removed by a brief centrifugation and the 
samples were loaded onto a 10%/4% SDS-PAGE with one lane reserved for 
markers. After electrophoresis, the gel was stained with Pro-Blue and the 
recombinant protein bands identified and excised with reference to the markers and 
their strong staining on the gel. The excised bands were cut into small pieces with 
a scalpel then placed into microfuge tubes and rinsed several times with 
130 
physiological saline (Sigma). The gel fragments were then passed through a 21 
gauge needle several times to reduce the size further in readiness for injecting into 
the rabbit. 
4.5.3 Rabbit Immunisation Program 
Three New Zealand White rabbits were provided and maintained by the MFAA unit 
in the Biochemistry Department, University of Edinburgh. All injections and test 
bleeds were carried out by staff members of the MFAA unit. 
A 3m1 sample of blood was taken from each animal prior to immunisation with 
recombinant protein to provide a pre-immune sample. Two preparative SDS-
PAGE yielded approximately 3m1 of crushed gel with half of this material used for 
the initial immunisation. and divided as evenly as possible amongst the rabbits. 
Each animal was injected subcutaneously at 4 positions over its back. A test bleed 
was taken from each animal alter 12 days with the blood allowed to clot and the 
serum collected by mild centrifugation (2000rpm Hereaus model 22R centrifuge) 
and pooled. The animals were boosted with further gel antigen after 4-5 weeks 
with a test bleed taken about 10-12 days later. 
4.6 Antibody Results 
4.6.1 Preliminary Results with Whole Serum 
A Western blot was prepared to determine if the rabbits were producing antibodies 
to the recombinant protein after the first test bleed. A 12 well 10%/4% SDS-PAGE 
was used with 6 samples run as two duplicate sets to allow probing with pre-
immune and test-bleed sera. A Western transfer to Hybond-C was carried out as 
described in the materials and methods (7.13) using a serum dilution of 1:100. 
Detection was with the chloro-napthol HRP system (7.13.2) and the results, 
presented in figure 4.5, show no obvious signs of antibody production from the 
rabbits but the pre-immune serum gave an indication that there were reasonably low 






2 pBMF32 Induced 4.5 hours 
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4 pBMF33 Induced 4.5 hours 
5 pBMF33 Insoluble fraction 
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Figure 4.5 Western blot probed with pre-immune serum and first test-bleed serum. 
Duplicate samples were run on an SDS-PAGE with the gel divided in half and then 
Western blotted. Lane 6 represents a sample from an initial, unsuccessful, attempt to 
purify recombinant protein by Ni-agarose affinity chromatography and was included 
as space was available. The markers had degraded. 
The experiment was repeated after further boosts had been applied to the rabbits. A 
Western blot using similar conditions to those described above was prepared. 
Extracts from cells expressing pBMF32 and pBMF33 were run on the SDS-PAGE 
with the pBMF33 sample producing a discernible band of the expected size of 
8OkDa and not seen in the pBMF32 sample (this result is not shown but a similar 
result is shown in figure 4.6). This result indicated antibodies were being 
produced against the recombinant protein. A further experiment was conducted to 
determine if specific proteins could be detected in samples from Drosophila, with 
extracts from ovaries, adult males and adult females prepared. Ovaries from 20 
females were collected and homogenised in lOOj.il of PBS followed by the addition 
of 100p.1 of 2xSDS loading buffer, then boiled for 3-5 minutes. OregonR adult 
flies were etherised with 25 of each sex sorted and placed into microfuge tubes. 
The flies were homogenised in 250p.l of PBS, then 250p.l of 2xSDS-PAGE 
loading buffer was added and the homogenates were boiled for 3-5 minutes. All 
three samples were centrifuged in a microfuge to pellet debris. Two sets of 6 
samples (details given in figure 4.6) were loaded on to a 10%/4% SDS-PAGE with 
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one half of the gel used for Western transfer to Hybond-C and the other half 
stained with Pro-Blue to check the amount of protein loaded. 
The results, in figure 4.6, show that the recombinant protein was detected in the 
cell extract from the E coli expression strain (pBMF33), and that high molecular 
weight signals were detected in adult fly lanes. This result was considered 
inconclusive at the time as the cDNA sequence had not been fully resolved and the 
expected wild type protein size was thought to be in the order of 75-85kDa based 




2 Ovary extract 
3 Adult male extract 
4 Adult female extract 
5 Eluate from Ni-agarose column 
IQW 	
6 pBMF32 whole cell extract 
7 pBMF33 whole cell extract 
Figure 4.6 Western blot with Drosophila samples included. This membrane also 
includes samples from E coli; pBMF32 (negative control) and pBMF33 where the 
recombinant protein is marked with an arrow and appears as a large diffuse band. 
High molecular weight proteins were also detected in the adult fly extracts and are 
also marked with an arrow. Detection was with 1-chloro-4-napthol-HRP system. 
The dye labelled markers failed to show. 
4.6.2 Affinity Purification of Recombinant Protein 
The histidine tag fusion protein facilitated by the pRSET expression system allows 
recombinant protein to be purified by Ni-agarose affinity chromatography under 
denaturing conditions for situations where the recombinant protein is insoluble. 
Either urea or guanidinium-HC1 can be used as the chaotropic agent, with urea 
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chosen for use in these experiments as it allowed samples to be analysed directly by 
SDS-PAGE. Protein was eluted from the Ni-agarose using imidazole. 
4.6.2.1 Expression of Recombinant Protein 
A 200m1 culture in T-broth expressing pBMF33 was prepared and induced as 
described above. The cells were recovered and divided into 5 aliquots. Soluble 
and insoluble fractions were prepared from one aliquot as before but used buffer 
X  (10mM Tris-HCI pH 8.0, 500mM NaCl, 2mM imidazole pH 7.9, 0.1%v/v 
Tween-20). The insoluble fraction of the cell extract was dissolved overnight in 
20m1 buffer X 1 U (buffer XI + 6M urea) with gentle stirring. Material that 
remained insoluble was removed by centrifugation. A 2m1 Ni-agarose column was 
prepared in a 30m1 syringe plugged with a glass bead. The column was 
equilibrated with 20ml (10 volumes) of buffer X 1 U then loaded with I Oml of the 
solubilised fraction. This fraction was passed over the column once more to ensure 
saturation af the Ni ions. The column was washed with lOml of buffer Y1U (as 
for buffer X1U but with 20mM imidazole pH 7.9). Bound protein was eluted with 
buffer Z I U (as for buffer X1U but with 200mM imidazole pH 7.9) with samples 
collected as aliquots in microfuge tubes. Samples were analysed on a 10%/4% 
SDS-PAGE gel with the results shown in figure 4.7. It was clear that recombinant 
protein was being obtained at a reasonable degree of purity from the column, 
however, for it to be of further use the urea needed to be removed. 
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1 Markers - Sigma wide range 	6 Ni-agarose column - elution fraction 2 
2 Ni-agarose column - loaded material 7 Ni-agarose column - elution fraction 3 
3 Ni-agarose column - fallthrough fraction 	8 pBMF33 Insoluble fraction 
4 Ni-agarose column - wash 	 9 pBMF33 new preparation 
5 Ni-agarose column - elution fraction 1 
Figure 4.7 SDS-PAGE of Ni-agarose affinity purified recombinant protein. Marker 
molecular weights are in kDa. Recombinant protein is marked with an arrow. 
4.6.2.2 Dialysis and Concentration 
The fractions collected from the Ni-agarose column were pooled and placed into 
dialysis tubing prepared as described in Sambrook et al (1989). The urea and 
imidazole were removed from the sample by dialysis against a series of buffers 
containing decreasing amounts of urea. The base buffer, W, was 10mM Tris-HCI 
pH 7.5, 100mM NaCl, 0.1%v/v Tween-20 and 5%v/v glycerol. Lots of 500m1 of 
buffer W were prepared with 4M, 2M, 1M and 0.5M urea. The recombinant 
protein was dialysed successively against each buffer beginning with W+4M for a 
minimum of 4 hours with stirring. A final dialysis was carried out with 3 changes 
of buffer W without urea. The recombinant protein was centrifuged at 10000 rpm 
for 15 minutes (Sorvall RC-5B) to remove any precipitated material, then 
concentrated on a centricon 50 ultrafilter (Amicon) using the manufacturer's 
instructions to a final volume of 1 .5m1. 
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4.6.3 Coupling of Recombinant Protein to Affi-Gel 10 
The amount of recombinant protein recovered from the affinity purification 
procedure was estimated to be 1.5 - 2mg on the basis of band densities on SDS-
PAGE gels (a faint band detectable by Pro-Blue staining represents about 1.tg of 
protein). Half of this protein was coupled to Affi-Gel 10 (BioRad, gift from A 
Jarman), an activated acrylic matrix, to make a column for affinity purifying 
antibodies. The Affi-Gel 10 was prepared by placing about 1.5m1 in a plugged 
syringe column and washing with 10-20 column volumes of sterile distilled water. 
The gel was then removed to a 5m1 bijou bottle and the recombinant protein added. 
The protein-gel slurry was incubated at room temperature on an orbital shaker with 
sufficiently vigorous shaking to prevent the gel settling. Unbound sites on the 
Affi-Gel 10 were blocked by the addition of lOOpi IM ethanolamine pH 8.0, 
incubated with shaking for one hour at room temperature followed by incubation 
overnight at 4°C. The gel was then transferred to a small glass column (BioRad) 
and washed with 20 volumes of PBS. 
4.6.3.1 Affinity Purification of Antibody 
The procedure described in Harlow and Lane (1988) was used for affinity 
purification of antibodies. Serum, 3m1, was thawed and centrifuged to remove 
precipitated material that would otherwise block the column. The serum was 
diluted to 30m1 with PBS and was passed over the column 3 times. The column 
was washed with 20m1 PBS followed by 25ml PBS + 500mM NaCl. A low pH 
elution was carried out with 15m1 of 100mM glycine pH 2.5. The pH of the 
column was then adjusted with 25m1 10mM Tris-HC1 pH 8.4 and further antibody 
was eluted with 15m1 triethylamine pH 11.5. The column was then washed with 
20m] of PBS with 0.1 %w/v Na-azide added to the final few millilitres of PBS to 
prevent microbial growth. 
Each eluted antibody fraction was concentrated separately to about lml using 
centricon 50s (Amicon) with lOx PBS added to make the solution lx PBS to 
stabilise the antibodies. An immunoblot was performed by spotting samples 
directly onto Hybond-C and using the Western blot procedures for probing and 
detection. The result showed antibody present in both high and low pH fractions 
(result not shown) These fractions were combined, then concentrated and 
diafiltered with 5 to 8 volumes of PBS in a centricon 50. 
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4.6.3.2 Western Blot with Affinity Purified Antibodies 
A Western blot was carried out using the affinity purified antibodies with ovary, 
adult fly extract, purified recombinant protein, and a pBMF32 culture extract as 
control. Detection was with the DAB system, with the result shown in figure 4.8. 
A strong band was observed in the ovary lane which was estimated to be 110- 
1 20kDA in size whereas a full length unconventional myosin would be expected to 
produce a 1 80-200kDA band. However, the markers failed to transfer so the 
sizing of bands on this membrane is uncertain. A large, diffuse band was observed 
in the recombinant protein lane consistent with that expected. The pBMF32 control 
lane showed weak background reactivity. 
12 	3 
I I I 
- 
1 Ni-agarose purified recombinant protein 
2 pBMF32 extract (negative control) 
3 Ovary extract 
Figure 4.8 Western blot with Drosophila extracts. The antibody used was affinity 
purified from an Affigel-recombinant protein column. dection was with the DAB 
system. The Sigma markers degraded. 
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4.7 Immunohistochemistry 
Experiments were undertaken using both whole serum and affinity purified 
antibodies on whole mount ovaries in order to determine the expression pattern of 
the class V myosin. The method used is described in the materials and methods, 
section 7.16. Initially an HRP detection system was used but it was found that 
post-fixed ovaries exhibited a natural peroxidase activity and thus strong 
backgrounds occurred in all samples. Experiments were undertaken with a 
fluorescent (FITC-conjugated) secondary antibody but again strong background 
signals masked any genuine signal that may have been present. As these 
techniques clearly require further refinement, the preliminary results (showing high 
background signals) have not been presented. 
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4.8 Summary 
Initial experiments designed to obtain expression from the pNMC7a EcoRI 
fragment proved unsuccessful. The most probable reason for this failure was that 
the expressed protein lacked the last 40 amino acids from the carboxyl tail of the 
wild type protein and thus was unstable and rapidly degraded in the E coli cell. 
When further cDNAs were isolated an improved expression plasmid was 
constructed utilising much more open reading frame and including all the carboxyl 
tail. This plasmid proved successful for producing recombinant protein although 
the protein was insoluble. However, the system used for expression allowed the 
recombinant protein to be purified using denaturing conditions. 
The most expedient means to raise antibodies in rabbits was to use polyacrylamide 
gel fragments containing the recombinant protein. The polyacrylamide acted as an 
effective adjuvant and SDS-PAGE circumvented the solubility problem 
encountered with the recombinant protein. The antibodies raised were shown to be 
reactive to the recombinant protein but it is unclear whether or not they recognise 
the wild type didum protein from Drosophila tissue extracts on Western blots. An 
early Western blot (figure 4.6) showed high molecular weight bands from the adult 
fly extracts, while a later Western blot (figure 4.8), using affinity purified 
antibody, produced a strong signal in the ovary extract lane with the size of this 
protein estimated to be 110-1 20kDa. The later result shows a protein much smaller 
than that expected for a full length unconventional myosin. Further experiments 
are required with the affinity purified antibody to resolve these differences. 
Use of the antibodies for immunohistochemical studies demonstrated that 
procedural problems need to be overcome. However, there is considerable scope 
for refinement of these experiments as only a preliminary examination was carried 
out. 
The successful expression of recombinant protein and the development of a 
procedure for its purification provide the basic tools required for studying the 
localisation of the didum protein in wild type and mutant flies. 
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Chapter 5 
Additional Genes Identified During This Work 
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5.1 Introduction 
The work presented in this thesis is primarily concerned with the function of an class V 
myosin in oogenesis. However, during the course of this investigation, several other 
genes were identified. This Chapter describes how these genes were identified and 
presents the complete sequence of one cDNA and the initial identification of another 
g n . - 
5.2 cDNA-34 
The Reverse Northern approach used towards the identification of genomic fragments 
containing 5' exons of the myosin V gene is described in detail in Chapter 2. Initial 
sequence analysis showed that no similarities could be found between the new cDNA 
(now termed cDNA-34) and the existing Drosophila myosin V DNA sequence or the 
mouse dilute unconventional myosin peptide sequence. On this basis it was concluded 
that cDNA-34 represented an unrelated cDNA and, therefore, a new gene. 
An initial restriction map indicated that the insert cDNA from this recombinant plasmid 
was about 2.4kb using the restriction endonucleases EcoRI and Hindu. A more 
extensive restriction map showed few of the restriction endonuclease sites from the 
pBluescript multiple cloning site cut within the insert. Those that did were MI, PstI 
and XbaI with the initial restriction map generated shown in figure 5.1. 
T3J_ 	 tT7 
200bp 
Figure 5.1 Schematic representation of the initial restriction map obtained for 
cDNA-34. T3 and T7 indicate the respective positions of T3 and T7 primers. 
Restriction endonucleases; C: Cal, E: EcoRI, H: Hindu, P: PsiI, X: XbaI. 
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5.2.1 Sequencing Strategy 
A similar subcloning method to that used on the 2.2kb myosin cDNA was employed to 
determine the DNA sequence of cDNA-34. A set of deletion constructs were prepared 
using Cal, PstI and XbaI. At the same time the fragments being deleted from the 
original plasmid were recovered and subcloned into pBluescript SK- as before. A list 
of the subcloned recombinant plasmids generated is given in Table 5.1. Although the-
original size of the insert had been estimated at 2.4kb, it was not possible to obtain a 
complete overlap of the sequences generated from these plasmids. The sequence data 
also revealed the presence of a second Cal site 11 8bp from the first site identified in 
the restriction map. In addition, 3 NcoI sites within the cDNA were identified from the 
sequence data and these sites were used to generate 2 additional NcoI subcloned 
recombinant plasmids in pGEM5 (Promega) and for a NcoI-XhoI deletion plasmid. 
As the overhangs produced by XhoI (in the multiple cloning site) and NcoI (within the 
cDNA) were incompatible for re-ligation, end-filling was required. This procedure 
was accomplished by treatment with dNTPs at 200j.tM each and 1 unit of Kienow 
enzyme. 
Table 5.1 List of Plasmids Used for Sequencing cDNA-34 
Plasmid 	Description 	 Vector 	Primers 
Name 
cDNA-34 Original cDNA, 2.67kb insert pBS SK- T7, T3 
pBMF35 ClaI deletion pBS SK- T7 
pBMF36 CIal subcloned fragment pBS SK- T7, T3 
pBMF37 PstI deletion pBS SK- T3 
pBMF38 PstI subcloned 0.15kb pBS SK- T7, T3 
pBMF39 PstI subcloned 0.3kb pBS SK- T7, T3 
pBMF40 PstI subcloned 1.85kb pBS SK- T7, T3 
pBMF41 XbaI deletion pBS SK- T3 
pBMF42 XbaI subcloned 0.5kb pBS SK- T7, T3 
pBMF44 NcoI subcloned 1.2kb pGEM5 T7, SP6 
pBMF45 NcoI subcloned 0.2kb pGEM5 T7, SP6 
pBMF46 NcoI-XhoI deletion pBS SK- 17 
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E 	 X 	N N 	 CC P 	NP P 
T3 	












Figure 5.2 Schematic diagram of cDNA-34 showing all subcloned plasmids 
generated for DNA sequencing (see also Table 5.1). Also shown are 2 
oligonucleotide primers, Dpol and Dpo5 used for sequencing. Restriction 
endonucleases; C: Cal, E: EcoRI, H: Hindffl, N: NcoI, P: PstI. X: XbaI, Xh: XhoI. 
5.2.2 Sequence Analysis 
The full DNA sequence of cDNA-34 is 2674bp and is shown in Appendix Ill. This 
sequence has been submitted to the GenEMBL database with accession number 
Y07720. Analysis of the sequence with the GCG MAP program revealed an open 
reading frame of 524 amino acids and is shown schematically in figure 5.3. A 3' 
untranslated region (3'UTR) of 654nt and 5'UTR of 433nt are also observed. 
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E 	 X 	N N 	 CC P 	NP P H 
I I 	I II 	I II 	I 
13 T7 
ATG 
Figure 5.3 Schematic representation of the open reading frame deduced from 
cDNA-34. Restriction endonucleases; C: ClaI, E: EcoRI, H: Hindu, N: NcoI, P: 
PstI, X: XbaI. 
5.2.3.1 The ATG and Poly Adenylation Sites 
Cavener (1986) reports the consensus sequence preceding the ATG start codon for 
Drosophila melanogaster genes as being C/A A A A/C ATG. The four nucleotides 
preceding the predicted start codon for cDNA-34 conform reasonably well to this 
consensus, being C A C C. 
The polyadenylation consensus signal is gven as AATAAA (Proudfoot, 1991). This 
sequence can be identified at nucleotides 2320-2324 which is 306nt into the 3'UTR. 
Two occurrences of the sequence AATTAA occur at nucleotides 2632- 2637 and 2641-
2646, very near the end of the cDNA. 
5.2.4 An Ion-Dependent Inorganic Phosphate Co-transporter 
The deduced protein sequence was used to search the GenEMBL database using the 
GCG TFASTA program and identified sequence similarity to a mouse sodium-
dependent inorganic phosphate co-transporter (BNPI, Ni et al [1994]). The BNPI 
protein spans the cell membrane and acts as a inorganic phosphate transporter across 
the membrane driven by a sodium ion gradient. 
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301 	 350 
Huinpo eYItSSLvQQ v.... SSsRQ SLPIKAi1KS LPvWAIsigs FtffWshnim 
Bunpo eYItSSLIQQ g.... SStRQ SLPIKAin1KS LPlWAIsfcc FaylwtysrL 
Moupo dYIiSSLmqq a.... SSgRQ SLPIKAm1KS LP1WAIi1ns FafiWsnslL 
Ratpo kYledaiges aklmnpvtkf ntPwrrffts mpvyAlivan FcrsWtfylL 
Dropo kflekslgas iq.... gskg ptPwKAiats rpvWlnvvaq wggiWglftL 
351 	 400 
Humpo tlYTPmf Ins mLHVNIkENG fLSSLPYLfA wICGn1AGq1 sDFfLtRnIl 
Bunpo ivYTPTlIns mLHVdIRENG LLISSLPYLfA wICGviAGht aDFLmsRnml 
Moupo vtYTPTfIst vLHVNvRENG LLSSLPYL1A yICG11AGqm sDFfLtRkIf 
Ratpo lisqPayfee vfgfelskvG LvSaLPhLvm tllvpigGqi ADFLrsRhIm 
Dropo mthaPtyfrl ihHwNIRatG fLSgLPhLmr mlfayvfsif ADyLLrtdkm 
401 	 450 
Humpo SviaVRKLFT a11PaiF gvCLpYLSst FYSiviFLiL AgatgSFclg 
Bunpo S1TaiRKLFT a4i11PivF  smCL1YLSsg FYStItFLiL AnassSFclg 
Moupo SivtVRKLFT t1t3fcPviF  imCL1YLSyn FYStviFLtL AnstlSFsyc 
Ratpo StTnVRKLmn c3gmeat1 llvvgYShs kgvalsFLvL Avgfsgfais 
Dropo SrTnVRKLat fiIjgtkg1i vlalayfgyn ataalvlvtv Atmlhgavss 
451 	 500 
Huinpo GvfINgDIA IYfGFiKac  StLtGMiGG1 IaST1tGLiL .kQDPEsaWf 
Bunpo GaLINajE4D1A PFYyvfiKgV ttLiGMtGGm tSSTvaGLfL .sQDPEssWf 
Moupo GqLINa[4DIA IP1YYGF1KaV  taLiGMfGG1 ISST1aGL1L .nQDPEyaWh 
Ratpo GfnvNhtf4DIA  PFYasilmgi SngvGtlsGm vcpiivGarnt .khktreeWq 
Dropo GpLasmJDLs P aGivlgV SgmiGgmpGf ISpfivGqlt hnnqtidaWk 
501 	 550 
Huinpo KtFiLMaaIN VtgliFYliv AtaEIQDWAK EkqhTRL* ............ 
Bunpo KiFLLMSiIN VisviFYliF AkaEIQDWAK EkqhTRL* ............ 
Moupo KisfiMagIN VtclvFYflF AkgEIQDWAK EiktTRL* ............ 
Ratpo yvFLiaSlvh yggvlFYgvF AsgEkQpWAe peemseekcg fvghdqlags 
Dropo nvFLLtSlml tgsgIlYvlF sesklQpWns gchqlpdsgl kelqnlgrdq 




Ratpo desemedeve ppgappappp sygathstvq pprppppvrd y 
Dropo ddeeekkplk sdhdketpiv aeqetktksd cdgk* ....... 
Figure 5.4 continued 
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Several similar genes have been described from mouse (Chong et a!, 1995), rabbit 
(Werner et al, 1991) and human (Miyamoto et al, 1995). An alignment of these 
sequences using the GCG PILEUP program is shown in figure 5.4. The percentile 
results of a pairwise comparison between these protein sequences using the GCG GAP 
program is shown in table 5.2. 
Table 5.2 Comparison of sodium-dependent inorganic phosphate co-transporters 
using GCG GAP program. Results are presented as percentage similarity followed by 
percentage identity. - 
Drosophila rat mouse rabbit 
human 	50/25 54/29 80/65 84/70 
Drosophila 	 57/32 	53/28 	50/27 
rat 	 55/30 57/32 
mouse 81/64 
It is clear from these results that the rat, rabbit and human sequences are closely related 
and the mouse and Drosophila sequences are more divergent. There are two features 
of the sequence which can be used to characterise these proteins as sodium-dependent 
inorganic phosphate co-transporters; a series of hydrophobic domains for spanning 
the cell membrane and a Ne binding domain. 
A comparison of the rat sequence of Ni et al (1994) and the Drosophila sequence using 
the hydrophobicity/hydrophilicity plot from the GCG PEPPLOT program shows a 
very similar profile between the two protein sequences (figure 5.5). The predicted 
membrane spanning sequences from the rat sequence have been identified by Ni et al 
(1994) and are shown underlined in figure 5.6, which shows an alignment with the 
Drosophila sequence. 
I lull 
PEPPLOT Of: retpo pep ck: 3291 • 1 to 561 February 7, 1997 12:29 
TRANSLATE Of: rtpo.svq check: 3535 from: 1 24t0: 1 8061)en1tU: 1 000.0 
0 	 500 
I 	 I 	 I 	 I 	 I 
basic Hydrophobic 
acidic 	 t4i 	I1•J 	 Hydrophilic 
Goldman et al 




PEPPLOT of: dropopep Ok: 3742. 1 t 525 FebruerU 7, 1997 12:30 
TRANSLATE of: 3con2.rev check: 8626 from: 439 to: 2674ru$1t: 1000.0 
	
0 	 500 
I 	 I 	 I 	 I 
basic 	 1j• 	 Hydrophobic 
acidic Hydrophilic 




0 	11W , - - -------------------- 	 W')W A 	4V J 	
Hydrophilic 
-3_ 	 -- 	 - 
I I 	 I 	 j 
0 	 500 
Figure 5.5 Results of GCG PEPPLOT showing hydrophobicity and hydophilicity of the rat (Ni et al, 1994) and Drosophila peptide 
sequences. A similar profile can be observed for both sequences. 
rat VVDCTCFGLPRRYI IAIMSGLGFCISFGIRCNLGVAIVSMV 	 . 91 
Dro ..... MGQVEARTVLWYMTFIGFIVNYMIRINLNITIVDMIAGKGAITSN 45 
rat . . .NNSTTHRG ................. GHVVVQKAQFNWDPETVGLIHG 121 
Dro ETHENSTDLAALAEMNERFSLERWFLDWANIPYEKNGFHWNEKQQGALLG 95 
rat SFFWGYIVTQI PGGFICQKFAANRVFGFAIVATSTLNMLIPSAMWHYGC 171 
Dro SFFWAHWTLQIPGGILATKYGTKLVFGWSNGIGVFCCFLIPIVSYWSYTG 145 
rat VIFRILQGLVEGVTYPACHGIWSKWAPPLERSRLATTAFCGSYAGAVVA 221 
Dro LIILRVFQGWITGLAWPSMHVLTAKWIPPNERSKF .VSAYLGSSVGVALF 194 
rat MPLAGVLVQYSGWSSVF'IVYGSFGIFWYLFWLLVSYESPALHPSISEEER 271 
Dro YPIFGYIIDWTRWEWVYYICGIVGTLWFIAWQFLVFDSPAEHPRIADSER 244 
rat KYIEDAIGESAKLMNPVTKFNTPWRRFFTSMPVYAIIVANFCRSWTFYLL 321 
:11.:. 
Dro KFIEKSLGASIQ ....GSKGPTPWKAIATSRPVWLNVVAQWGGIWGLFTL 290 
rat LI SQPAYFEEVFGFEISKVGLVSALPHLVMTIIVPIGGQIADFLRSRHIM 371 
Dro MTHAPTYFRLIHHWNIRATGFLSGLPHLMRMLFAYVFSIFADYLLRTDKN 340 
rat STTNVRKLMNCGGFGMEATLLLVVGY. SHSKGVAISFLVLAVGFSGFAIS 420 
1111111. 	.I.:::I.::I 	.... 
Dro SRTNVRKLATFICCGTKGLIVLALAYFGYNATAAIVLVTVATMLHGAVSS 390 
rat GFNVNHLDIAPRYASILMGISNGVGTLSGMVCPXIVGANT. KHKTREEWQ 469 
Dro GPLASMVDLSPNYAGIVLGVSGMIGGMPGFISPFIVGQLTHNNQTIDAWK 440 
rat YVFLIASLVHYGGVIFYGVFASGEKQPWAEPEEMSEEKCGFVGHDQLAGS 519 
III.. 
Dro NVFLLTSLMLTGSGILYVLFSESKLQPWNS ............ GCHQLPDS 478 
rat DESEMEDEVEPPGAPPAPPP. .SYGATHSTVQPPRPPPPVRDY*... 561 
. ....... 
Dro GLKELQNLGRDQDDEEEKKPLKSDHDKETPIVAEQETKTKSDCDGK* 525 
Figure 5.6 GCG GAP comparison of the rat sequence and the new Drosophila 
sequence with the putative hydrophobic membrane spanning regions of the rat 
sequence highlighted. 
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The Ne binding domain has been highlighted in figure 5.4. These amino acids have 
been highlighted on the basis of alignments from Ni et al (1994) who used a variety of 
sodium-dependent transporter systems. The sequences used, with the consensus 
amino acids capitalised, included: 
rat Na/phosphate 382 cgGfg ...... aisgfnvnhLdiaPRya 434 
rabbit Na/phosphate 340 a1GL1 ...... clggAlinaLdlaPRyy 393 
rabbit Na/glucose 378 lrGLm ...... irkkAsekeLmiaGRlf 429 
human Na/glucose 378 lrGLm ...... vrkrAsekeLmiaGRlf 429 
and the Drosophila sequence is: 
354 ficcgtkgl. .vssGpLasmvlJLsPnYa 403 
On first examination it would seem that the Drosophila sequence shows poor 
conformity to the consensus. However, there are many amino acids which are 
conserved in this region among the sequences shown in figure 5.4 and there are 
conservative changes in the Drosophila sequence for several important positions, eg, L 
-> V at position 396 and R -> N at position 401. The leading part of the consensus 
sequence shows a conserved glycine (G) which does not align in the Drosophila 
sequence but there are two glycine residues within the region. The lack of alignment 
may be due to a greater divergence in the Drosophila sequence as all the other 
sequences compared have been from mammalian sources. 
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5.3 PCR Identifies Sequences from an ATPase 
The myosin head domain shows a reasonable degree of conservation amongst all 
myosins. Two motifs within the head domain are highly conserved, the ATP-binding 
domain and the actin binding domain. In the class V myosins, the ATP-binding 
domain is located about 160 amino acids from the amino-terminus of the protein and 
covers 10 highly conserved amino acid residues (using the mouse dilute myosin V as 
the paradigm). The actin-binding domain is about 650 amino acids from the amino-
terminus in the mouse dilute sequence with the most conserved part containing 6 amino 
acids. A degenerate oligonucleotide primer was designed based on the sequence of the 
ATP-binding domain in an attempt to obtain cDNA sequence by PCR. The ATP -
binding site was chosen over the actin-binding domain as it contained a higher number 
of conserved residues and it was closer to the 5' end of the gene. Figure 5.7 shows a 
diagrammatic representation of this experiment. 
Race2 Racel 
4 00 	Drosophila myosin V (cDNA) 
160 	 650 	 1 	 I 
LN 11111111: 	1 F III 	1"] I 	I 
I 	 I mouse dilute myosin V 
about 650 - 800 amino acids or 1.9 -2.4kb 
ATP-binding domain 
SM 	Actin-binding domain 
Coiled-coil a-helices 
Figure 5.7 Diagram of the AT?-binding and actin-binding domains in mouse dilute 
myosin V (not to scale). Numbers represent the relative postion of each domain 
from the amino terminus. The approximate size of a PCR product is represented by 
the bar. 
5.3.1 Primer Design 
The ATP-binding domains from a number of unconventional myosins were aligned 
and an oligonucleotide primer designed based on this alignment. Sequences chosen 
were two class I myosins, Myo-la and Myo-Ib (Morgan et al, 1994), and a class VI 
myosin (Kellerman and Miller, 1992) from Drosophila, and the chicken p190 class V 
myosin (Espreafico et al, 1992). This alignment and the oligonucleotide primer are 
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shown in figure 5.8. Codon usage in Drosophila was taken into account in the primer 
design. Ashburner (1989) lists the codon usage for a large number of genes. This 
information has been summarised in percentage from for the amino acids in the ATP -
binding domain in Table 5.3. Degenerate bases were built into the primer on the basis 
of the more frequently used codons. 
Dro Myo VI 	TCC GGA GAG TCC GGC GCC GGC AAG ACG 
Dro Myo IA 	TCC GGT GAG TCC GGT GCG GGC AAA ACG 
Dro Myo lB 	TCC GGA GAG AGT GGT ITCCI GGC AAG ACA 
Chic P190 	AGT GGA GAA TCT GGG GCA GGA AAG ACG 
Consensus 	S G E S G A G K T 
A 	 A A A 
Oligonucleotide TCC GGC GAG TCC GGC GCC GGC AAA AC 
T 	T T T G T G 
T 
Figure 5.8 Alignment of ATP-binding domain from 3 Drosophila unconventional 
myosins and the chicken p190 class V myosin. The boxed codon in the Myo lB 
sequence represents a serine residue. The degenrate oligonucleotide designed from 
this alignment is shown. 
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Table 5.3 Codon usage in Drosophila 
presented as percentages from Asbumer 
(1989). 
Amino Acid 	Codon 	Percent 
A 	 GCT 	20 
Alamne 	GCC 50 
GCA 	13 
GGG 16 
G 	 GGT 24 





S AGC 12 





T 	 ACN 
Threonine 
5.3.2 PCR and Cloning 
A standard PCR was performed using the NB40 early embryonic library as template 
with combinations of ATP-binding domain primer, Race 1 and Race2 used. The NB 40 
library was chosen as it was considered to be the library resource most likely to contain 
a full length cDNA. The PCR conditions used were: 
94°C for 2 minutes 
80°C hold, Taq Polymerase added 
40 cycles of: 	94°C 0.5 minute 
53°C 0.5 minute 
72°C 3 minutes 
72°C 7 minutes 
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A product of approximately 2kb was obtained as shown in figure 5.9. This PCR 
product was purified from an agarose gel (7.5.4.3) and prepared for cloning into 
pBluescript KS+. The PCR product was treated with a number of enzymes to ensure 
blunt ends were obtained and to add the phosphate groups necessary for ligation. This 
treatment consisted of: 
DNA 20j.il 
T4 polynucleotide kinase buffer 5tl 
2mMATP 5pJ 
10mM dNTPs 1 xl 
T4 DNA polymerase (NEB) I unit 
T4 polynucleotide kinase 	(NEB) I unit 
Kienow (NBL) 1 unit 
Sterile distilled water to 50pi 
37°C for 30 minutes 
The treated PCR product was phenol/chloroform extracted and ligated to a de-
phosphorylated EcoRV treated pBluescript KS+ plasmid in a lOj.tI volume. Half of 
this ligation was used to transform E co/i XL 1-Blue cells using standard methods 
(7.3.1). Only one transformed colony carrying a recombinant plasmid was obtained 
from several transformation experiments. This plasmid is referred to as pATP-B 
I 5  4 3 2 1.6 0.5 
Figure 5.9 Result of PCR with ATP-binding domain and Race2 primers on the 
NB40 embryonic library. The arrow marks the —2kb product. Marker sizes shown 
are in kb. 
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5.3.3 Mapping and Sequence Analysis 
A restriction mapping experiment was performed on a medium scale plasmid 
preparation (7.6.2.2) of pATP-B with a diagrammatic representation shown in figure 
5.10. Only restriction endonucleases PstI, XhoI and PvuII cut within the inserted 
DNA from a selection of BarnHI, C/al, EcoRI, Hindu, KpnI, PstI, PvuII, Sad, XbaI 
and XhoI that were tested (results not shown). 
Xh 	 Pv 	 PXh 	 P 
J I II 
T3 	 T7 
200bp 
El Cloned PCR product 
Figure 5.10 Schematic representation of the retriction map of pATP-B in 
pBluescript KS+. Restriction endonucleases; P: PA. Pv: Pvull, Xh: XhoI. 
In addition to restriction mapping, DNA sequencing was carried out using automated 
cycle sequencing (7.7.2.2) with T3 and T7 primers to determine the sequence at the 
ends of the inserted DNA. This sequence was used to search the database using the 
GCG FASTA program with similarity to a cDNA from Caenorhabditis elegans called 
mei-1 revealed (Clark-Maguire and Mains, 1994). A comparison between the 
sequence from the T7 end of pATP-B and the mei-1 deduced protein sequence using 
TFASTA showed 49% identity over 131 amino acids in frame 1 with this result shown 
in figure 5.11. A shift to frame 3 at a position where frame I identity ceased 
continued to show sequence similarity with 34.5% identity over 55 amino acids. 
Amino acid sequence showing identity to the ATP-binding domain can be identified 
near the beginning of the cloned sequence, consistent with PCR amplification with the 
ATP-binding primer. Interestingly, the sequence derived from the T3 primer (from the 
opposite end of the cloned PCR product) also showed similarity to the ATP-binding 
consensus sequence. 
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SCORES 	Frame: (1) Initl: 	176 Initn: 	267 Opt: 
358 
48.9% identity in 131 aa overlap 
210 	220 	230 	240 	250 	260 
cemeil KQVLAVTLPLLVPEFFQGLRSJK.NVLAGPPGTGKTLIARAIASESSs'rtyrVSSTD 
:1 	:1:1111 	I::I I 
pATP-B 	 GXNIIGPVrLNSILDSGESGSGKTLIAKSIASQAKFFSINPSS 
10 	20 	30 	40 




50 	60 	70 	80 	90 	100 
330 	340 	350 	360 	370 	380 
cemeil DGSQNDSRRVFVLMTNIPWELDEALRRRFEKRIFIPLPDIDPRKKLIEKSMEGTPKS 
pATP-B DGAASN-EEIRLVIGTNRPQELDEAVRRFVGRLYVPLPTRKHTKSLKSXFIRXSTr 
110 	120 	130 	140 	150 	160 
SCORES 	Frame: (3) Initi: 	62 Initn: 	75 Opt: 
92 
34.5% identity in 55 aa overlap 
330 	340 	350 	360 	370 	380 
cemeil SRRVVLAATNIPWELDEALRRRFEKRIFIPLPDIDARKKLIEKSGTPKS-DEINYDD 
:1:: 	:11:1:111:::::: 
pATP-B GNPSAGNRSHQPTAGAGXGCAPSICRASVRSLTHEEARHKI IELIHQVKLHVMQLIE 
120 	130 	140 	150 	160 	170 
390 	400 	410 	420 	430 	440 
cemeil LARTEGFSGDWSLCRTAAINVLRRYKSLRGGELTAESLKAELVRNIDFEAQ 
II: 	:1:11:11 	:111 	I::: 
pATP-B LAELTDGYSGTDVEYrLCRYASMAPFAPXBLTNGVIQTITCLPFLLDD 
180 	190 	200 	210 
Figure 5.11 TFASTA of pATP-B showing significant similarity to the mei-1 
sequence from Caenorhabditis elegans (Clark-Maguire and Mains, 1994). 
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5.4 Summary 
Two approaches used towards isolating further cDNA sequence from the myosin V 
gene have resulted in the identification of two previously uncharacterised genes. A 
2674bp eDNA (called cDNA-34) was plasmid rescued from the XZAP library as a 
result of screening with FIX-IA genomic DNA. This cDNA was sequenced in full 
and encodes a putative sodium-dependent inorganic phosphate co-transporter. While 
the sequence identity between the Drosophila sequence and other sodium-dependent 
inorganic phosphate co-transporters is not high, the Drosophila sequence possesses 
characteristics common to these proteins; a series of hydrophobic membrane spanning 
regions and a putative Na binding domain. An experiment to determine if Xenopus 
oocytes show an increase in phosphate uptake when injected with in vitro transcript 
from this cDNA should confirm the function of cDNA-34. 
A PCR approach using a primer based on the ATP-binding domain resulted in the 
identification of sequence with significant similarity to an ATPase involved in meiotic 






6.1 Cloning of an Unconventional Myosin 
The main focus of this project was the cloning of an unconventional myosin. It 
became clear that the gene had the potential to encode an unconventional myosin when 
a Northern analysis was undertaken and an estimate of the transcript size had been 
made. The ovarian cDNA XZAP library had yielded a number of recombinants of 
2.2kb but the problem was how to progress towards the 5' end of the gene in view of 
this library having been inadequately prepared resulting in all EcoPJ sites being 
restricted. 
It was decided to screen all cDNA libraries that were available in the laboratory. 
However, this approach was unsuccessful as the cDNA was not found in any of the 
cDNA libraries examined. The genomic XFIX library was also screened with this 
library yielding a recombinant phage that contained less coding sequence than was 
available from the existing cloned cDNAs. The breakthrough came when it was found 
that the cDNA hybridised to the recombinant P1 DS00574. Isolation of the subcloned 
pPl-X7 plasmid and the finding that it contained sequence coding for amino terminal 
residues from the myosin V gene allowed the RT-PCR strategy to be developed to 
obtain most of the coding sequence. Although the 5'RACE product has not been 
confirmed as being part of the myosin V sequence, it is hoped that this situation will be 
resolved in the near future. The gene has been named didum. 
6.2 A Class V Myosin 
This gene has been referred to as coding for a Class V myosin or a Class V 
unconventional myosin. Conventional myosins are the filament forming myosins 
found in skeletal muscle, smooth muscle and most non-muscle cells (reviewed in 
Cheney and Mooseker [1992] and Mooseker and Cheney [1995]). These myosins are 
also known as type II on the basis of dimer formation through the association of long 
coiled-coil domains in the carboxyl terminals. A monomeric myosin, or myosin I, was 
originally identified in Acanthamoeba by Pollard and Korn (1973). As more non-
muscle myosin types were discovered the term "unconventional myosin" was 
introduced. A comparison of the many myosin types based on a phylogenetic 
comparison of the conserved head domain has resulted in the division into, currently, 
11 classifications as shown in figure 6.1 (Cheney et al [1993a], Mooseker and Cheney 
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[1995]). A brief description of each unconventional type will be given followed by a 
more detailed discussion of the class V myosins. 
Dictyostehum M-LA 
k.— 	Dictyostellum M-IB 
Acanthamoeba M-IB 
Human M-lc 
Human Brush Border M-1 
Rat myrl (M-Ia) 
Rat myr2 (M-ltl) 








HM Myosin VIII 
	
/ 	Arabidopsis ATM1 
Arabidopsis ATM2 
I 	4" 	ChicicenMyosin.V 
Mouse Dilute 











1 5% Sequence Divergence 
Figure 6.1 An unrooted phylogenetic tree of the myosin superfamily taken from 
Mooseker and Cheney (1995). A hypothetical model is shown for each class based 
on sequence prediction. 
6.2.1 Class I 
The class I myosins have been the most intensively studied unconventional myosins 
with examples from organisms as diverse as yeast and mammals described. 
Phylogenetic analysis of the head domains has resulted in these myosins being 
subdivided into 4 subclasses. 
6.2.1.1 Myosin I subclass 1 
As mentioned above, the first unconventional myosin was identified in Acanthainoeba 
and ameoboid organisms continue to be a main area of investigation into this class with 
multiple class I myosins being identified from Acanthamoeba and Dictyostelium. 
9 
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There are 5 examples in Diclyostelium which have either a short basic residue rich tail 
region (myoA, myoE) or a longer tail region with 3 distinct domains; TH1, TH2 and 
TH3 (TH = tail homology, myoB, myoC, myoD). The TH1 domain is rich in basic 
residues while the TH2 domain is rich in glycine, proline and either alanine or 
glutamine. This TH2 domain appears to be a ATP-independent actin binding domain 
(Jung and Hammer, 1994). The TH3 domain contains an SH3 domain, domains well 
known to facilitate protein-protein interactions. 
The ATP-independent actin binding domain (TH2 domain) allow this class of myosin 
to form cross-linked actin arrays as demonstrated in Acanthamoeba (Pollard et al, 
1991). Maximal actin activity requires phosphorylation at a site containing either a 
threonine or serine within the actin binding domain of the head domain (Bement and 
Mooseker, 1995). 
Studies in Dictyostelium and Acanthamoeba suggest that this class of myosin has 
major functions in actin based motility, for example pseudopod extension and 
phagocytosis. Gene knockout studies in Diclyostelium have shown that there is 
considerable functional overlap between these myosins (Peterson et al, 1995). 
6.2.1.2 Myosin I subclass 2 
This subclass is characterised by the chicken brush border myosin-1. Other 
homologues of this myosin have been cloned from various mammalian species and all 
appear to be expressed predominantly in enterocytes. However, there are structurally 
similar proteins which are expressed in a wider variety of tissues such as myrl from 
rat (Ruppert et al, 1993). These proteins bind calmodulin and have 3-6 IQ motifs. 
The tail domain is rich in basic residues and, in the case of the chicken brush border 
myosin-1, has been shown to be the target of a kinase and protein kinase C. 
6.2.1.3 Myosin I subclass 3 
Members of this class are quite similar to the brush border myosins and contain 3 IQ 
motifs. The Drosophila myosin lb gene (Morgan et a!, 1995) falls into this 
subclassification. This myosin is only expressed in the gut and in the follicle cells 
during oogenesis. 
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6.2.1.4 Myosin I subclass 4 
The second class I myosin from Drosophila, myosin Ia (Morgan et a!, 1994), falls 
within this grouping as do myr4 from the rat (Bähler et al, 1994) and myosin la from 
C elegans. The Drosophila and rat sequences have 2 IQ motifs with the rat sequences 
shown to bind calmodulin. The tail domains are rich in basic residues. The 
Drosophila myosin la protein is expressed solely in the gut (Morgan et a!, 1995). 
Expression begins late in embryogenesis when gut development starts with an initial 
pattern similar to -myosin lb. Later development shows differing subcèllular locations 
of these two myosins in the Drosophila gut. 
6.2.2 Class III 
The only members of this class are coded for by the ninaC gene in Drosophila with 
two proteins which vary in the size of their tail domain produced by alternative splicing 
(Montell and Rubin, 1988). The ninaC proteins are unusual in that they contain a 
putative kinase domain at the amino terminus. These proteins are found exclusively in 
the photoreceptors cells of the adult eye and are essential for the correct functioning of 
these cells. Mutants show degeneration of the retina over time and with exposure to 
light (Porter et al, 1992). The larger 174kDa protein seems to carry out the major 
functions, but both forms seem important in maintaining calmodulin levels within the 
photoreceptor cell. 
6.2.3 Class IV 
This class was identified in Acanthamoeba by Horowitz and Hammer (1990) in a 
screen for novel myosins. In addition to the myosin head domain, this protein 
contains a single IQ motif and a large -87kDa tail region which incorporates an SH3 
domain. 
6.2.4 Class VI 
Two examples of this class have been described from Drosophila (95F, Kellerman and 
Miller, 1992) and pig (Hasson and Mooseker, 1994). Interestingly, these two 
sequences show a higher degree of identity over the tail domains than over the head 
domains suggesting a conserved and vital role for the tail domain. 
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Some understanding of the function of this class comes from studies on Drosophila 
95F. It is expressed during early embryogenesis and has a crucial role in the nuclei 
divisions within the syncytial blastoderm. The 95F myosin is required for the actin 
based movement of cytoplasmic granules (Mermall et al, 1994, Mermall and Miller, 
1995). Use of an anti-95F antibody to disrupt this process results in improper nuclear 
divisions. 
Antibodies to pig myosin-VI reveal that it is expressed in a wide range of tissues 
including brain, heart, liver, kidney, lung and intestine (Hasson and Mooseker, 1994). 
6.2.5 Class VII 
At present, no full length sequences have been described for members of this class, but 
partial sequences have been isolated from Drosophila (myosin 35BC, Chen et al, 
1991), pig and human. Antibodies react with a large protein of about 240kDa 
suggesting that the transcript for this protein is also large (Hasson et al, 1995). 
Sequences from the shaker-i locus in the mouse share similarity to the partial cDNAs 
described so far (Gibson et al, 1995). The shaker-] mutation results in deafness in 
mice and the locus is believed to be the orthologue of the Usher syndrome lb which 
results in deaf-blindness in humans (Steel and Brown, 1994). Familial analysis has 
revealed mutations in the human myosin Vllb supporting the hypothesis that this 
syndrome is caused by a dysfunctional unconventional myosin (Weil et al, 1995) 
6.2.6 Class VIII 
This class represents a distinct group of unconventional myosins described in plants. 
The ATM1 myosin was identified in Arabidopsis thaliana by a PCR based strategy 
(Knight and Kendrick-Jones, 1993) while a second related gene, ATM2, has also been 
reported (Kinkema et al, 1994). These sequences have 3 and 4 IQ motifs respectively 
and regions in the tail domain predicted to form coiled-coil a-helices. 
6.2.7 Class IX 
A complete sequence from the rat (myr5, Reinhard et a!, 1995) and a partial sequence 
from human (Bement et al, 1994) identify this class of unconventional myosins. They 
both feature a large insertion of 140 amino acids within the head domain that is thought 
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to influence the actin binding domain although no aberrant biochemical properties have 
been reported as yet (Reinhard et al, 1995). These myosins feature 4 IQ motifs and the 
large tail domain has four distinct subdomains, none of which appear capable of 
forming coiled-coil domains. The first subdomain is rich in proline and the second has 
cysteine residues and a structure similar to the zinc and phospholipid binding domains 
of protein kinase C. Assays using a bacterially expressed fusion protein of this 
domain demonstrate zinc binding but not phospholipid binding (Reinhard et al, 1995). 
The third subclomain shows homology to the GTPase-activating proteins from the 
rho/rac family (Lamarche and Hall, 1994). The final subdomain shows divergence, 
possibly as a result of alternative splicing, between the myr5 and myosin-IXb 
sequences, being acidic in myr5 and proline rich in myosin-IXb. The finding of signal 
transducing domains in this myosin perhaps establishes a link between signal 
transduction and cytoskeletal rearrangements. 
6.2.8 Class X 
The main feature of this class of myosin are the PH (pleckstrin homology) domains in 
the tail domain (Oliver et al [1996], see also Mooseker and Cheney, [1995]). These 
PH domains are found in proteins associated with signal transduction pathways. Very 
little is known about these myosins although the bovine sequence shows 3 IQ motifs in 
the neck region. 
6.2.9 Class XI 
This class comes from studies in Arabidopsis with a PCR based approach identifying 
two full length sequences, MYA1 and MYA2, and four partial sequences (Kinkema 
and Schiefelbein [1994] and Kinkema et al [1994]). The MYA1 sequence has been 
included in the alignment of the class V myosins in Chapter 2 as it shares features of 
this class. However, the discovery of several related proteins has resulted in their re-
classification (Mooseker and Cheney, [1996], Kinkema et al { 1994]). In addition to 
the myosin head domain, the MYA1 and MYA2 proteins have 6 IQ motifs and regions 
predicted to form coiled-coil a-helices. 
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6.3 The Class V Unconventional Myosins 
After the class I myosins, this class is probably the best characterised of the 
unconventional myosins. To date, examples have been described in mouse (dilute, 
Mercer et al, 1991), chicken (p190, Espreafico et al, 1992), yeast (MY02, Johnston et 
al [1991] and MY04, Haarer et al [1994]) and rat (myr6, Zhou et a!, 1996). It has 
also been established that the sequence described by Huang et a! (1990) as a glutamate 
decarboxylase is a second class V myosin within the mouse. 
The dilute gene was the first to be described as a result of investigations into this 
common mutant locus in the mouse. The dilute locus has 2 distinct phenotypes, a 
lightening of the coat colour and a neurogenic defect resulting in lethality (Mercer et al, 
1991). The lightening of the coat colour is a result of abnormal melanocyte 
morphology while the cause of the neurogenic defect is unknown. The dilute gene is 
expressed in a wide variety of tissues including brain, kidney, spleen, thymus, testis 
and muscle but not in the liver. Interestingly, RT-PCR identified the second class V 
myosin in the liver. 
The best biochemically characterised class V myosin is p190 from the chicken brain. 
This myosin was purified as protein from brain extracts (Espindola et al, 1992) and 
cDNAs were obtained from an expression library (Espreafico et al, 1992). The IQ 
motifs were expressed in bacteria and the recombinant protein shown to bind 
calmodulin although this binding does not appear to have a strict requirement for 
calcium. Antibody staining in cells cultured from rat hippocampus showed very strong 
staining in the perinuclear region of the cell body. Staining was also observed along 
dendritic and axonal processes with the myosin associating with F-actin in these 
processes. 
Further efforts have shown the stoichiometric relationship between calmodulin and this 
myosin V to be 4:1 (Cheney et a!, 1993b). Two additional light chains of l7kDa and 
23kDa were identified with this myosin from the purification studies. Visualisation of 
the myosin by electron microscopy has given clues to the structure of this molecule. A 
2-headed molecule was observed, suggesting a dimer, with the heads spaced further 
apart than those seen in the conventional myosin H. This greater spacing is probably 
due to the myosin V having 6 IQ motifs versus 2 in myosin H. A stalk domain and a 
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globular domain consistent with the coiled-coil a-helices and the carboxyl globular 
domain predicted from the sequence data were also observed (Cheney et a!, 1993b). 
The chicken p190 protein has been shown to bind to actin filaments and to translocate 
towards the barbed end by in vitro experiments (Cheney et a!, 1993b). The ATPase 
activity was shown to be enhanced in the presence of Ca 2 ions but the translocation of 
actin filaments was strongly reduced by these ions. The effect on translocation by Ca'  
was reduced when exogenous calmodulin was added suggesting that the effect of Ca  21  
is on the binding and turnover of the calmodulin light chains. 
Two examples of class V unconventional myosins, MY02 and MY04, have been 
identified in Saccharomyces cerevisiae. The MY02 gene is essential and is required 
for bud formation (Johnston et al, 1991). A mutant for this gene showed accumulation 
of vesicles suggesting that the role of the protein was in transporting material to the 
bud site. Budding occurs in several stages; bud site selection, bud site assembly, 
cytoskeleton organisation and polarised growth. Mutants for MY02 fail to deposit the 
chitin ring which is required for bud site formation but these mutants were able to 
complete the cell division when shifted to the restrictive temperature at a late stage 
suggesting no role for this myosin in cytokinesis or nuclear migration (Johnston et al, 
1991). The myo2p myosin has been shown to be regulated by calmodulin but in 
contrast with results seen for the chicken p190 myosin, this regulation is independent 
of C2 ions (Brockérhoff et al, 1994). 
The MY04 gene was isolated by random cloning and sequence comparison (Haarer et 
al, 1994). Deletion of the gene showed that it was not essential. Recently the MY04 
gene was identified as SHE], one of 5 genes involved in the switching of the mating 
type. The HO endonuclease switches the mother cell mating type during cell division. 
It is postulated that the SHE genes are responsible for transporting an HO 
endonuclease repressor into the daughter cell (Jansen et a!, 1995). 
6.4 Is There a Second Myosin V in Drosophila? 
It can be seen that there are two distinct myosin V genes in the budding yeast. Results 
from this laboratory and the recent description of myr6 from the rat show that there is a 
second myosin V in the mouse in addition to the dilute gene. What are the possibilities 
of a second myosin V in Drosophila? 
A Reverse Northern approach was used to determine whether genomic DNA cloned 
into FIX-lA contained any 5' sequence from the didum myosin V gene. This 
experiment was undertaken before any map of FIX-lA had been determined. A clear 
result was obtained showing hybridisation to bands different to those hybridising to 
the myosin V cDNA (see figures 2.12 and 2.13 in Chapter 2). Thus, this result 
suggested that FIX- lA contained 5' sequence from the myosin V gene. However, use 
of the cloned genomic DNA from FIX- lA to screen the ovarian 2ZAP library resulted 
in the isolation of an unrelated cDNA - cDNA-34, encoding a putative ion-dependent 
inorganic phosphate cotransporter. 
How then should the Reverse Northern result be interpreted? It only became apparent 
that the original FIX- lA isolate contained two independent recombinant phage when 
this DNA was being used to match the didum and cDNA-34 cloned DNA to genes in 
the 43BC region. The gene encoding cDNA-34 does not map to the 43BC region and 
the bands seen on the Reverse Northern are now known to associate with the same 
genomic region as cDNA-34 does. Since the probe used to obtain the Reverse 
Northern result was generated using reverse transcription from the didum myosin V 
transcript using a gene specific primer, this probe should be specific to the myosin 
head domain. Therefore, it seems reasonable to predict that the genomic sequence 
upstream of the cDNA-34 gene contains sequences related to a myosin head domain, 
possibly from a second class V myosin. Further investigation into this hypothesis can 
be undertaken by determining the DNA sequence from the recombinant plasmid pE7 
and searching for myosin V homology. 
As stated in Chapter 2, a 5'RACE product of -400bp was obtained using gene specific 
primers. At this stage the RACE product sequence cannot be merged into the existing 
bulk cDNA. Perhaps this product is from a second myosin V gene. It is likely that a 
second myosin V will show greater sequence identity to the didum sequence over the 
myosin head domain than over the tail domain. Thus the second myosin could also 
amplify from primers designed to the didum gene. 
A developmental profile (A McCormack, personal communication) has shown that the 
didum myosin V gene is expressed predominantly in the gonads of both adult males 
and females. Some expression is also seen in the early embryo. This embryonic 
signal might be considered to be a result of maternal transcript carried into the embryo 
as strong expression of this gene is seen at late stages of oogenesis. However, for this 
gene to match one of the 3 candidate genes within the 43C region (43Ca, 43Cb and 
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43Cc), embryonic expression must occur as all 3 genes produce an embryonic lethal 
phenotype. It is possible that this gene is expressed elsewhere in the fly but at levels 
undetectable by Northern analysis. 
6.5 Role in Oogenesis 
The expression pattern of the didum gene in oogenesis gives a few clues as to its role. 
The gene is expressed very early in oogenesis so perhaps there is a function in oocyte 
differentiation. It is not known what signals control the determination and 
differentiation of the oocyte. Two genes that are essential for this process are 
Bicaudal-D and egalitarian. Now that a mutant myosin is close at hand it should be 
possible to undertake some epistatic genetic analyses to determine where the didum 
myosin fits within these pathways. Analysis of the in situ hybridisation pattern of the 
didum myosin within Bicaudal-D and egalitarian mutant backgrounds shows that it is 
disrupted (A McCormack, personal communication). 
The second interesting feature of the localisation is the accumulation at the anterior 
margin of the developing oocyte. However, it should be noted that many transcripts 
localised to the oocyye undergo a temporal accumulation at the anterior margin, eg, 
oskar (Kim-Ha et al, 1993) and bicoid (St Johnston et al, 1989). It is possible that this 
myosin is involved in specific transport processes across the oocyte. Most 
investigations of transportation systems within the oocyte have focused on the 
microtubule network with all localised RNAs shown to be dependent on this network. 
Indeed, didum transcript's localisation can also be affected by depolymerising the 
microtubule network (A McCormack, personal communication). 
While there is considerable information about the role of microtubules within 
oogenesis, less is known about the actin cytoskeleton. Actin is known to part of the 
ring canals (reviewed in Cooley and Theurkauf, 1994) as are the products of the hu-li 
tao shao and kelch genes. The hu-li tao shao product appears to recruit actin to the ring 
canals while the kelch product is probably required for ring canal stability. An actin 
cytoskeleton is used to anchor the nurse cell nuclei at the time the nurse cells rapidly 
transfer their cytoplasm to the oocyte. Three genes, chickadee, singed and quail have 
been identified that affect this process with all 3 genes producing actin binding 
proteins. These genes have been discussed in Chapter 1, but briefly chickadee 
encodes a homologue of profilin, a protein which controls the assembly of actin 
filaments. The singed gene encodes a fascin homologue, while quail encodes a Villin 
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homologue with both these proteins involved in stabilising actin bundles. There are 
probably many other proteins that interact with the actin cytoskeleton that have yet to 
be discovered. 
As stated above, localisation of the posterior determinant oskar is dependent on 
microtubules. A surprising finding is that this localisation is also dependent on 
tropomyosin II (Erdélyi et al, 1995). In a screen for mutations with defects in germ 
cell- formation 9 alleles of the tropomyosin II gene were recovered. Creation of 
germline clones carrying lethal alleles of tropomyosin II resulted in the recovery of 
sterile adults as well as embryos showing abdominal defects. This result shows that 
the tropomyosin II gene is required for posterior localisation of oskar and the 
formation of pole plasm. Examination of the actin cytoskeleton using rhodamine-
conjugated phalloidin showed that it was normal in ovaries mutant for tropomyosin II, 
therefore, limiting the effect of this mutation to oskar localisation. 
This observation, that oskar localisation is dependent on tropomyosin II as well as the 
microtubule network, suggests an interrelationship between the actin cytoskeleton and 
the microtubule network. There is increasing evidence that this is the case. Studies on 
the giant axon from the squid show that organelles use both actin and microtubule 
networks (Kuznetsov et al, 1992). It has been suggested that microtubules are used 
for transport over longer distances within the cell while actin filaments are used over 
shorter distances (reviewed by Langford, 1995). In the case of tropomyosin II in 
oogenesis, one hypothesis is that actomyosin transport is required to move the oskar 
transcripts to the microtubule network at the anterior of the developing oocyte and the 
microtubule network is then responsible for transporting oskar transcripts to the 
posterior (Erdélyi et al, 1995). This hypothesis is supported by the observation that 
oskar transcripts accumulate at the anterior in the tropomyosin II mutants. 
6.6 Myosins in Oogenesis 
Several myosins are known to function in oogenesis. The myosin-Ib gene is 
expressed in the follicle cells during oogenesis, initially in all follicle cells, but by stage 
10, only in the columnar cells surrounding the oocyte (Morgan et al, 1995). Antibody 
detection shows that this myosin has a basolateral location followed later by an apical 
location within the follicle cells. This apical location may be associated with the 
microvilli that extend from the follicle cells into the perivitelline space. The microvilli 
HOW 
have an actin core and are possibly associated with secretion from the follicle cells of 
yolk proteins, the vitelline membrane and the chorion (Morgan et al, 1995). 
The 95F class VI myosin has essential functions during embiyogenesis (Mermall et al, 
1994, Mermall and Miller, 1995). Work in this laboratory has also shown that this 
myosin functions in oogenesis (W-M Deng, personal communication). Disruption of 
95F myosin function by use of an antisense construct resulted in defects in follicle cell 
migration. - Follicle cell movements are also dependentS  on nonmuscle myosin II, a 
conventional myosin (Edwards and Kiehart, 1996). Nonmuscle myosin II forms 
bipolar filaments and is thought to drive cellular contractile events. Mutations in the 
regulatory light chain gene, spaghetti squash, of this myosin complex affects the 
centripetal migration of the follicle cells that surround the anterior of the developing 
oocyte (Edwards and Kiehart, 1996). Strong staining of this myosin is also seen in 
the border cells. 
6.7 Antibodies 
While limited progress was made with the antibodies generated to the didum protein, 
the basic foundation has been established. An expression plasmid has been 
constructed, recombinant protein produced and a procedure for purifying the 
recombinant protein has been determined. Antibodies have been raised and it has been 
possible to affinity purify these antibodies. It should be possible to raise further 
antibodies using purified recombinant protein and refine the procedures required to 
observe the wild type protein location in whole mount ovaries. 
6.8 Future Work on the didum Gene 
An immediate goal for future work is to identify the remaining coding sequence and 5' 
untranslated sequence. This goal should be readily achievable using the 
oligonucleotide primer set available. It would also ideal to physically map and clone 
upstream 5' sequence. A physical map is useful for mapping P-element mutations that 
would be generated as part of a mutagenesis study. Genetic mapping has placed the 
didum gene in the 43C region and indications are that the candidate gene results in 
embryonic lethality. To study the role of this gene in oogenesis will require the 
generation of chimeric germ line clones. The technique developed by Chou and 
Perrimon (1992) using site-specific homologous recombination with a yeast 
recombinase driven by a heat shock promoter can be used. Originally this method 
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could only be done with X-linked mutants because the mutant ovoDi,  which allows the 
selection for germ line recombinants, was on the X chromosome. Now lines exist 
with ovo''  on P-elements inserted into each autosome arm (Chou et al, 1993). Using 
other mutants it can be set up such that only flies with a mutant germline clone actually 
lay eggs - so thousands of flies do not have to be screened to find abnormal eggs. It 
would also be possible to mis-express the didum gene with P-element vectors and to 
mis-localise it to the posterior using the oskar 3'UTR to gain insights into its function. 
Any viable mutations obtained from a P-element mutagenesis can be used in 
conjunction with other mutated genes to establish genetic pathways and hierarchies. 
The localisation of other mRNAs, eg bicoid, oskar, and gurken can be examined in a 
didum mutant background, thus identifying the genes which depend upon the correct 
function of the myosin for normal expression. 
Perhaps one of the most interesting questions surrounding not only this myosin but all 
unconventional myosins is: "what molecules other than actin do these myosins interact 
with?" A yeast two-hybrid screen would be an ideal experimental system to initiate to 
begin to answer these questions. 
6.9 The cDNA-34 Gene 
Interest in membrane spanning inorganic phosphate cotransporters has focused on the 
kidney of mammalian systems where reabsorption of phosphate is an essential part of 
maintaining the organism's phosphate homeostasis (Werner et al, 1991). This area of 
research has resulted in the cloning of three renal sodium-dependent inorganic 
phosphate cotransporters from rabbit (Werner et al, 1991), mouse (Chong et al, 1995) 
and human (Miyamoto et al, 1995). These cDNAs appear closely related with the 
predicted proteins showing at least 80% similarity. In the case of the rabbit gene, 
expression appears confined to the kidney and to a lesser extent, the liver (Werner et 
al, 1991). 
A different approach was taken by Ni et a! (1994) leading to the discovery of the brain 
sodium-dependent inorganic phosphate cotransporter. These workers used a screen to 
identify differentially expressed genes after exposure to an excitatory amino acid N-
methyl-D-aspartate (NMI)A). This screen resulted in the isolation of 11 cDNAs, one 
of which was the sodium-dependent inorganic phosphate cotransporter and designated 
BNPI. 
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The deduced amino acid sequence from BNPI shows a lower level of sequence identity 
to the predicted proteins from the renal systems, although it contains at least six 
predicted membrane spanning regions and was shown to mediate phosphate uptake in 
the Xenopus oocyte assay. Thus BNPI establishes a separate family or subfamily of 
phosphate cotransporters. The new Drosophila sequence shows a similar level of 
sequence identity to the renal phosphate cotransporters as does the rat sequence. 
Sequence identity to the rat BNPI predicted protein is slightly higher and many 
conservative substitutions can be- observed. The Drosophila-sequence shares a very 
similar hydrophobicity/hydrophilicity profile to that of the BNPI protein suggesting 
that it is a membrane spanning protein. 
Analysis by Northern blot shows that BNPI is expressed only in the brain, while in 
situ hybridisation studies show expression is in a neuronal rich subset of brain 
structures such as the cerebral cortex, hippocampus and cerebellum (Ni et al, 1994). 
Speculation is that the BNPI cotransporter may be involved in regulating inorganic 
phosphate levels within the neuron as part of protein phosphorylation and ATP 
metabolic cycles. The cDNA was isolated as part of a differential screen in cerebral 
granule cells in response to NMI)A transmitter stimulation. Northern analysis has 
shown that BNPI levels increased 2-3 fold in response to NMDA treatment (Ni et al, 
1994). 
The Drosophila cDNA-34 gene was isolated from an ovarian cDNA library. Analysis 
by in situ hybridisation shows expression in the follicle cells with the RNA located at 
the cell cortex (A McCormack, personal communication). It is possible that this 
putative phosphate cotransporter is required to maintain high levels of intracellular 
phosphate during oogenesis to support the growth requirements of the developing 
oocyte. It is also conceivable that this protein could serve as a regulator of intracellular 
phosphate levels in a similar manner to that speculated for the rat BNPI protein. There 
are many signalling events involved in oogenesis for axes determination (see Chapter 
1) and protein phosphorylation is a part of these signalling systems. 
6.10 A Putative ATPase 
Use of a PCR based technique to isolate didum sequence from the ATP-binding site 
resulted in the cloning of a PCR product from an unrelated gene. Sequence generated 
from this PCR product revealed similarity at both the DNA and protein levels to the 
mei-1 gene from Caenorhabditis elegans (Clark-Maguire and Mains, 1994). The mei-1 
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gene was isolated from a series of mutants which disrupt the transition from meiosis to 
mitosis in the C elegans oocyte. Loss-of-function mutations in this gene disrupt the 
formation of the meiotic spindle whereas a dominant gain-of-function allele leads to 
abnormal mitotic cleavages after normal meiosis takes place. This genetic analysis 
suggests that mei-1 is required only for meiosis. 
Meiosis occurs in the developing oocyte in Drosophila at stage 13. It is possible that 
the cloned PCR product is the results from transcripts of the Drosophila homologue of 
mei-1 being carried through oogenesis into the embryo. Another possibility is that this 
cloned PCR represents an ATPase from a family of related genes. The cloned PCR 
product can be used as a probe to isolate cDNAs from ovarian libraries to allow this 
Drosophila gene to be investigated further. 
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Chapter 7 
Materials and Methods 
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7.1 General 
7. 1.1 Chemicals and Radioisotopes 
All chemicals were of analytical grade unless otherwise specified and were purchased 
from Sigma Chemical Co, Boehringer Mannheim, Fison or BDH Chemicals Ltd. 
Radioisotopes Deoxycytidine 5 '(a- 3 P) tnphosphate and Deoxyadenosine 5 '((X- 35 S) 
triphosphate were purchased from Amersham. 
7.1.2 Buffers and Solutions 
All buffers and solutions were prepared with double distilled water and autoclaved or 
filter sterilised unless otherwise stated. All buffers were pH adjusted and used at room 
temperature unless otherwise stated. Solutions used for RNA work were prepared 
using sterile water treated with DEPC (Diethyl pyrocarbonate) Common buffers used 
were: 
TE: 10mM Tris-HC1, 1mM EDTA, pH 8.0 
TBE: (Borate buffer for agarose gel electrophoresis) 89mM Tris-HC1, 89mM boric 
acid, 2.5mM EDTA, pH 8.3 
TAE: (Acetate buffer for preparative gel electrophoresis) 40mM Tris-acetate, 1mM 
EDTApH7.8 
MOPS (for RNA agarose gels) 20mM Na-MOPS pH 7.0, 50mM Na-acetate, 10mM 
EDTA 
Ringer's (saline for dissection): 6.5g NaCl, 0.14g KC1, 0.2g NaHC0 31  0.12g CaCl 2 , 
0.01g NaH2PO4 per litre, sterilised by autoclaving. 
PBS (phosphate buffered saline): 8g NaCl, 0.2g KC1, 1.44g Na 2HPO41  0.24g 
KH2PO4 dissolved in 800m1 water, pH adjusted to 7.4, made to 1 litre, sterilised 
by autoclaving. 
SM (bacteriophage buffer): 100mM NaCl, 8.1mM MgSO 4, 50mM Tris-HC1 pH 7.5, 
0.5%w/v gelatin. 
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7.2 The Culturing of Bacteria and Bacteriophage 
7.2.1 Growth Media 
Luria Broth (LB-broth): 1% Bactotryptone, 0.5% yeast extract, 1% NaCl, pH 7.0 
(Luria and Burrous, 1957). 
Terrific Broth (T-broth): Bactotryptone 12g, Bacto yeast extract 24g, glycerol 4m1, 
dissolved in 900m1 of water and sterilised by autoclaving. A lOOml sterile 
solution of 12.5 1  K2HPO4 and 2.3 1  KH2PO4 is then added. 
2xYT: Bactotryptone 16g. Bacto yeast extract lOg, NaCl 5g, per litre, pH adjusted to 
7.0 with NaOH, sterilised by autoclaving. 
7.2.2 Bacterial Strains and Plasmids 
Table 7.1 Bacterial Strains and Markers 
E coli 	 Markers 	 Comments 
Strain 
Y1090 	 F-, z(lac) Ui 69 ion- 100 	For plating Xgt 
arazS139, rspL(Str'), supF, libraries 
mcrA, trpC22:Tn10 (pMC9:Tet' 
Amp') 
NM422 	 F', 1acPz(lacZ)M15 proAB 	For plating 2LFIX 
IsupE thi (lacproAB)/ ii(hsdMS library 
mcrB)5 (rKmK McrBC) 
B121 DE3 	 F, ompT [ion] hsdSB 	 carries prophage DE3, 
used for protein 
expression 
XL1 Blue 	 Al, gyrA96, thi, hsdR17, 	general use for 
supE44, (F', proAB, 	 recombinant DNA 
1acPZ4M15) 	 work, XZAP libraries 
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Table 7.2 Plasmids Used in this Work. 
Plasmid 	Description 	 Features 	 Source 
pBluescript 	General cloning vector Contains A15 region of Stratagene 
LacZ ampicillin 
resistance 
pGEM5 General cloning vector As for pBluescript Promega 
pRSET Expression vector Bacteriophage T7 Invtrogen 
Polymerase promoter 
system 
7.2.2.1 Description of pBluescript Cloning Vectors 
The pBluescript series of vectors have a number of useful features which are worth 
describing here. They contain the lacZ a-peptide which contains a multiple cloning 
region and produces functional -galactosidase when complemented in a strain 
containing the IacZDM15 gene. Functional -galactosidase results in blue colonies 
when plated on media containing 5-bromo-4-chloro-3-indo1yl-3-
galactopyranoside.(X-Gal), whereas disruption of the lacZ a-peptide by insertion into 
the multiple cloning region results in no complementation and white colonies on agar 
plates containing BCIG. Induction of the lac promoter was facilitated by the inclusion 
of the lactose analog isopropyl--D-thio-galactopyranoside (IPTG) in the agar plates. 
The pBluescript vectors contain the origin of replication of the filamentous 
bacteriophage f 1, which allows production of single stranded DNA for sequencing. In 
addition, the universal M13 sequencing primers (see also section 7.7.2) can be used to 
sequence DNA cloned in the multiple cloning region and transcripts can be produced 
from inserts using T3 and T7 promoter sites. 
7.2.3 Excision of pBluescript Phagemid from AZAP Bacteriophage 
The ?ZAP bacteriophage vector has the useful feature of allowing the cDNA to be 
excised in the form of a pBluescript recombinant plasmid eliminating the need for 
subcloning. A 2LZAP plaque was selected and suspended in 0.5m1 of SM solution 
with 20il chloroform added followed by incubation overnight at 4°C. A culture of 
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XL1-Blue E coli was grown to an 0D 650 of —1.0 with 0.2%w/v maltose and 10mM 
magnesium included in the LB-broth. A 100.tl aliquot of eluted phage was added to 
200m1 of XL1-Blue cells with lp.l of helper phage (VCMS13) also added, then 
incubated at room temperature for 15 minutes followed by 15 minutes incubation at 
37°C to allow adsorption and penetration of the phage DNA. To this mix was added 
2m1 of 2xYT followed by incubation at 37°C for 2-3 hours with shaking. The culture 
was then heated to 70°C for 20 minutes to kill the E coli cells followed by 
centrifugation at 4000g for 15 minutes. The supernatant was collected as a phagemid 
stock with 20p1 chloroform added to prevent bacterial growth. Bacterial colonies 
carrying the pBluescript recombinant plasmid were prepared by adding ijil and 10.tl 
of phagemid stock to 200m1 XL 1-Blue cells with incubation at 37°C for 15 minutes. 
This culture was plated on to LB-agar plated containing 100pg/ml ampidillin and 
allowed to incubate overnight at 37°C. 
7.2.4 Antibiotics 
Antibiotics were used in growth media where appropriate at the following final 
concentrations: 
Ampidillin: 	100pg/ml for pBluescript and pRSET-C. 
Carbenicillin 100 jig/mi 
Kanamycin 	50 jig/mi 
7.2.5 Preparation of Bacteriophage Plating Cells 
Plating cells were prepared by inoculating a single colony into 20m1 LB-broth 
supplemented with 10mM MgSO4 and 0.2%w/v maltose. The culture was grown to 
an 0D650 of approximately 1.0. Cells, lOOj.tl for 90mm plates, 1 .5m1 for 25cm x 
25cm plates, were mixed with the bacteriophage and incubated at room temperature for 
10 minutes followed by incubation at 37°C for 15 minutes. Top agarose (0.7% 
agarose in LB-broth) at 42-50°C was added to the celllphage mix and poured 
immediately onto a fresh LB-agar plate. Once set, the plates were covered, inverted 
and incubated overnight at 37°C. 
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7.2.6 Libraries Used in This Work 
7.2.6.1 The AFFIX Genomic Library 
This library was purchased from Stratagene Inc. It uses the AFIX-II bacteriophage 
vector which contains XhoI restriction endonuclease sites in the multiple cloning site. 
The library was constructed by ligating a size fractionated partial Sau3AI digestion of 
Drosophila CantonS genomic DNA to partially filled XhoI sites in the vector. Insert 
sizes vary from 9-23kb and each end is flanked by a T3 or T7 promoter. 
7.2.6.2 The NB40 Early Embryonic Library 
This library was constructed using the pNB40 plasmid vector (Brown and Kafatos, 
1988). First strand cDNA was synthesised using a oligonucleotide primer with 12 T 
residues and a unique 14 nt 5' end, then tailed with 10-15 G residues using terminal 
transferase. The cDNA was annealed with two vector fragments, one containing a 
poly C overhang and the other with sequence complementary to the 14 nt part of the 
primer. The annealing reaction was diluted and ligated to promote recircularisation, 
then used to transform E coli. 
7.2.6.3 The Ovarian Agt22 Library 
This library was constructed by Stroumbakiss et a! (1994). Directional cloning was 
carried out to give unique EcoRI and Sail restriction sites at the cDNA 5' end and a 
unique NotI site flanking the Poly(A) tail. Initial complexity was 1.5 x 106 
independent recombinants. 
7.2.6.4 The Ovarian ?ZAP library 
This library was constructed by Stratgene Inc for the Jan laboratory (Jongens et al, 
1992) and uses the AZAP vector which allows recombinant cDNAs to be excised as 
pBluescript plasmids. 
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7.3 Transformation of Escherichia coli 
The E coli strains XL 1-Blue or BL21 DE3 were made competent using either of the 
following methods. Fresh competent cells were prepared for each transformation. 
7.3.1 Cold CaC1 2 Method 
The method of Lederberg and Cohen (1974) was used as follows: Mid-log phase 
cultures were pelleted by centrifugation, then resuspended in one-half volume cold 
0.1M MgCl, and left on ice for 15 minutes. The cells were pelleted by centrifugation, 
then resuspended in one-half volume cold 0. 1M CaC1 2 and incubated on ice for 30 
minutes. The cells were again pelleteci by centrifugation, then resuspended in 1/20th 
volume 50mM CaC12 , 15% glycerol and used immediately. Transformation was 
carried out by mixing approximately SOng of DNA with lOOpi of cells followed by 
incubation on ice for 30 minutes. The transformed cells were heat shocked at 42°C for 
2 minutes in a water bath. LB-broth (900j.ti) was added and the cells allowed to grow 
at 37°C for 1-1.5 hours on a shaker. The culture was then spread onto antibiotic plates 
to select for transformants. 
Transformation efficiency was measured by transforming lOpJ of a bOng/mi solution 
of the plasmid pBluescript KS-. 
7.3.2 Electroporation 
7.3.2.1 Preparation of Cells 
A 5m1 overnight culture of E coli was used to inoculate 300-500m1 of fresh LB-broth 
at a 1:100 ratio. The culture was incubated at 37°C with shaking until growth reached 
mid-late log phase, then chilled on ice for 15 minutes. The cells were collected by 
centrifugation at 4000rpm (Sorvall RC-5B, GSA rotor). The cell pellet was 
resuspended in a volume of cold sterile distilled water equal to that of the LB-broth 
initially used (a low ionic buffer, eg. 1mM Hepes pH 7 can be substituted for water at 
this point). The cells were again collected by centrifugation, then resuspended in 
about 20m1 of cold sterile water as before and transferred to chilled 30m1 glass Corex 
tubes. The cells were washed twice more with about 20m1 of cold sterile water and 
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finally resuspended in 2m1 of water or in 2m1 of 10%v/v glycerol if aliquots were to be 
stored. The cells were now ready for electroporation. 
A microfuge tube was pre-cooled on ice before 40jtl of cells were added followed by 
1-2p1 of DNA solution. A Gene-Pulser (BioRad) was set at 2500V, 25tF and 200 
ohms. The DNA-cell mix was added to a precooled electroporation cuvette, placed into 
the pre-cooled safety slide, pushed between the contacts and pulsed immediately. A 
pulse time of 5-6msec was a typical result and indicated --successful transformation. 
The cuvette was removed from the safety slide and immediately imi of LB-broth 
supplemented with 2.5mM KC1, 10mM MgC1 21  10mM MgSO4 and 20mM Glucose 
was added and mixed with a pasteur pipette. The culture was transferred to a 
microfuge tube and incubated at 37°C with shaking for 1 hour to allow expression of 
the antibiotic resistance gene, then plated on LB-agar plates containing the appropriate 
antibiotic. 
7 4 Drosophila melanogaster 
7.4.1 Strains used in This Work 
The wild type strain used throughout this work was OregonR (Lindsley and Zimm, 
1992). Table 7.3 lists the developmental stages of OregonR at 25°C. Other strains of 
flies used in this work are noted and referenced in the relevant results section. 
Table 7.3 Life Cycle of Drosophila melanogaster 
Hours Days Developmental Stage 
0 0 Fertilisation and fusion of pronuclei 
1.5 0 Preblastoderm stage. 	Migration of cleavage 
nuclei and pole cell formation 
3 0 Blastoderm stage. Migrated nuclei form cells 
3.5 0 Gastrulation begins 
6 - 8 0 Segmentation begins 
18 0 Larval differentiation nears completion 
24 1 Hatching from egg. Onset of first larval instar 
48 2 First moult. Second larval instar begins 
72 3 Second moult. third larval instar begins 
120 5 Puparium formation with white puparium 
122 5 Puparium darkens 
124 5 Puparium moult 
132 5 Pupation. Eversion of imaginal discs 
216 - 240 9-10 Eclosion of adult from pupal case 
7.4.2 Maintenance of Fly Stocks 
Stocks were maintained at 18°C on Staffan cornmeal food consisting of comfiour 
(250g), sugar (500g), yeast pellets (175g) and agar (bOg) dissolved in distilled water 
to a final volume of 10 litres. The food was boiled and allowed to cool to 
approximately 60°C before being poured into bottles or vials. A fungicide, Nipagin, 
was added to a final concentration of 4.5 .tgfL. To prevent mite contamination, strips 
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of Whatman 3M paper soaked in 3%v/v benzyl benzoate (in ethanol) and air dried 
were placed on top of the cornmeal food. 
Adh food consisted of lOOg dried flake yeast, lOOg brown sugar, 16g agar and 
Nipagin at 4.5mg/nil final concentration in one litre. 
7.4.3 Collection of Sexed Adult Flies 
Adult flies of various ages were anaesthetised with diethyl ether and sexed according 
to external morphology; presence of sex combs on the male forelegs or abdominal 
pigmentation. 
7.4.4 Collection of Virgin Females 
All existing adult flies were tipped from the bottle which was then returned to the 25°C 
incubator. Newly eclosed flies were examined and sexed early in the morning and late 
in the day and placed into separate vials. 
7.5 DNA Manipulation 
7.5.1 Enzymatic Reactions 
Restriction endonucleases were supplied by Bestheda Research Laboratories (BRL), 
New England Biolabs (NEB), Boehringer Mannheim, Promega or Northumbria 
Biological Laboratories (NBL). Digestion was carried out as recommended by the 
manufacturer using buffers supplied with the enzymes in volumes ranging from lOp.! 
to 100p.l, with typically 5 units of endonuclease per jig of DNA. 
T4 Polynucleotide kinase, DNA Polymerase I (Kienow fragment), T4 Polymerase, 
calf intestinal alkaline phosphatase (ClAP) and T4 DNA ligase were supplied by 
Bestheda Research Laboratories (BRL) or Boehringer Mannheim and used as 
specified. Mung bean nuclease was supplied by BRL and used as specified. 
DNA Polymerase for use in PCR reactions was supplied by BRL, Promega or 
Dynazyme 
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RNase was obtained from Sigma Chemical and prepared as a solution of 10mg/mi as 
described in Sambrook et a! (1989) which was boiled for 20 minutes to remove 
contaminating DNase activity. 
7.5.2 Dephosphorylation of Plasmid Vectors 
Dephosphorylation with calf intestinal alkaline phosphatase (ClAP) was carried out to 
facilitate cloning of DNA fragments into the vectors by preventing vector religation. 
The plasmid was restricted with the desired restriction endonuclease, then ClAP and 
0.5x ClAP buffer was added. Incubation was continued at 37°C for a further 30 
minutes then at 55°C for 30 minutes. The plasmid DNA was extracted 2 or 3 times 
with phenol chloroform and the DNA precipitated with ethanol as described below. 
The plasmid was redissolved in a volume of TE to give a concentration of about 
lOOng/j.tl. 
7.5.3 Phenol Extraction and Alcohol Precipitation 
Phenol-chloroform extraction is a common procedure for the removal of proteinacious 
material from DNA solutions. Phenol was equilibrated with Tris-HC1 pH 8 as 
described by Sambrook et al (1989) then mixed in a ratio of 25:24:1 phenol 
chloroform: iso-amyl alcohol respectively and stored at -20°C in 1. 5ml  portions. 
DNA was extracted by the addition an equal volume of phenol-chloroform and mixed 
by vortexing, or if shearing of DNA was to be avoided by repeated, gentle, 
inversions. The phases were separated by centrifugation and the organic phase was 
carefully removed by pipettor, then a second extraction was performed, with further 
extractions performed if required. A final extraction with an equal volume of 49:1 
chloroform: iso-amyl alcohol was performed to ensure complete removal of phenol. 
Precipitation was carried out by adding 1/10th volume 3M Na-acetate pH 5.2 with 
either 2 volumes ethanol or 1 volume isopropanol, at -20°C for at least one hour. The 
DNA was pelleted by centrifugation in a microfuge for 20 minutes. Additional salts 
were removed by rinsing of the pellet with 70%v/v ethanol with a brief centrifugation 
and careful removal of the rinse solution. The DNA pellet was dried under vacuum 
and then redissolved in a solution of choice for further manipulation. 
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7.5.4 Agarose Gel Electrophoresis 
7.5.4.1 Molecular Weight Standards 
All agarose gels were run with one of the following molecular weight (MW) standards: 
BRL 1 kilobase ladder (1 kb ladder) 
200- 500 ng of marker was used in a standard gel lane. 
7.5.4.2 Standard Gel Electrophoresis 
Horizontal slab gels were used for routine separation of DNA fragments in a 
submarine apparatus (Sambrook et a! 1989). Gel-agarose concentrations varied from 
0.4%w/v to 1 .2%w/v in TBE buffer depending on the size of the fragments to be 
separated. Agarose from Boehringer Mannheim was used. 
7.5.4.3 Preparative Gel Electrophoresis 
Submarine gels were prepared with BRL ultrapure agarose in TAE buffer and run as 
for standard gels, see above. 
7.5.4.4 Recovery of DNA fragments 
DNA fragments were extracted from preparative agarose gels using kits obtained from 
Qiagen. In most cases Qiaex was used but at times the Qiaquick column method was 
employed. Qiaex uses a NaSI based solution (QX1) and heating to 55°C to dissolve the 
gel slice with the DNA then being bound to a silica based particle system. Impurities 
are washed away with QX1 and the ethanol based PE wash buffer, the silica particles 
dried briefly, then the DNA eluted with TE solution, with a 55°C elution step used for 
DNA molecules larger than 5kb. The Qiaquick system is very similar but uses a 
microfuge column in place of the loose silica particles in the Qiaex kit. It was felt that 
Qiaex produced better, more consistent yields than the Qiaquick system. 
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7.5.5 Radiolabelling of DNA 
DNA was labelled with a32P dCTP or digoxigenin as follows: 
7.4.5.1 End labelling of 1 kilobase ladder 
For Southern blots it is useful to have reference markers as for normal ethidium 
bromide stained gels: This is most easily accomplished by end filling the 'sticky ends' 
of the standard 1 kilobase ladder (BRL, Life Technologies Inc). Approximately 200ng 
of 1 kilobase ladder was radiolabelled in a 40j.tl reaction mix with lunit of Kienow 
enzyme (Boehringer Mannheim), 50mM each of dATP, dGTP and dTTP, and lp.l of 
cx32P dCTP. The reaction mix was incubated at 37°C for 30 minutes. Unincorporated 
radiolabel was removed by use of a Pharmacia Sephadex Nick column. 
7.5.5.2 Random Prime Labelling 
To generate probes for Southern and Northern hybridisations, DNA was radiolabelled 
using a random priming kit based on the method of Feinberg and Vogelstein (1983). 
Approximately 50-200ng of DNA was denatured first by boiling then immediately 
plunged into ice. The DNA was labelled in a reaction mix containing, 10.tl OLB 
buffer, 5.tl of a32P dCTP, ipi of 20mg/mi BSA and 5 units of Kienow enzyme in a 
final volume of 50pJ by incubating at 37°C for 30 minutes. OLB consists of a ratio of 
2:5:3 of components A, B and C which are described below. 
Solution A: 	950pi of solution '0' 
18i.tl of 3-mercaptoethanol 
25pJ each of 20mM dATP, dGTP and dTTP 
Solution B: 	2000mM HEPES pH 6.6 
Solution C: Hexanucleotides 90 OD/ml (Boehringer Mannheim or 
Pharmacia) 
Solution 0: 	125mM MgC12 
1250mM Tris-HC1 pH 8 
Later stages of the project used the Pharmacia Ready-To-Go kit which provided 
hexanucleotides, dATP. dGTP, dTTP, Klenow polymerase and buffer salts as a 
lyophilised mix that was redissolved in 20pi of sterile distilled water. The DNA was 
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denatured in a 25tl volume as before, added to the reaction mix tube along with 5pJ 
(50mCi) of a-32PdCTP and then incubated at 37°C for 1 hour. 
Unincorporated radiolabel was removed using a Pharmacia Nick Column. These 
columns use the Sephadex G-50 for gel filtration allowing the larger labelled DNA 
molecules to pass through the column while retaining the unincorporated nucleotides. 
The column was prepared by tipping off the storage solution, rinsing with one column 
-volume- of -TE followed by one column volume of TE-run=through the column. - The- 	- - 
labelling reaction was pipetteted directly on to the top support surface of the gel bed 
and washed in with 400pJ of TE. The material collected at this stage contained very 
little labelled DNA and was discarded while a second wash of 400 j.i1 eluted the bulk of 
the labelled DNA. 
Efficiency of incorporation was not determined other than by rough estimation from 
hand held monitors. 
7.5.5.3 Labelling of DNA with Digoxigenin 
DNA, 500-1000ng in a volume of 15j.il was denatured by boiling in a waterbath for 5 
minutes followed by plunging into ice. A Boehringer Mannheim labelling kit was 
used with a labelling reaction consisting of denatured DNA, 2t1 hexanucleotides, 2tl 
digoxigenin labelling mix and 1 unit of Kienow enzyme. Labelling was carried out for 
at least 60 minutes at 37°C. Unincorporated label was removed by precipitation of the 
labelled DNA with lp.l 0.5M EDTA, 1.5jiJ 10M LiC1 and 2.5 volumes of ethanol at - 
70°C for 15 minutes. The labelled DNA was collected by centrifugation, washed with 
70%v/v ethanol and air dried. The labelled DNA was redissolved in the appropriate 
buffer and denatured by boiling and plunging into ice prior to use. 
7.6 DNA Preparation 
7.6.1 Genomic DNA Preparation 
Adult flies were collected by etherising, sorted as required and placed in a vial for 
several hours to void yeast. The flies were then transferred to a microfuge tube and 
immersed in liquid nitrogen briefly to render them motionless. The flies were 
homogenised (Kontab homogeniser) in Flybuffer (5%w/v sucrose, 80mM NaCl, 
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100mM Tris-HC1 pH 8.0, 50 mM EDTA pH 8.0, 0.05 %w/v SDS) added at a ratio of 
0.5nil per 50 flies. The homogeniser rod was rinsed with an equal volume of 
Flybuffer, then the homogenate was frozen for 15 minutes at -70°C. The homogenate 
was thawed on ice and RNase added to a final concentration of lOj.tg/ml, then 
transferred to a 70°C waterbath and incubated for 30 minutes. Potassium acetate (3M 
stock) was added to a final concentration of 160mM with incubation on ice for 30 
minutes. Debris and insoluble material was separated by centrifugation in a microfuge 
for 5-10 minutes and the supernatant then transferred to a fresh microfuge tube. The 
solution was phenol/chloroform extracted twice and chloroform extracted once, then 
precipitated with 0.75 volumes of isopropanol. The precipitate was collected by 
centrifugation for 15 minutes in a microfuge and washed with 70%v/v ethanol, then air 
dried. The pellet was dissolved in a suitable volume (dependent on the number of flies 
used) of TE overnight at 4°C. 
7.6.2 Plasmid Preparation 
7.6.2.1 Small Scale 
The method of Birnboim and Doly (1979) was used to prepare 2-5p.g of plasmid DNA. 
Colonies were selected and inoculated into 5m1 LB-broth plus antibiotic then incubated 
overnight at 37°C. 1 .5m1 of culture was centrifuged in a microfuge for 30 seconds with 
the cell pellet resuspended in 100p1 of Solution I (40mM Tris-HC1 pH 8.0, 10mM 
EDTA pH 8.0, 50mM Glucose) followed by incubation at room temperature for 5 
minutes. This step was followed by the addition of 200pJ of Solution 11(1% SDS, 
200mM NaOH) with mixing by gentle rolling of the tube to prevent shearing of genomic 
DNA, then incubated on ice for 10 minutes after which 150p1 of Solution III (3M 
Sodium acetate pH 4.8) was added with gentle mixing as before and incubation on ice 
for 10 minutes. Cell debris was pelleted by centrifugation in a microfuge for 5 minutes 
with the supernatant being transferred to a fresh tube. The DNA was precipitated by the 
addition of lml ethanol at room temperature, mixed, then centrifuged in a microfuge for 
at least 5 minutes. The supernatant was removed and the pellet washed with 80%v/v 
ethanol, re-centrifuged, then dried in a speedvac desiccator. The DNA was dissolved in 
50p1 of TE buffer. 
7.6.2.2 Medium Scale, LiCl method 
This procedure was used for preparation of 50-200g of plasmid DNA from 100-200 
ml of culture. It was developed from a small-scale procedure as described by Ausubel 
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et al (1989), incorporating suggestions from G Albertson (personal communication). 
100-200 ml of culture was grown overnight in L-broth plus antibiotic. The cells were 
pelleted by centrifugation at 5000 rpm for 10 minutes, then resuspended in 3m1 Solution 
I (as for miniprep procedure), and left to stand at room temperature for 5 minutes. The 
cells were lysed by the addition of 6m1 of Solution II (as for small-scale prep), mixed 
gently and allowed to stand at room temperature for 10 minutes. This was followed by 
the addition of 4.5m] of 3M potassium acetate pH 4.8 with gentle mixing and incubation 
on ice for 45 minutes. Cell debris was separated by centrifugation at 8000 rpm for 10 
minutes. The supernatant was transferred to a fresh tube and centrifuged at 15 000 rpm 
for 30 minutes to pellet the last traces of cell debris. The supernatant was precipitated by 
the addition of 1 volume of isopropanol at room temperature for at least 10 minutes. The 
precipitate was collected by centrifugation at 15 000 rpm for 30 minutes, dried, then 
redissolved in 0.5m1 TE and transferred to a microfuge tube. 20j.tl of 10mg/mi DNase 
free RNase was added and the tube was incubated at 60°C for 15 minutes. Next 375p1 
of 7M LiC1 was added, incubated on ice for 20 minutes, then microfuged for 15 
minutes. The supernatant was transferred to a fresh tube then phenol/chloroform 
extracted followed by a chloroform extraction. The DNA was precipitated by the 
addition of 1 volume of isopropanol for 30 minutes at room temperature or overnight at 
-20°C. The DNA was pelleted by microfuging for 15 minutes, washed with 80%v/v 
ethanol, dried, then redissolved in 200-500.tl TE. 
7.6.2.3 Use of DNA Preparation Kits for Plasmid Preparation 
The advent of kit technologies allows DNA to be readily prepared from a variety of 
sources. Kits from Qiagen and Promega (Wizard) were used to prepare high purity 
plasmid DNA. Both systems began with an alkaline lysis procedure as described above 
then utilised the manufacturer's proprietary matrix systems to preferentially bind DNA. 
Impurities were removed with supplied wash buffers and the DNA eluted with a low 
salt (TE) solution or water. 
7.6.2.4 Preparation of Single-Stranded DNA 
The pBluescript plasmids contain the origin of replication for the fi filamentous 
bacteriophage allowing production of single-stranded DNA for sequencing purposes 
when the plasmid-containing bacterium is infected with a suitable helper phage. The 
plasmid must be contained in a host suitable for helper phage infection, in this case the 
strain used was XL1-Blue and the helper phage used was VCSM13. 
188 
A 10-20m1 culture was inoculated from an overnight culture of the strain carrying the 
desired plasmid and then incubated for 30 minutes with vigorous shaking at 37°C. The 
culture was then infected by the addition of VCSM13 helper phage at a ratio of 10-20 
phage particles per cell. Incubation was continued for a further 6 to 8 hours with 
vigorous shaking. The bacterial cells were separated by centrifugation at 12 000rpm 
for 10 minutes, - the phage particles remained in the supernatant. Phage particles were 
precipitated by the addition of 0.25 volume of 20% PEG/2.5M NH 4C1, mixed and 
incubated on ice for 30 minutes and then collected by  centrifugation at 12 000rpm for 
15 minutes. The phage particles were resuspended in 400 jii TE buffer then the protein 
coat was stripped from the DNA by the addition of 400j11 of chloroform:isoamyl 
alcohol (49:1) with vortexing for 1 minute followed by centrifugation at 12000rpm for 
5 minutes. The upper phase was transferred to a fresh tube and extracted with 400pi of 
phenol/chloroform with vortexing for 1 minute and centrifuging for 5 minutes. This 
step was repeated one or two times more until no material was visible at the interface. 
The upper aqueous phase was transferred to a fresh tube and extracted with 400p1 of 
chloroform as above. The aqueous phase was transferred to a fresh tube and 
precipitated by the addition of 0.5 volume of 7.5M ammonium acetate and 2 volumes 
of ethanol and incubated at -20°C for at least 30 minutes. The single-stranded DNA 
was pelleted by centrifuging for 20 minutes in a microfuge, then rinsed with 80%v/v 
ethanol. The single-stranded DNA was redissolved in 20-50111 of TE buffer, and 
quantified by estimation from agarose gel electrophoresis. 
7.6.2.5 Preparation of Bacteriophage lambda DNA 
An inoculum of 100i1 of 1010  pfu/ml of bacteriophage was added to 2m1 of late log 
phase of the appropriate E coli strain grown in L-broth supplemented with 10mM 
MgSO4 and 0.2%w/v maltose. The infected bacterial culture was then added to 20m1 
LB-broth also containing 10mM MgSO 4 and 0.2%w/v maltose. Incubation was 
carried out at 37°C with vigorous shaking for 5 to 7 hours whereupon lysis of the 
bacteria was observed. The bacteria were completely lysed by the addition of 300j.il of 
chloroform with shaking continued for a further 10 minutes. The cell debris was 
removed by centrifugation for 10 minutes at 7000rpm (Sorvall RC-5B, SS34 rotor). 
Solutions of DNase and RNase, 20111 of 20mg/mi and 50111 of 10mg/mi respectively, 
were added to the clarified supernatant with incubation at 37°C for 1 hour to digest the 
bacterial nucleic acids. 
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Next, 4m1 of TES buffer (2.5%w/v SDS, 250mM Tris-HC1 pH 7.5, 25mM EDTA) 
was added and the mixture was incubated at 70°C for 30 minutes then allowed to cool 
to room temperature for 10 minutes. This step was followed by the addition of 5m1 of 
4.8M K-acetate (pH 4.8), mixed, then incubated on ice for 15 minutes. The 
potassium-SDS precipitate was removed by centrifugation for 15 minutes at 12 
000rpm (Sorvall RC-5B). Isopropanol at 0.7 volumes was added to the supernatant 
with incubation at room temperature for 10 minutes. The phage particles were 
collected by centrifugation at 15 000rpm for 30 minutes. The supernatant was 
decanted off and the pellet was dried then dissolved in 500tl of TE. This solution was 
then extracted twice with phenol/chloroform and once with chloroform followed by 
precipitation with 0.7 volumes of isopropanol. The precipitate was washed with 
70%v/v ethanol, dried and redissolved in lOOpi TE. 
7.7 DNA Sequencing 
DNA was sequenced by two methods. Initially manual sequencing was performed 
until a departmental automated sequencer became available, whereupon template DNA 
was prepared and supplied to the sequencing facility. All sequencing was carried out 
using the cloning vectors pBluescript (Stratagene) or pGEM5 (Promega Corp). The 
universal forward and reverse primers were used for all sequencing reactions. 
7.7.1 Manual Sequencing 
The dideoxy chain termination method of Sanger et al (1977) was used in the form of a 
Sequenase' version 2.0 kit (United States Biochemical Corporation) or a TaqTrack kit 
(Promega). Double stranded DNA was sequenced as described in the kit support 
manual, which labelled the sequenced DNA with a 35S dATP. The sequencing 
reactions were run on a 6% polyacrylamide/7Murea gel in TBE buffer. Gels were 
electrophoresed at a constant power setting of 40W for 40cm long gels or 65W for 
60cm gels. The gel was fixed in a solution of 10%v/v methanoll10%v/v acetic acid for 
30 minutes. The gel was transferred onto Whatman 3MM paper and dried under 
vacuum for at least 1 hour at 85°C. The dried gel was exposed to X-ray film (GRI) at 
4°C for 1-3 days depending on the amount of radioactive signal present. 
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7.7.2 Automated Sequencing 
The Applied Biosystems 373A sequencer also uses the dideoxy chain termination 
method of Sanger et al (1977). However, DNA bands are detected by fluorescent 
dyes which are either incorporated in the primers or into the dideoxy nucleotides. 
Templates were supplied for sequencing initially on a 373A sequencer then for a 377A 
machine with results provided in the form of a computer file. - 
7.7.2.1 Dye-primer Sequencing 
A primer based on the universal M13 -20 sequence was synthesised by Oswel Ltd 
with fluorescent dyes incorporated at the 5' terminus of the primer. Nucleotide and 
dideoxynucleotide stock solutions were prepared as shown in Tables 7.4 and 7.5 
using Pharmacia chemicals. 
Table 7.4 Nucleotide Mixes for Dye-Primer Sequencing (volumes in p1) 
dNTPsat 
5mM 
A C G T 
dATP 10 40 80 80 
dCTP 40 10 80 80 
dGTP 40 40 20 80 
dTTP 40 40 80 20 
water 270 270 540 540 
Total 400 400 800 800 
Table 7.5 Dideoxynucleotide Mixes for Dye-Primer Sequencing (volumes in p1) 
ddNTP (5mM) volume water Total 
ddATP 240 160 400 
ddCTP 120 280 400 
ddGTP 40 260 760 
ddTTP 400 400 800 
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The dNTP and ddNTP stocks were used at a ratio of 1:1 although it should be noted 
that ratios of dNTPs to ddNTPs can be varied to suit different templates as follows 
1.5:1, 1:1.5, 1:2, 2:1, 3:1. CSB buffer is 400mM Tris-HC1 pH 8.9, 100mM 
(NH4) 2SO4, 25mM MgC12 . 
A master mix was prepared for each base as follows: 
For A and C 
lj.tl 	5 x CSB buffer 	 x 	No of templates 
1.tl dNTP/ddNTP x - No of templates 
ljtl 	dye-primer at 3.2pmollml 	x 	No of templates 
1 jii Taq polymerase mix 	x No of templates 
After thermal cycling all four individual reactions for a particular template were 
transferred to a 0.5m1 microfuge tube containing 80.tl 95%v/v ethanol and 1.5111 Na-
acetate pH 5.2. These mixes were incubated on ice for at least 10 minutes and the 
sequenced DNA then collected by centrifugation for 15 minutes at 4°C. The ethanol 
phase was removed by pipettor and the pellet washed with 80%v/v ethanol, then dried. 
The dried pellet was supplied to the automated sequencer operator for loading. Prior 
to loading the pellet was dissolved in 5.11 of formamide/50mM EDTA and heated to 
90°C for 2 minutes followed by immediate plunging into ice. 
7.7.2.2 Cycle Sequencing 
To determine DNA sequence with a gene specific or non dye-labelled primer, the 
Perkin-Elmer PrismTm Ready reaction DyeDeoxy Tm Terminator system was used. This 
system incorporates the fluorescent dyes read by the automated sequencer into the 
dyedeoxy terminators. Double stranded templates were used in a reaction which 
consisted of 9.5p1 terminator mix, 1tl of primer at 3.2pmol/.tl, approximately 0.5ig 
of template DNA in a total volume of 20111. The reaction mixture was overlaid with 
mineral oil and cycle sequencing was performed using the following conditions: 
96°C 	30 seconds 
50°C 15 seconds 
60°C 	4 minutes 
25 cycles 
Unincorporated dye-terminators were removed by phenol/chloroform extraction as 
follows. The sequencing reaction volume was increased to 100111 by the addition of 
80111 of water and the mineral oil overlay was removed by extracting with 100111 
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chloroform. 	The aqueous phase was extracted twice with 100 p.1 
phenol:water:chloroform at a ratio of 68:18:14 then precipitated by the addition of 1 5pJ 
Na-acetate pH 5.2 and 300p.l of 95%v/v ethanol. This mix was centrifuged for 15 
minutes, the ethanol phase removed, then washed with 70%v/v ethanol and dried. 
The reaction was then supplied to the automated sequencer operator as before. 
Further improvements in automated sequencing technology has resulted in a modified 
dye-terminator method. A sequencing reaction mix of 8p.l terminator mix, 1p.l of 
primer at 3.2pmoIJp.1 and template at 250-500ng for double stranded plasmid or 30-
90ng for PCR products was made to 20p.1 final volume and cycle sequenced as before. 
The sequenced DNA was recovered by adding the reaction mix to 2p1 of Na-acetate 
pH 5.2 and 50p.1 ethanol followed by incubation on ice for at least 10 minutes. The 
DNA was collected by centrifugation for 20 minutes and the pellet washed with 250p.l 
70%v/v ethanol, dried, then supplied to the sequencer operator. 
7.7.3 Sequence Analysis 
Sequence analysis was carried out using University of Wisconsin Computer Genetics 
Group (GCG) software (Devereux et al, 1984) using VMS VAX and Unix operating 
systems. Sequence editing was performed using the SEQED program, and sequence 
alignment was performed using the GELSTART set of programs. Manual sequences 
were input by hand while sequences generated by the automated sequencer were edited 
with GeneJockey II (BioSoft) or Factura (Applied Biosystems Inc) software before 
being transferred to GCG readable files. 
7.8 The Polymerase Chain Reaction 
Polymerase Chain Reactions (PCR) were carried out using a Hybaid thermal cycler. 
Details of cycles used are given in the appropriate Chapters. The standard reaction 
volume was SOp.l in sterile 0.5m1 tubes with 30-50p.l of mineral oil added to prevent 
evaporation. Pharmacia deoxynucleotide triphosphates (dNTPs) were used for all 
reactions. Actual concentrations of dNTPs and primers are given in the appropriate 
Chapter. The standard PCR buffer used was 50mM KC1, 20mM Tris-HC1 pH 8.3, 
2mM MgCl2  and 1mg/mi gelatin. 
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7.9 Oligonucleotides 
Oligonucleotides were obtained from Oswel or Perkin Elmer and were supplied 
dissolved in —imi of sterile distilled water or —imi 20% acetonitrile in water 
respectively. Synthesis scales were either 40nmol or 200nmol using cyanoethyl 
phosphoramidite chemistry (Gait, 1984). 
7.10 RNA Preparation 
Total RNA was prepared using one of two methods; earlier preparations were done 
with the RNeasy system from Qiagen while later preparations were made using the 
Trizol solution from BRL. Ovary and testis RNA was prepared from gonadal tissue 
dissected from etherised adult flies. During the dissection procedure, the tissue was 
collected in a microfuge tube held in dry ice. When sufficient tissue had been collected 
the lysis buffer (Qiagen) or Trizol solution was added as described in the 
manufacturer's protocol and the tissue homogenised with a Kontab hand-held 
homogeniser. The RNeasy procedure utilised a silica-gel based microfuge column to 
bind the RNA with wash steps to remove impurities. The RNA was eluted from the 
column in 2 lots of 50j.il using DEPC treated water supplied with the kit and heated to 
65°C. 
The Trizol system, a solution of phenol and guanidium isothiocyanate, is based on the 
method of Chomczynski and Sacchi (1987). Tissue, up to 100mg, was homogenised 
in 0.5m1 Trizol solution with a further 0.5m1 of Trizol then added. The homogenate 
was incubated at room temperature for 5 minutes then 200p.l of chloroform was added, 
the solution shaken and incubated at room temp for 3 minutes whereupon the aqueous 
and organic phases were separated by centrifugation at 12000g at 4°C. The aqueous 
phase was removed and the RNA was precipitated by the addition of 0.7 volumes of 
isopropanol at room temperature for 10 minutes followed by centrifugation at 12 000g 
for 15 minutes at 4°C. The supernatant was removed and the RNA pellet washed with 
imi of 70%v/v ethanol with centrifugation at 7500g for 5 minutes. The ethanol wash 
was removed and the pellet air dried then dissolved in DEPC sterile water. 
Yield and quality were estimated by standard TBE/agarose gel electrophoresis although 
prior to electrophoresis the gel apparatus was soaked in a solution of SDSINaOH and 
thoroughly rinsed with distilled water to remove any contaminating RNases. 
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7.11 Hybridisation Techniques 
The following solutions were used during hybridisation procedures: 
SSC: 20x: 	3M NaCl, O.3M tn-sodium citrate 
SSPE 20x 3.6M NaCl, 0.2M sodium phosphate, 0.02M EDTA pH7.7 
Denaturing solution: 1 .5M NaCl, 0.5M NaOH 
Neutralising solution: 1.5M NaCl, 0.5M Tris-HC1 pH 7.2, 0.001M EDTA 
Denhardt's solution: (lOOx): 2%w/v bovine serum albumin, 2%w/v Ficolff, 
2%w/v polyvinylpyrolidone 
Prehybridization Solution: 	5x SSPE, 5x Denhardt's, 0.5%wlv SDS 
7.11.1 Southern Blotting 
The protocol for transferring DNA to Hybond-N and Hybond-N+ membranes 
(Amersham) was that supplied with the membranes, which is outlined below. 
7.11.1.1 Alkali Transfer 
DNA was separated in agarose gels using standard methods previously described. 
After electrophoresis, the gel were soaked in a 0.25M HC1 solution for approximately 
30 minutes to depurinate and improve transfer of large fragments. The gel was rinsed 
with water. Transfer of DNA to the membrane (Hybond-N+ only) was performed 
using O.4M NaOH for at least 3 hours on a capillary blot (Southern, 1975). After 
transfer, the membrane was rinsed in 2xSSC. The membrane was then prehybridised 
at 65°C for a minimum of 1 hour and hybridised with denatured probe. 
7.11.1.2 SSC Transfer 
The gel was electrophoresed and treated with HC1 as above, rinsed in distilled water, 
then soaked in denaturing solution until the running dyes had returned to their original 
colours. The gel was then soaked in 2 changes of neutralising solution for 15 minutes 
each. A capillary blot was set up as above and transfer was carried out with 20xSSC 
to Hybond-N or Hybond-N+. After transfer, the membrane was rinsed in 2xSSC 
then the DNA was fixed by exposure to 254nm and 365nm uv light for 10 minutes. 
Prehybridisation and hybridisation were carried out as above. 
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7.11.2 Northern Blots 
All solutions were prepared with DEPC water. RNA was separated on 0.7%w/v to 
1 .0%w/v denaturing agarose gels in a MOPS buffering system. Agarose was 
dissolved in lOmi 1OxMOPS and 73m1 of water and cooled to about 55°C, then 17m1 
of 37%v/v formaldehyde was added, the solution mixed, and poured immediately into 
a gel tray. Gels were run in a 1xMOPS buffer. = 
RNA samples were incubated at 65°C for 5 minutes in the following buffering system: 
RNA 5tl, formamide 12.5jtl, 1OxMOPS 2.5p1, formaldehyde 4j.il, then chilled 
immediately on ice. Prior to loading, 2.5j.tl loading solution (50%v/v glycerol, 
0.1mg/mi bromophenol blue) was added. 
After electrophoresis the RNA was transferred to Hybond-N or Hybond-N+ using the 
SSC transfer protocol. 
7.11.3 Colony and Plaque Lifts 
Bacteriophage were plated as described in section 7.2.5 whereas recombinant plasmids 
were screened by patch plating colonies onto agar plates. The DNA was transferred to 
the Hybond-N membrane by overlaying the membrane on to the agar surface for a 
minimum of 1 minute as described in the Amersham protocol. The membranes were 
placed plaque/colony side up for 7 minutes in a dish of denaturing solution. The 
membranes were transferred in a dish of neutralising solution for 3 minutes followed 
by a second dish of neutralising solution for a further 3 minutes, then rinsed in a dish 
of 2xSSC. The DNA was fixed by exposing to uv light for 10 minutes as for 
Southern blots. The membranes were then ready for prehybridisation and 
hybridisation. 
7.11.4 Prehybridisation, Hybridisation and Washing 
Prehybridisation was carried out using the Amersham protocol. Membranes were 
prehybridised at 60°C for 1 hour (42°C for 4 hours for Northerns) in 25m1 (50m1 for 
larger membranes) of prehybridising solution containing 1mg/mi of non-specific 
sonicated salmon sperm DNA (Sigma) prepared as described in Sambrook et al 
(1989). The probe, prepared as described in section 7.5.5.2, was denatured in a 
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heated block at 110°C for 5 minutes, then plunged into ice. Hybridisation was carried 
out by adding probe directly to the prehybridisation solution. If a hybridisation 
solution was being reused, the prehybridisation solution was removed and stored and 
the probe solution added. Hybridisation was carried out at 65°C for at least 12 hours 
(42°C for for Northerns). 
A wash procedure described in the Amersham protocol was used for all 
hybridisations. The probe solution was carefully removed. Approximately lOOml of - 
2xSSCI0.l% SDS was added and gently shaken for 10 minutes at room temperature. 
A second, identical wash was carried out. Approximately 1 00m of 1xSSC/0.1% SDS 
was added with gentle shaking and incubation at 65°C for 15 minutes. Membranes 
were then wrapped in Saranwrap and exposed to X-ray film (GRI) at 70°C in 
cassettes containing one or two intensifying screens for times varying from a few 
hours to several days. 
7.11.5 Stripping of Membranes 
To remove a probe from a membrane to allow use of a fresh probe, the membrane was 
boiled in a solution of 0.1 %w/v SDS for 5 minutes. Membranes were checked for 
absence of probe by exposing to X-ray film, as described above, overnight. 
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7.12 SDS-PAGE Electrophoresis of Proteins 
Proteins were analysed by discontinuous SDS polyaciylamide gel electrophoresis 
(SDS PAGE) as described in Sambrook et a! (1989) using an Atto system. Gels of 
12cm x 12cm x 1mm thick were prepared in the casting apparatus at final acrylamide 
concentrations ranging from 7.5% to 12.5%. Once poured, the separating gel was 
overlaid with a buffer saturated butanol solution to allow an even interface on setting. 
Stacking gels were at a final acrylamide concentration of 4%. 
Gels were run at a constant 100-150V for 4-5 hours or overnight at 30-60V. Once 
run, the glass plates were carefully separated, the stacking gel removed, and the 
separating gel transferred to a staining box. Gels were initially fixed in a solution of 
12%w/v trichioroacetic acid for 1 hour, then prestained with lOOmI of a 1:5 dilution of 
ProBlue (Integrated Separation Systems) solution A. Staining was carried out with the 
ProBlue solution (20m1 methanol, 16m1 Solution A, 64m1 water, 1.6m1 Solution B) 
for a minimum of 4 hours but typically overnight. Gels were destained with a 10% 
v/v methanol solution. When sufficiently destained, gels were photographed on a light 
box using 35mm Ilford PanF ISO 18° negative film through a red filter, then dried 
between 2 sheets of BioRad cellophane prewetted with distilled water at 75°C on a 
Hoefer gel-dryer for 2-3 hours. 
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Table 7.6 Protein Molecular Weight Markers 
Protein 	 BioRad 	Sigma 	Sigma 
Prestained* Prestained Wide range 
Rabbit muscle myosin 205 
-galactosidase (E coli) 123 116 




Bovine serum albumin 82 66 




Ovalbumen (chicken) 48.3 50 45 




Triose phosphate kinase (rabbit) 34 
Carbonic anhydrase (bovine) 33.4 29 
trypsinogen 24 
Trypsin inhibitor (soybean) 28.3 20 
Lyoszyme 19.4 
Lactalbumin (milk) 14.2 
Aprotinin (bovine) 6.5 
* These molecular weights vary depending on batch 
7.13 Western Blotting 
7.12.1 Transfer from SDS-PAGE 
Proteins were transferred from SDS-PAGE gels to Hybond-C (Amersham) with a 
BioRad trans-blot-cell apparatus. Transfer buffer was prepared as follows: Tris base 
3g11, gilycine 14.4g11, SDS lgfl, methanol 200m1/1 with about 31 required for the 
apparatus. Proteins were transferred at a constant 60V for 4 hours or at a constant 
IRZ 
l5mA overnight. After transfer, the protein could be visualised on the membrane by 
staining with Ponceau-S (recipe) 
7.13.2 Immunodetection. 
The membrane was blocked with 3%w/v skim milk powder in Tris-buffered saline 
(TBS: 10mM Tris-HC1 pH 8.0, 100mM NaCl, 0.05%v/v Tween-20) for at least one 
hour at room temperature. Primary antibody, at an appropriate dilution, in TBS was 
added to the membrane with gentle agitation and incubation overnight at room 
temperature. Na-azide at a final concentration of 0.01 %w/v was used to prevent 
microbial contamination. 
Excess primary antibody was removed by successive washes with lBS at 30 minute 
intervals. At least 5 washes were used to ensure all Na-azide was removed as this 
chemical inhibits the HRP detection system. The secondary antibody was then added 
(typically HRP-conjugated anti-rabbit IgG) in TBS at a dilution recommended by the 
supplier, normally 1:500 to 1:1000. Incubation was for a minimum of one hour at 
room temperature. 
Early Western blot experiments used chloro-napthol detection; four 30mg 1-chloro-4-
napthol (Sigma) tablets were dissolved in 20m1 of methanol then added to lOOml TBS 
followed by lOOj.tl of 30%w/v H 202 . This solution was added to the membrane and 
allowed to incubate for approximately 30 minutes at room temperature. The membrane 
was rinsed several times in TBS then photographed, as the signal tended to fade 
rapidly. Later Western blots used the DAB detection system, a Sigma Chemical Co kit 
which supplied DAB and peroxidase as tablets sufficient to prepare lml of solution. 
Several sets of tablets were used for larger membranes with the solution diluted about 
1:5 with PBS to ensure even coverage. 
7.14 Purification of Inclusion Bodies 
The method described by Harlow and Lane (1988) was used for the purification of 
inclusion bodies from E coli. Cells from a 50m1 culture expressing the recombinant 
protein were collected by centrifugation at 5000rpm for 5 minutes (Sorvall RC-5B, 
SS-34 rotor) with the pellet resuspended in 5m1 of buffer lB (100mM NaCl, 1mM 
EDTA, 50mM Tris-HC1 pH8.0). Lysozyme was added to give a final concentration of 
1mg/mi with the cell suspension incubated at room temperature for 20 minutes. The 
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cell suspension was centrifuged for 5 minutes at 5000g (6500 rpm SS-34) with the 
supernatant discarded (a sample was kept for SDS-PAGE analysis). The pellet was 
suspended in 5m1 of buffer 1132 (buffer lB plus 0.1 %w/v Na-deoxycholote), then 
incubated on ice for 10 minutes with occasional mixing. The solution was adjusted to 
8mM MgC12 and 10ig/ml DNaseI, then incubated at 4°C until a noticeable reduction in 
the viscosity of the solution occurs. The inclusion bodies were collected by 
centrifugation at no more than 10 000g (-9200rpm SS34) for 10 minutes then washed 
by re-suspension in buffer 1B3 (buffer LB plus 0.1 %v/v NP-40) followed by 
collection by centrifugation. Further washes were carried out with buffer lB. 
7.15 in situ Hybridisation to Polytene Chromosomes 
7.15.1 Preparation of Chromosomes 
Larvae at the 3rd instar stage were grown on cornmeal food supplemented with dried 
yeast. The larvae were collected from the sides of vials or bottles with a moist 
modeller's paintbrush then the salivary glands were dissected in Ringer's solution 
under the dissecting microscope. The salivary glands were transferred to a drop of 
1:2:3 fixative (1 part lactic acid, 2 parts water, 3 parts acetic acid) on a clean 
microscope slide, then a clean siliconised coverslip was carefully placed on top. The 
salivary gland cells were disrupted by tapping the coverslip with the back end of the 
paintbrush in a circular motion and spread by gently streaking across the coverslip. 
An edge of the coverslip should be held during tapping and streaking to prevent it 
sliding and damaging the chromosomes. The slide was then sandwiched between 
layers of blotting paper and the chromosomes squashed by applying considerable 
thumb pressure. The chromosomes were examined for quality at 250x or 400x 
magnification using phase contrast. 
The slides were marked to show which side the chromosomes were on. Coverslips 
were removed by dipping the slide into liquid N 2 then quickly flicking the coverslip 
from the slide with a scalpel blade. The chromosomes were dehydrated in 70%v/v 




Prior to denaturation the chromosomes were treated in 2xSSC at 65°C for 30 minutes 
followed by treatment in 2xSSC at room temperature for 10 minutes. Chromosomes 
were denatured by treating in 70mM freshly prepared NaOH for 2-3 minutes followed 
by rinsing in 2xSSC. Dehydration through an ethanol series as described above was 
then carried out. 
7.15.3 Hybridisation 
A digoxigenin labelled DNA probe, prepared as described in section 7.5.5.3, was 
denatured by boiling in a water bath then plunging into ice. A 20p1 volume of probe 
was added to each slide and a coverslip carefully placed over each slide. The slides 
were then placed into a box on a bed of pasteur pipettes which in turn rested on a wad 
of damp paper tissue. The box was sealed and hybridisation was allowed to take place 
overnight at either 42°C or 55°C. The coverslips were removed by placing the slides in 
2xSSC and allowing them to float off. A 1 hour wash in 2xSSC at the equivalent 
hybridisation temperature was then performed. 
7.15.4 Washing and Detection 
After 2xSSC treatment, the slides were given 2 washes in PBS for 5 minutes each, 
followed by 1 wash in PBS-TX (PBS + 0.1%v/v Triton X-100) for 5 minutes 
followed by a further wash in PBS. 
A 1:80 dilution of anti-digoxigenin-HRP conjugated antibody was prepared in PBS 
and 50j.tl applied to each slide with a coverslip added. The slides were incubated in the 
moist box at room temperature for 1-2 hours. 
A series of PBS washes as above was carried out to remove excess antibody. Signal 
was detected using a DAB system (Sigma Chemical Co) - a DAB pellet and a 
peroxide/urea pellet were dissolved in lml of water with about lOOj.tl applied to each 
slide and allowed to incubate at room temperature for 10-20 minutes in the moist box. 
Excess DAB solution was washed away by rinsing in PBS, then the slides were 
examined under phase contrast for appearance of signal (dark brown - black bands). 
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A giemsa (BDH) counterstain was used to allow visualisation of the chromosome 
bands. 
7.16 Immunohistochemical Detection of Protein in situ 
The method presented here is an amalgam of methods described by Siegel et al (1993) 
and Hedge and Stephensen (1993). 
Ovaries were dissected under the dissecting microscope in Ringer's solution and 
transferred immediately to a microfuge tube containing paraformaldehyde fixative. 
The fixative was prepared by dissolving 4%w/v paraformaldehyde in PBS at 65°C 
then adding 5% /v DMSO. The ovaries were fixed for 1 hour on a rotating wheel at 
room temperature. The fixative was carefully removed and imi of PBT (PBS + 
0.1 %vlv Triton X- 100) was added. Incubation was continued for a further 5 minutes 
then the ovaries were extracted with PBS + 1%v/v Triton X-100 for a minimum of 2 
hours (or overnight) on a rotating wheel. The ovaries were then washed with 3 
changes of PBT for 5 minutes per wash. Blocking was accomplished by incubation 
with 10%v/v goat serum in PBT for 1 hour on the rotating wheel. 
Antibody in PBT at the appropriate dilution was added and incubated overnight at 
room temperature on the rotating wheel. The antibody solution was removed and 
residual antibody was washed away with 3 changes of PBT with 30 minutes 
incubation per change. The secondary antibody was pre-absorbed with fixed ovaries 
treated in the same manner as above apart from incubation with primary antibodies. 
The secondary antibody was then applied to the ovaries and incubated from 2 hours to 
overnight. Experiments using fluorescent secondary antibody were wrapped in foil to 
prevent quenching by natural light. Excess secondary antibody was removed with 3 
PBT washes at 30 minutes each as before. 
Detection was then carried out. Ovaries treated with fluorescent secondary antibody 
were mounted on slides in a solution of propyl gallate in glycerol and examined under 
the fluorescent microscope. Those ovaries treated with a peroxidase secondary 
antibody were placed in a cavity slide to allow monitoring of the reaction and detected 
with a DAB solution (Sigma Chemical Co). The DAB reaction was stopped by rinsing 
with several changes of PBT. 
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7.17 Detection of Transcript by in situ Hybridisation to 
Whole Mount Ovaries 
A method modified from that of Tautz And Pfiefle (1989) was used. All incubations 
were carried out on a rotating wheel unless otherwise stated. Ovaries were dissected 
from adult female flies which had been tipped to fresh food supplemented with dried 
yeast the day before. Dissected tissue was placed in a microfuge tube and maintained - 
at a low temperature in dry ice. When sufficient tissue was collected it was fixed in 
imi of a freshly prepared 4%wlv paraformaldehyde in PBS for one hour at room 
temperature on a rotating wheel. The fixative was removed and the ovaries washed in 
3 changes of PBT (PBS +Tween-20) with 5 minute incubations between changes. 
Proteinase K was added from a 20mg/mi stock to give a final concentration of 
50mg/mi with incubation for 30 minutes at 37°C. The ovaries were then washed in 2 
changes of PBT followed by a 20 minute treatment in fixative followed by 3 further 
washes in PBT with 10 minute intervals. 
To prepare the ovaries for hybridisation, they were washed in a 1:1 solution of 
PBT:HS for 20 minutes (HS: 50%v/v formamide, 5xSSC, 50mg/mi heparin, 0.1%v/v 
Tween-20, lOOp.g/ml sonicated salmon sperm DNA) followed by incubation in 1xHS 
for 60 minutes. Prehybridisation was carried out in 1xHS for a minumum of 40 
minutes at 45°C in a heating block. Hybridisation was carried out at 45°C overnight by 
replacing the HS with probe labelled with digoxigenin as described in section 7.5.5.3. 
The probe was removed by 20 minute washes, first in 1xHS, then by HS:PBT washes 
at ratios of 4:1, 3:2, 2:3, 1:4 and finally in 2 washes of PBT. Signal was detected by 
incubation at room temperature with anti-digoxigenin antibody (Boehringer 
Mannheim) at a dilution of 1:5000 for I hour. The antibody solution was preabsorbed 
with ovaries treated in an identical manner as above but without being exposed to a 
probe. Excess antibody was removed with 4 washes of PBT at 20 minute intervals 
followed by three 5 minute washes in NMTLT buffer (100mM NaCl, 50mM MgCl 2 , 
100mM Tris-HC1 pH 9.5, 1mM levamisole [freshly prepared], 0.1%v/v Tween-20). 
The ovaries were transferred to a cavity slide and 4.5m1 NBT (0.5g nitro-blue-
tetrazolium salt in lOmi dimethyformamide) and 3.5m1 X-phosphate were added with 
thorough mixing. The signal was developed in the dark for 10 to 30 minutes and the 





Appendix I eDNA Sequence of the didum Gene 
The first 666 nucleotides are uncorrected sequence from 5'RACE and RT-PCR 
experiments to determine the 5' end of the gene. The sequence determined from 
cDNA, genomic DNA and RT-PCR sequencing is shown from nucleotide 700 with the 
predicted protein sequence shown below. Primers used in this work have also been 
shown. Sequence from the cloned cDNA (pBMFiOand NMC7) begins at the =EcoRL= - - 














TGTGACCcGAAAGwtGGTGAAC t tATACTTGATCAGGTTGAAGTgCAGGGGamACCCTGA 
------------------------------------------------------------ 300 
ACACTGGgCTTTCWaCCACTTGaaTATGAACTAGTCCAACTTCACGTCCCCtkTGGgACT 
























------------ > did2 
AGTGAAGAGGTCGAGCTAAAGGCCGATGGCAGCGATCTGCCTCCACTGCGCjTCC3 
------------------------------------------------------------ 759  
TTCACTTTCTCCAGCTCGATTTCCGGCTACCGTCGCTAGACGGAGGTGACGCGTTAGGCC 
Race3 
V K EVE L K AD G SD L PP L RN PA - 
CCATTCTGGTGGGACAGAACGACTTGACCACCCTGTCCTACCTGCATGAGCCGGGGGTGT 
------------------------------------------------------------ 819  
GGTAAGACCACCCTGTCTTGCTGAACTGGTGGGACAGGATGGACGTACTCGGCCCCCACA 








< ---------  
LV A IN P Y A EM PLY G PSI IRA - 
CGTATCGGGGTCATGCTATGGGTGATCTGGAGCCGCACATCTTTGCCCTGGCGGAGGAGG 
------------------------------------------------------------ 999  
GCATAGCCCCAGTACGATACCCACTAGACCTCGGCGTGTAGAAACGGGACCGCCTCCTCC 
-didl2 
Y 	G H A MG DL E PHI F ALA E E A- 
CGTACACAAAACTGGAGCGCGAGAACTGCAACCTGAGCATCATCGTCAGTGGGGAATCGG 
------------------------------------------------------------ 1059  
GCATGTGTTTTGACCTCGCGCTCTTGACGTTGGACTCGTAGTAGCAGTCACCCCTTAGCC 
Y T K L ER EN C N L Sli V S GE S G- - 
207 
GTGCGGGCAAAACGGTGTCCGCCAAATACGCCATGAGGTACTTTGCCGCTGTTGGATT 
------------------------------------------------------------ 1119  
CACGCCCGTTTTGCCACAGGCGGTTTATGCGGTACTCCATGACGGCGACACCTCCM 




E SET Q V ER K V LASS P1 ME A F- 
- 	did8 --------------- - --== 
TCGGAAATGCCAAGACAACCCGGAATGACAACAGTTCCCGCTTTGGGAAATTTACCCC 
------------------------------------------------------------ 1239  
AGCCTTTACGGTTCTGTTGGGCCTTACTGTTGTCAAGGGCGAAACCCTTTTGGTTGG 
G N A K T T RN D N SS R F G K F TN L- - 
TGCTGTTCCGGAACCAGATGGGTGTGATGTTCCTGCAGGGACCCACTATGCACACCTACC 
------------------------------------------------------------ 1299  
ACGACAAGGCCTTGGTCTACCCACACTACAAGGACGTCCCTGGGTGATACGTGTGGATGG 




did6 < ----------------- 




Q L CA AR SKY P EL V L D H Q D K F- 
TCCAGTTTCTGAACATGGGTGGCGCTCCTGAAATTGAACGAGTTTCGGATGCGGAGCAGT 
------------------------------------------------------------ 1479  
AGGTCAAAGACTTGTACCCACCGCGAGGACTTTAACTTGCTCAAAGCCTACGCCTCGTCA 













E G SEE ED SD SC DI F H N DI H L- - 
TGCAGATCACCGCCGATCTACTGCGGGTGAGCGCCGATGATCTGCGCCGGTGGCTTTTGA 
------------------------------------------------------------ 1719  
ACGTCTAGTGGCGGCTAGATGACGCCCACTCGCGGCTACTAGACGCGGCCACCGAJAACT 
Q IT A DL L R VS AD DL R R W L L M- - 
TGCGTAAGATAGAGTCGGTCA1TGAATATGTGCTGATACCGAATAGCATTGAGGCGGCTC 
------------------------------------------------------------ 1779  
ACGCATTCTATCTCAGCCAGTTACTTATACACGACTATGGCTTATCGTCTCCGCCGAG 
R K I ES V NE Y V LIP N S 	E A A Q- 
AGGCGGCTCGAGACGCTCTGGCCAAGCACATCTATGCGAAACTGTTTCAGTATATAGTCG 
------------------------------------------------------------ 1839  
TCCGCCGAGCTCTGCGAGACCGGTTCGTGTAGATACGCTTTGACAAAGTCATATATCAGC 
A A RD ALA K HI YAK L F Q Y IV G- 
GTGTGCTGAACAAGAGCCTCAACAACGGTAGCAAGCAGTGCAGCTTCATTGGCGTCCTCG 
------------------------------------------------------------ 1899  
CACACGACTTGTTCTCGGAGTTGTTGCCATCGTTCGTCACGTCGAAGTAACCGCAGGAGC 
V L N KS L N N G SK Q CS FIG V L D- - 
ATATCTACGGCTTCGAAACGTTCGAGGTGAACTCCTTTGAkCAkTTTTGCATACTATG 
------------------------------------------------------------ 1959  
TATAGATGCCGAAGCTTTGCAAGCTCCACTTGAGGAAACTTGTTAAAACGTATTTGATAC 
I Y G FE T FE V NSF E 	F C IN Y A- - 
did9 -----------------> 
CAAACGAAAAGCTTCAGCAGCAGTTCAACCAGCATGTCTTCAAGCTGGAGCAGGAGGAGT 
------------------------------------------------------------ 2019  
GTTTGCTTTTCGAAGTCGTCGTCAAGTTGGTCGTACAGAAGTTCGACCTCGTCCTCCTCA 
NE K L Q Q Q F N Q H V F K L E 	E E Y- - 
ACCTTAAGGAAGGAATCACCTGGACGATGATTGACTTTTACGACAATCAACCGTGTATCG 
------------------------------------------------------------ 2079  
TGGAATTCCTTCCTTAGTGGACCTGCTACTAACTGAAkTGCTGTTAGTTGGCACATAGC 
L KEG IT W TM ID F Y D N Q P C I D- - 
ATCTAATTGAATCTCGCTTGGGAGTGCTGGACCTGCTCGACGAGGAGTGTCGAATGCCAA 
------------------------------------------------------------ 2139  
TAGATTAACTTAGAGCGAACCCTCACGACCTGGACGAGCTGCTCCTCACAGCTTACGGTT 
LIES R L G V L DL L D E E C 	M P K- 
NQ 
AGGGCTCGGACGAGAGCTGGGCTGGCAAGCTCATCGGAAAGTGCAATAAATTTCCGCATT 
------------------------------------------------------------ 2199  
TCCCGAGCCTGCTCTCGACCCGACCGTTCGAGTAGCCTTTCACGTTATTTAAAGGCGTAA 
G SD ES WAG K L 	G K C N K F P HF - 
TCGAGAAGCCACGCTTTGGCACAACCAGCTTCTTTATCAAACATTTCTCGGACACGGTCG 
------------------------------------------------------------ 2259  
AGCTCTTCGGTGCGAAACCGTGTTGGTCGAAGAAATAGTTTGTAAAGAGCCTGTGCCAGC 
E K PR F G T T SF F 1K H F SD TV E- - 
AGTATGACGTGAACGGATTCTTGGAAAGAATCGTGACACAGTCTCCAAGGAGTTGACGC 
------------------------------------------------------------ 2319  
TCATACTGCACTTGCCTAAGAACCTTTTCTTAGCACTGTGTCAGAGGTTCCTCAACTGCG 
didlO < ----------------- 




V L SE S 	MS LA K Q V MT LEE ID- 
did4 -----------------> 
ATACTCTGTGCGTGGATTCCGCTAAATCCTCCACCTTGGGCGGCCGCGTCGTGATCAGTG 
------------------------------------------------------------ 2439  
TATGAGACACGCACCTAAGGCGATTTAGGAGGTGGAACCCGCCGGCGCAGCACTAGTCAC 
T L C V D S A K S ST L G G R V VISA - 
CTGGCCGCAAACAGGTGGTGCCATCCAAGCAGCATAGAAAAACGGTGGGATCGCAGTTCC 
------------------------------------------------------------ 2499  
GACCGGCGTTTGTCCACCACGGTAGGTTCGTCGTATCTTTTTGCCACCCTAGCGTCAAGG 
G R K Q VV P S K Q HR K TV G S 	F Q- - 
AGGAGAGTCTGGCGTCGCTGATATCTACGTTACATGCCACAACTCCGCACTATGTGCGCT 
------------------------------------------------------------ 2559  
TCCTCTCAGACCGCAGCGACTATAGATGCAATGTACGGTGTTGAGGCGTGATACACGCGA 













did3 < ------------------ 
W L Y PD F Y MR Y Q L L 	Y 	S K L D- - 
ACAkACGACATGAGGCTGTCGTGCCGGAACATTGTGATGAJGTGGATCCAAGACGAAG 
------------------------------------------------------------ 2799  
TGTTTTTGCTGTACTCCGACAGCACGGCCTTGTAACACTACTTCACCTAGGTTCTGCTTC 
K N D M R L S C R N I V M KW I Q D E D- - 
ATAAGTACCGATTTGGCAACACGCAGATTTTCTTCCGCGCCGGCCAAGTGGCCTTCCTTG 
------------------------------------------------------------ 2859  
TATTCATGGCTAAACCGTTGTGCGTCTAAAAGAAGGCGCGGCCGGTTCACCGGAAGGAAC 









FVYRR Q VLRI Q KV IN G I Q K H- - 
ATGCGCGCGGATATCTTGCTCGCGAGCGTACTCAGAAAATGCGCGAAGCTCGTGCGGGAT 
------------------------------------------------------------ 3039  
TACGCGCGCCTATAGAACGAGCGCTCGCATGAGTCTTTTACGCGCTTCGAGCACGCCCTA 












didi < -----------------  
MR D H Y 	A V Q I Q R F V R GALA R- - 
211 
GGCGAGCTTACCAAAAGCGGCGTCGCAACATCATCATTTGTCAAGCGGCGATTCGGAGAT 
------------------------------------------------------------ 3279  
CCGCTCGAATGGTTTTCGCCGCAGCGTTGTAGTAGTAAACAGTTCGCCGCTAAGCCTCTA 
RAY Q KR R RN III C Q A Al R R F - 
TCTTGGCCCGTCGTAAGTTTAAACGCATGAAGGCCGAGGCCAAGACCATCTCGCACATGG 
------------------------------------------------------------ 3339  
AGAACCGGGCAGCATTCAAATTTGCGTACTTCCGGCTCCGGTTCTGGTAGAGCGTGTACC 
L AR R K F KR M K A E A K TI S H ME - - 
AAAACAAATACATGGGGCTGGAAAACAAGATTATTTCCATGCAGCAGCGGATCGATGAGC 
------------------------------------------------------------ 3399  
TTTTGTTTATGTACCCCGACCTTTTGTTCTAATAAAGGTACGTCGTCGCCTAGCTACTCG 
N KY MG LEN K II SM Q Q RIDE L- - 
TGAATCGCGACAACAGTAATCTGAAGCACAAGACCAGCGAAATCAGTGTATTGAAAATGA 
------------------------------------------------------------ 3459  
ACTTAGCGCTGTTGTCATTAGACTTCGTGTTCTGGTCGCTTTAGTCACATAACTTTTACT 
N RD N S N L K H K T SE I S V L KM K- - 
EcoRI 
AGCTTGAGCTGAAGAAGACCCTGGAGGCTGAATTCAAAAATGTCAAGGCCGCCTGCCAGG 
------------------------------------------------------------ 3519  
TCGAACTCGACTTCTTCTGGGACCTCCGACTTAAGTTTTTACAGTTCCGGCGGACGGTCC 
L ELK K T LEA E F K N V K A AC Q D- - 
ACAAGGACAAGCTGATCGAAGCACTTAACAAGCAGTTGGAGGCGGAGCGAGACGAAAAAA 
------------------------------------------------------------ 3579  
TGTTCCTGTTCGACTAGCTTCGTGAATTGTTCGTCAACCTCCGCCTCGCTCTGCTTTTTT 








Race2 < ---------------------- 
R Q E N E E L R R Q I D E I I D M A K N- 
ACGCAGAAGTCAACCAGCGTAACCAGGAGGACCGAATGCTAGCCGAGATTGATAACAGGG 
------------------------------------------------------------ 3759  
TGCGTCTTCAGTTGGTCGCATTGGTCCTCCTGGCTTACGATCGGCTCTAACTATTGTCCC 
-----------------------Racel 





L NE A Y Q R A 1K D K E VIE N EN F - 
TCATGCTGAAGGAAGAGCTCAGTCGATTAACGGCTGGCAGTTTCAGTTTGCACGGCCGCA 
------------------------------------------------------------ 3879  
AGTACGACTTCCTTCTCGAGTCAGCTAATTGCCGACCGTCAAAGTCAAACGTGCCGGCGT 
ML KEEL SR L TAGS F S L HG R K- - 
AGGCTAGCAACGCCTCCAGCCAAAACGAGGACGATGTGGGATACGCCTCCGCCAAGAACA 
------------------------------------------------------------ 3939  
TCCGATCGTTGCGGAGGTCGGTTTTGCTCCTGCTACACCCTATGCGGAGGCGGTTCTTGT 




L DIN R pp DL L SK NY S Y ND S T- - 
CCAGTCTGGTGGTGAAGTTGAGATCCATTCTCGAGGAGGAGAAGCAAAAGCAC?AGGTCT 
------------------------------------------------------------ 4059  
GGTCAGACCACCACTTCAACTCTAGGTAAGAGCTCCTCCTCTTCGTTTTCGTGTTCCAGA 
S L 	V K L R S 	LEE E K Q K H K V L- - 
TGCAGGAGCAGTACATTAAGTTGTCCAGTCGGCATAAGCCCACCGAGGATTCCTTCCGCG 
------------------------------------------------------------ 4119  
ACGTCCTCGTCATGTAATTCAACAGGTCAGCCGTATTCGGGTGGCTCCTAAGGAAGGCGC 
601 < ----------------------- 




SE L EVEN E K L R R R Y D Q L R T 5- 
GCATTAAACACGGTGTTGAGATCAACGAGCTCAATGCACAGCATGCCGCCTTGCAGGAAG 
------------------------------------------------------------ 4239  
CGTAATTTGTGCCACAACTCTAGTTGCTCGAGTTACGTGTCGTACGGCGGAACGTCCTTC 




V R R R RE E CI Q L K A V L L Q Q S Q- - 
213 
AGTCCATGAGATCGCTCGAGCCGGAAAGTCTACAGATGCGTGGCAACGATGTCAACGAAC 
------------------------------------------------------------ 4359  
TCAGGTACTCTAGCGAGCTCGGCCTTTCAGATGTCTACGCACCGTTGCTACAGTTGCTTG 
S 	R S L E P ES L Q MR G N DV NE L- 
TGATGGAAGCCTTCCATTCCCAGAGCTAATTAATCGTCAATTGGAGTCTGAGCTCAAGG 
------------------------------------------------------------ 4419  
ACTACCTTCGGAGGTAAGGGTCTTCGATTAATTAGCAGTTAACCTCAGACTCGAGTTCC 
ME A F H S 	K L IN R Q L ES ELK A - 
CCATCACCGAGGAGCACAACAGTAAGCTCGTGGAGATGACACAGGAGATCGAGAGATTGA 
------------------------------------------------------------ 4479  
GGTAGTGGCTCCTCGTGTTGTCATTCGAGCACCTCTACTGTGTCCTCTAGCTCTCTAACT 
IT E E H N SK L 	EM T Q El ER L N - 
ACAATGAGAAGGATGAGCTGCAAAAAGTAATGTTCGAGAGCATCGACGAGTTCGAAGATT 
------------------------------------------------------------ 4539  
TGTTACTCTTCCTACTCGACGTTTTTCATTACAAGCTCTCGTAGCTGCTCAAGCTTCTAA 
NE K DEL Q K V M F ES I D E FEDS - 
CCAATGTGGATACGCTGAGACAGAACGATCGCTATCTGCGACGAGAACTGCAGAAGGCTG 
------------------------------------------------------------ 4599  
GGTTACACCTATGCGACTCTGTCTTGCTAGCGATAGACGCTGCTCTTGACGTCTTCCGAC 
N V D T L R Q N DRY L R RE L Q K A V- - 
TAGCCCAGTTCCTGCTCGTTCAGGAGGAGCTCAAACTGGCAAATGCCAAGCTTIAAGCTT 
------------------------------------------------------------ 4659  
ATCGGGTCAAGGACGAGCAAGTCCTCCTCGAGTTTGACCGTTTACGGTTCGAATTTCGAA 
A Q FL L 	Q EEL K L A N A K L KAY - 
ATCGGCAGGATGGAGGCCAGCTGGAGCACAAGATAGAGGAGGAGATGATTCGCAACAAGT 
------------------------------------------------------------ 4719  
TAGCCGTCCTACCTCCGGTCGACCTCGTGTTCTATCTCCTCCTCTACTAAGCGTTGTTCA 
R Q D G G Q L E H K IEEE MI RN KS - 
CCAACGGAACGTCCGCCGATGTAGGCGCGAATGTGACGAAGCAAAAGTCTCAGAATCCGC 
------------------------------------------------------------ 4779  
GGTTGCCTTGCAGGCGGCTACATCCGCGCTTACACTGCTTCGTTTTCAGAGTCTTAGGCG 
N G T SAD VGA N VT K Q K S 	N P Q- - 
AAGGGCTGATGAAGTTCCACAGCAGCGATCTGGACAAGATCTTGCAACGCCTGCTTAGCG 
------------------------------------------------------------ 4839  
TTCCCGACTACTTCAAGGTGTCGTCGCTAGACCTGTTCTAGAACGTTGCGGACGAATCGC 
1311 <----------------------- 













F VI Q 1K KM HR T PH PIE N R VI - 
TTTGGCTCGTCAATTCCATTACGCTGCTAAATCTTATGAAGCAATACGGCGACGTGGATG 
------------------------------------------------------------ 5079  
AAACCGAGCAGTTAAGGTAATGCGACGATTTAGAATACTTCGTTATGCCGCTGCACCTAC 




B100 < ---------------- 
Y V K F NT E K Q N Q Q Q L K N F N L F- 
TTGAATACCGTCGCGTAATTCTTGATTTATTTGTGAACCTGTACCAGGCGCTGATCATGC 
------------------------------------------------------------ 5199  
AACTTATGGCAGCGCATTAAGAACTAAATAAACACTTGGACATGGTCCGCGACTAGTACG 
E Y 	R VI L DL F V N L Y Q A L 	M Q- - 
AGATCCAGGGTCTGTTGGACCCAAAAATAGTGCCAGCGATTCTCAACAATGATGAGATTC 
------------------------------------------------------------ 5259  
TCTAGGTCCCAGACAACCTGGGTTTTTATCACGGTCGCTAAGAGTTGTTACTACTCTAAG 
I Q G L L D P K IV PAIL N ND El Q- - 
1806 -----------------> 
AGCGTGGGCGGCAGGCGCACGGAATGCGTAGTCGGGCCACGTCGATTGGAGCATCCTCGT 
------------------------------------------------------------ 5319  
TCGCACCCGCCGTCCGCGTGCCTTACGCATCAGCCCGGTGCAGCTAACCTCGTAGGAGCA 
R G R Q A H GM R SR AT S 	GAS S 5- 
CACCGGAGCACGGTGGCGGTCCGGCCTGGAAGCAACTGATCGGGCAGCTGGAGCATTTCT 
------------------------------------------------------------ 5379  
GTGGCCTCGTGCCACCGCCAGGCCGGACCTTCGTTGACTAGCCCGTCGACCTCGTAAAGA 
P E HG G G PAW K Q L 	G Q L E H F Y- - 
215 
ACAAACAGTTTCAGCACTTCGGCTTGGACA.ACTGCTATGCGGAGCAGATATTCCATCC 
------------------------------------------------------------ 5439  
TGTTTGTCAAAGTCGTGAAGCCGAACCTGTTGACGATACGCCTCGTCTATAAGGTAGTTG 
K Q F Q H F G L D N C Y A E 	IF H Q L- - 
TGCTTTACTTCATTTGCGCTGTGGCCCTTAATTGTCTGATGCTTAGGGGCGATATTTGCA 
------------------------------------------------------------ 5499  
ACGAAATGAAGTAAACGCGACACCGGGAATTAACAGACTACGAATCCCCGCTATAAACGT 
L Y F IC A V AL N CL ML R G DI CI - 
TATGGGAGACTGGCATGATAATCCGCTACAATATCGGCTGCATTGAGGATTGGGTGCGCA 
------------------------------------------------------------ 5559  
ATACCCTCTGACCGTACTATTAGGCGATGTTATAGCCGACGTAACTCCTAACCCACGCGT 
926Y 
WET GM II R Y NI G CI ED WV R S- 
GTAAAA.AGATGTCTAACGATGTGCTGACAGCTTTGGCGCCTCTGAATCAGGTCTCCCM.T 
------------------------------------------------------------ 5619  
CATTTTTCTACAGATTGCTACACGACTGTCGAAACCGCGGAGACTTAGTCCAGAGGGTTA 
K K MS N DV L TA LAP L N Q VS Q L- 
TGCTGCAGTCTCGGAAGAGCGAGCAGGATGTTCAGACCATTTGTGATCTGTGTACTTCTC 
------------------------------------------------------------ 5679  
ACGACGTCAGAGCCTTCTCGCTCGTCCTACAAGTCTGGTAAACACTAGACACATGAAGAG 




ST A Q V L K V M KS Y K L D DYES E- - 
AAATAACGAACGTTTTTCTGGAGAAJCTAACCGAGAkCTGAACGCCCGACAAATGCAM 
------------------------------------------------------------ 5799  
TTTATTGCTTGCAAAAAGACCTCTTTGATTGGCTCTTTGACTTGCGGGCTGTTTACGTTT 
IT N V FL E K L T E K L N AR Q M Q K - 
AGAGCAATAGTGACGAATTCACCATAGACCAGAAGTTCATTCAGCCATTTAAGGTTGTCT 
------------------------------------------------------------ 5859  
TCTCGTTATCACTGCTTAAGTGGTATCTGGTCTTCAAGTAkGTCGGTA1TTCCAACAGA 
S 	SD E F TI D Q K F I Q P F K V V F - 
TCAGGTATAGTGACATCAAGCTGGAGGATATTGAACTACCGTCGCATCTTAATCTGGACG 
------------------------------------------------------------ 5919  
AGTCCATATCACTGTAGTTCGACCTCCTATAACTTGATGGCAGCGTAGAATTAGACCTGC 




------------------------------------------------------------ 5979  
TCAAGGAATGTTTCTAAATTTGCAGCGCACGGACGCAGAACGGCCAGCTCTTGAAACGGT 
FL T K I * 
TTTTGGATGACATTACACTGCTTAGTTTTTGTGTATTATACGAGTATAACGATTCTAGAA 

















------------------------------------------------------------ 6339  
TTTGCGTTATTTACGAACCTCAATCTGAGACTGGTATTCTTTAGTAAGGAACGGATTTGG 






------------------------------------------------------------ 6459  
ACAACGGAATTTCTGCACATTTCGGATGTCTACTATCTCATTCTGAGTATCTCGAGTGGC 
ATGATGCATTGCTGTTGCATTCCATCTATTTATGTATTCTCATTTTCTGCGTAGCTTGTA 
------------------------------------------------------------ 6519  
TACTACGTAACGACAACGTAAGGTAGATAAATACATAAGAGTAAAAGACGCATCGAACAT 
ACTCGTTAGTTGGGTTTCTTAGATATGTCGTTAGACTATGCAAGCCTAAACTACGTTGGC 










3'UTR3 1 -2 < ------------- 
GTTAAC . AAAAAAAAAAAAAAAGCTT 
--------------------------  6733 
CAATTG. TTTTTTTTTTTTTTTCGAA 
218 
Appendix II Genomic Sequence of the didum Gene 
Uncorrected genomic DNA sequence of the didum gene beginning at the XbaI site of 
pPl-X7. Introns have been identified in lower case lettering. A polymorphism 

























































































































------------------------------------------------------------  2340 
ataaaaggtatgcgaacagcaagcgagtggcggt tgagggagcc taacgggttgtcgttc 




------------------------------------------------------------  2460 
ggaatttgcttattggtgtttgtaaaattgttaaattaagctgaaccttgtaaacaaaat 
attaaagttactaatttagtccggattcaaatgacaaggctaaatggcccagtaatgctg 
------------------------------------------------------------  2520 
taatttcaatgattaaatcaggcctaagtttactgttccgatttaccgggtcattacgac 
attagaaagaatcaaagttgc ttatagac taacaattcastacc tccgcaaataaataat 
------------------------------------------------------------  2580 
taatctttcttagtttcaacgaatatctgattgttaagtsatggaggcgtttatttatta 
aataataaatgatgataggaatttgtcaaataggtgattcaatatattatcaataaaata 


















----+ ---------+---------+---------+---------+---------+ 3000 
































































































































































































































































---+ ---------+ 8000 
cggagtgaaccttgacgtta 
Appendix III eDNA Sequence of cDNA-34 
DNA sequence of cDNA-34 encoding a putative sodium-dependent inorganic 
phosphate cotransporter. The translated predicted open reading frame is shown from 
nt 439 to nt 2013. Oligonucleotide primers have been marked at their respective 
positions. 
AAGCTTTCTTCAGGAATATCTAGTCTTCATCTCTCGTAACGCGATAACGAAACCCACAGG 
































































Y P1 F G Y lID W TRW E WV Y Y IC - 
230 
GGAATCGTGGGCACTCTCTGGTTCATCGCCTGGCAGTTCCTTGTGTTCGATAGTCCCGCT 
---+---------+---------+---------+---------+ ---------+ 1140 
CCTTAGCACCCGTGAGAGACCAAGTAGCGGACCGTCGGMCACAAGCTATCAGCGA 
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